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ABSTRACT
Supplementation ofhigh levels of vitamin D3 (D3) to cattle has enhanced beef
tenderness. However, high levels of D3 possess a food safety concern. Therefore, the
objective of this thesis was to evaluate feeding strategies that would reduce the amount of
D3 required to increase serum calcium (Ca) to levels where tenderness has been
improved. In experiment 1, 15 steers (452 ±30kg) were fed with 75% barley grain-base
concentrate and 25% barley silage (as fed) and 1.25,2.5 or 5 Mill D3/hd/d for 7 d. Feed
intake was depressed (P<0.05) while total (T) and ionized (1) Ca were increased (P<0.05)
in relationship to the amount ofD3 fed. Feeding 5 MID D3increased TCa and ICa by 2
and 1 mgldl, respectively. Peak values were reached 3-5 d post-supplementation. Serum
Ca levels were similar to those related with meat tenderization. In experiment 2, 15
steers (607 ± 12 kg) were supplemented with 0, 2.5 or 5 Mill D3/hd/d for 7 d. Feed
intake, TCa, and ICa showed similar trends as in experiment 1. Plasma D3and 25(OH)D3
were increased (P<0.05) quadratica~ly and linearly, respectively. Parathyroid hormone
(PTH) was depressed (P<0.05). In experiment 3, 19 steers (522 ± 33 kg) were fed with a
low Ca diet for 10 d prior to supplementation with 0, 1.25, 2.5 or 5 MID D3/hd/d for 7 d.
Blood TCa, ICa, and D3decreased (P<0.05) during the first 2-4 d of the low Ca period.
All variables responded as in experiment 2. Plasma 1,25(OH)2D3 was increased
(P<0.05). Calcium response was no higher. In experiment 4, 20 steers (448 ± 26 kg)
were fed a low Ca for 14 d and then switched to a high Ca diet and anionic salts (NH4CI
and MgS04) at -1500 and -3000 mEq/hd/d for 3 and 7 d, respectively, and fed with 0,
0.6, 1.2 or 2.4 Mill D3/hd/d (10 d). All variables responded as in experiment 3. Similar
ii
total and ionized serum Ca levels were achieved with 30 to 80 % less D3, indicating that
such a feeding strategy may be a successful approach to improving beef tenderness.
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CHAPTER I
INTRODUCTION
Since domestication beef cattle have been a source of highly nutritious food for
people around the world. Intense and continuous research in genetics, nutrition,
reproduction, and management has resulted in the production ofhighly specialized
animals that grow faster and produce beefof excellent quality. Beef quality is
determined by its color (both meat and fat), intramuscular fat content, firmness, lean
content and tenderness (Greaser 1986; Hedrick et al. 1994; Canadian Beef Grading
System). These factors are used to predict eating quality. Of all the attributes of eating
quality, tenderness is considered by consumers to be the most important factor (Morgan
et al. 1991a; Smith et al. 1995). Generally, consumers are willing to pay a premium for
meat known to be tender (Boleman et al. 1997). However, there is concern within the
industry with respect to the tenderness of today's beet: in particular, the lack of
consistency and uniformity (Morgan et al. 1991a; Smith et al. 1995). Inconsistency in
beef tenderness can have a negative effect on the consumer's preference for beef relative
to other meats and/or more importantly affect international markets (reducing beef
exports). In Canada, beefhas lost market share in comparison to other meats over the
past decade. At this moment the consumption ofbeef per capita (23 kg) is similar to
pork (22 kg), but less than chicken (29 kg) (Canfax 2002). If this trend continues, the
contribution of the beef industry to the national economy will be seriously affected. On
the other hand, Canada is the third largest exporter ofbeef in the world (Canfax 2002).
To maintain or increase the volume of exports, it is important to assure a product of
consistent quality. Morgan et al. (1991a) found that current beefproduction practices
result in considerable variation in beef tenderness and an unacceptable percentage (> 20
%) oftough meat. Therefore, methods that can be used to improve beef tenderness and
lead to the production ofuniform and consistent products will be ofparticular importance
to the beef industry (Pringle et al. 1999).
Tenderness is influenced by several pre- and post-slaughter factors. Once the
animal has been slaughtered, the rate and extent ofrigor development and subsequent
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loss of rigor within muscle tissues appears to be the most important determinant
influencing the final degree of tenderness (Dayton et al. 1981; Huff-Lonergan et al. 1996;
Goll et al. 1998). This process is how meat becomes tender following slaughter of the
animal and is referred to in industry as "aging" of the meat. Tenderization refers to the
process by which meat losses its postmortem rigidity as a result of the degradation of
nluscle proteins. Under normal conditions this process usually takes between 14 to 21
days to complete (Lawrie 1991). It has been found that it is possible to modify the rate
and extent ofproteolysis by stimulating higher activity of the proteolytic enzymes
(Geesink and Koohmaraie 1999). This reduces the time to reach maximum tenderness to
7 days or less and results in more tender (lower shear force values) beef (Koohmaraie et
al. 1988a; Goll et al. 1998; Lonergan et al. 1998). Reducing the time to reach full
relaxation ofrigor in muscles could lead to the reduction in processing costs (days in cold
room), and improve meat quality, benefits that will inlpact the whole beef industry.
The proteolytic calpain enzyme system (Jl-calpain, m-calpain, and calpastatin) is
considered to be the principal group ofproteases involved in postmortem myofibril
degradation (Etherington 1984; O'Halloran et al. 1997; Pringle et al. 1999). The calpains
are activated by calcium (Ca), and when intracellular Ca in muscle is increased, the
proteolytic activity of these enzymes is increased (Koohmaraie et al. 1990; Ilian et al.
2001), resulting in improved beef tenderness (Swanek et al. 1999; Montgomery et al.
2000; Karges et al. 2001).
Research has focused on methods to increase the concentration of Ca in muscle.
Two approaches have proved to be effective, although substantially different. The first
deals with injection, infusion or marination of calcium chloride (CaCh) to carcasses or
meat cuts (Koohmaraie et al. 1987, 1988a,b; Wheeler et al. 1992; Whipple. and
Koohmaraie 1992). The main disadvantages of this method in commercial applications is
it involves a significant increase in labor and facilities to treat the meat, and has a high
likelihood ofproducing bitter and off-flavors in meat (St. Angelo et al. 1991; Miller et al.
1995).
The second application is the supplementation ofhigh levels ofvitamin D3 to
feedlot animals for a short period of time prior to slaughter. It has been found that
feeding 5 or more million IV (Mill) ofvitamin D3 to cattle for 5 to 10 days prior to
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slaughter has significantly increased (around 20 %) plasma Ca concentrations, which led
to higher levels ofCa in muscle (20-40 %) and improvements in the eating quality of the
meat (Owens et al. 1998). The higher intracellular Ca in muscle is thought to activate
and enhanced the proteolytic activity of the calpain enzymes, resulting in an
improvement in tenderness, as measured by mechanical (reduction in shear force values)
and gustative (sensory panelists) means (Swanek et al. 1997, 1999; Montgomery et al.
1998; 2000; 2002; Karges et al. 2001).
However, supplementation ofhigh levels of vitamin D3 induces higher
concentrations of it and its metabolites in plasma, muscle and other tissues (Montgomery
et al. 2000). This situation raises two main concerns with the use of supplemental
vitamin D3. The first is related to the animal, to its well-being and performance;, and the
second, with food safety and human health. Feeding high levels ofvitamin D3 for
prolonged periods to finishing animals could lead to vitamin D3 toxicity (Karges et al.
1999b; Berry et al. 2000). The second and most important is in relation to the risk of
excessive amounts ofvitamin D3 (and its metabolites) in meat and other edible tissues
(Owens et al. 1998; Montgomery et al. 2000). Residual vitamin D3 (and its metabolites)
in meat can induce vitamin D3 toxicity in consumers, which will cause disturbances in Ca
metabolism, resulting in formation of renal stones and calcification of soft tissues (Glerup
and Eriksen 2000).
As a result of these concerns, it would be of interest to reduce the level of vitamin
D3 required to raise plasma Ca to levels that stimulate proteolytic enzyme activity in post-
rigor muscle tissue.
The objective of this thesis was to characterize the effects of supplemental
vitamin D3 on Ca homeostasis of finishing steers under western Canadian feedlot
conditions, and to determine if specific feeding management strategies can be devised
that will allow a reduced amount ofvitamin D3 to be fed yet still achieve the desired
increase in serum Ca concentration.
The literature review will cover muscle fiber structure and function, rigor
development, Ca metabolism in ruminants, and methods to alter plasma Ca
concentrations.
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CHAPTER II
LITERATURE REVIEW
2.1 Beef Tenderness
A goal of the Canadian beef industry is to produce beefof excellent quality. In
recent years the beef cattle industry has contributed over $25 billion annually to the
national economy (Canfax 2002). Approximately 55 % of the beef from Canadian cattle
is exported. This makes Canada the third larger exporter in the world (Canfax 2002).
This success in the international beef trade has been based on quality products and safety.
The domestic beefmarket, in contrast, has been losing meat market share (i.e. from 35 to
29 % in 1990 and 2000, respectively; Canfax 2002). In this sense, beef tenderness has
been identified as the second most important factor affecting meat quality and
subsequently consumer preference. The main problem related to beef tenderness is the
lack ofconsistency and uniformity (Morgan et ale 1991a; Smith et ale 1995).
Generally, consumers are willing to pay a premium for meat known to be tender
(Boleman et ale 1997). This situation is clearly observed when one looks at the
relationship that exists between the expected tenderness of a specific meat cut and its
price. Morgan et ale (1991a) found that current beefproduction practices result in
considerable variation in beef tenderness and an unacceptable percentage oftough meat
(> 20 %). Therefore, methods that can be used to improve beef tenderness and lead to the
production ofuniform and consistent product will be ofparticular importance to the beef
industry (Davis et at. 1979; Pringle et ale 1999).
Numerous factors influence the tenderness ofmeat. Some variables are related to
the animal such as breed, age, and sex; others are related to the muscle itself such as the
amount of intramuscular fat, sarcomere length, collagen content, size and type ofmuscle
fibers; while others are related to postmortem aging such as pH, temperature, and enzyme
proteolytic activity (Davis et ale 1979; Dayton et ale 1981; Wheeler et ale 1990; Whipple
et ale 1990; Geesink and Koohmaraie 1999). Once the animal has been slaughtered, the
most important factors influencing meat quality are those associated with postmortem
agtng.
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2.1.1 Muscle Structure and Function
There are more than 300 muscles in the animal body (Lawrie 1991). These can be
classified into three types: skeletal, smooth and cardiac muscle. Skeletal muscle
constitutes the greater proportion of the carcass weight. Smooth muscle is associated
primarily with the gastrointestinal tract and blood vessels, while cardiac muscle is
confined solely to the heart. Skeletal and cardiac muscle are also known as striated
muscle because of the transverse banding pattern. Muscle tissue can also be classified as
voluntary (skeletal) and involuntary (smooth and cardiac) muscle (Bhagavan 1992;
Hedrick et al. 1994).
In terms of structure, muscle tissue is surrounded and separated from other
external and internal structures by a sheath of connective tissue. The connective tissue
surrounding the muscle, the bundles, and each individual muscle fiber are known as
epimysium, perimysium (which contains the larger blood vessels and nerves) and
endomysium (Figure 2.1). The relative proportions of connective tissue and muscle
fibers vary between muscles and, in part, account for the relative toughness ofmeat
(Bechtel 1986).
The structural unit of skeletal muscle tissue is the muscle fiber cell. Muscle fibers
constitute 75 to 92 % ofthe total muscle volume. Connective tissues, blood vessels,
nerve fibers, and extracellular fluid make up the remaining volume, with extracelluar
fluid comprising the major proportion of this volume. Skeletal muscle fibers are long,
unbranched, threadlike cells that taper slightly at both ends. Although fibers may attain a
length ofmany centimeters, they generally do not extend the length of the entire muscle.
They vary considerable in diameter, ranging from 10 J..lm to more than 100 J..lm (West
1985; Hedrick et al. 1994; Guyton and Hall 1996).
The main components of the muscle fiber are the sarcolemma, sarcoplasmic
reticulum, nuclei, myofibrils, myofilaments, mitochondria, lysosomes, and Golgi
complex. The sarcolemma is the plasma membrane of the muscle cell, which is
composed ofproteins and lipids, and is relatively elastic, a property that enables it to
endure great distortion during contraction, relaxation, and stretching. It surrounds the
contractile units and regulates the uptake and release of specific molecules by the muscle
cell. The sarcolemma also depolarizes in response to a nerve impulse. The transverse
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tubule (T-tubule) system is a series of small invaginations of the sarcolemma. Its
function is to bring the membrane depolarization event from the sarcolemma to the inner
regions of the muscle cells. The sarcoplasmic reticulum forms a matrix around the
myofibrils between the T-tubules; and has the function to release and sequester Ca in the
muscle cell. Calcium is sequestered by the sarcoplasmic reticulum against a
concentration gradient, a process that requires energy. Muscles with faster contraction
speeds have a more developed sarcoplasmic reticular system. A more developed
sarcoplasmic reticulum may allow for faster, more uniform release and uptake ofCa
(Bechtel 1986). The sarcoplasm is the cytoplasm ofthe muscle fiber. Water constitutes
about 75 to 80 % of the sarcoplasm, but in addition, sarcoplasm of skeletal muscle
contains lipid droplets, glycogen granules, ribosomes, numerous proteins, nonprotein
nitrogenous compounds, and a number of inorganic constituents. Skeletal muscle fibers
are multinucleated, however, the number ofnuclei per fiber is not constant. Nuclei are
located at the periphery of the fiber, just beneath the sarcolemma (Lawrie 1991; Hedrick
et aZ. 1994).
Each individual muscle fiber is composed of a number of smaller units, the
myofibrils (Figure 2.2). The myofibrils are composed ofnumerous parallel filaments, the
myofilaments. Myofilaments are referred as thick and thin filaments of the myofibril.
Thick filaments are approximately 14 to 16 om in diameter and 1.5 J.lm long. Thin
filaments are about 6 to 8 om in diameter and they extend approximately 1 J.lm on either
side of the Z disk. Thick filaments are aligned parallel to each other and arranged in
exact alignment across the entire myofibril. Thin filaments are aligned exactly across the
myofibril, parallel to each other and to the thick filaments. This arrangement of
myofilaments, and the fact that thick and thin filaments overlap in certain regions along
their longitudinal axis, gives the appearance of alternating light and dark areas and
accounts for the characteristic banding or striated appearance of the myofibrils (Smith et
aZ. 1983; Hedrick et al. 1994).
Thick filaments constitute the A band of the sarcomere. Since the predominant
protein in thick filaments is myosin, they are referred to as myosin filaments. Thin
filaments constitute the I band of the sarcomere and also extend beyond the I band into
7
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structure (Adapted from Guyton and Hall 1996, 1997),
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the A band, lying alongside the thick myosin filaments. Since actin is the most abundant
protein in the thin filament, they are called actin filaments (Guyton and Hall 1997).
The sarcomere is the repeating structural unit of the myofibril, and it is also the
basic unit involved in muscle contraction (Figure 2.2). The sarcomere is encompassed
between two adjacent Z disks. The sarcomere includes both an A band and the two half I
bands located on either side of the A band (Guyton and Hall 1996).
The Z disk is a dense fibrous structure in which one end of each thin (actin)
filament is anchored. An actin filament on one side of the Z disk lies between two actin
filaments on the opposite side of the Z disk. This arrangement indicates that the actin
filaments do not pass through the Z disk. Ultrathin filaments, called Z filaments,
constitute the material of the Z disk, and they connect with actin filaments on either side
of the Z disk. Each actin filament connects to four Z filaments that pass through the Z
disk (Murphy 1998; Cunningham 2002).
There are more than 20 different proteins associated with the myofibril.
However, six of these comprise approximately 90 % of the total myofibrillar protein
content. These six proteins in order of abundance are myosin, actin, titin, tropomyosin,
troponin, and nebulin. Myofibrillar proteins are classified by their function as contractile,
regulatory, or cytoskeletal. Actin and myosin constitute the major contractile proteins,
and they participate directly in the processes ofmuscle contraction through the formation
of the actomyosin complex. The major regulatory proteins include tropomyosin,
troponin, a-actinin, and ~-actinin. They are called regulatory proteins because of their
role in regulating the actin-myosin interaction during muscle contraction and in
maintaining myofibril integrity. The cytoskeletal proteins serve as the template and/or
provide the scaffold for the alignment ofmyofilaments during myofibril and sarcomere
formation. In mature muscle, they maintain its overall longitudinal and lateral alignment
as well as its structural integrity (Lawrie 1991; Hedrick et ale 1994).
Myosin is a fibrous protein that constitutes approximately 45 % of total
myofibrillar protein content. The structure of the myosin molecule is an elongated rod
shape, with a thickened portion at one end. The thickened end of the myosin molecule is
usually referred to as the head region, and the long, thin portion that forms the backbone
of the thick filaments is called the rod or tail. When myosin is subjected to proteolytic
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enzyme degradation, it is split into two fractions that differ in molecular weight; light
meromyosin and heavy meromyosin (Guyton and Hall 2000).
Actin constitutes approximately 20 % of the myofibrillar protein. It is a globular
shaped molecule approximately 5.5 nm in diameter. This molecule is called G-actin (for
globular actin) and as such constitutes the monomeric form of actin. The fibrous nature
of the actin filament is due to the G-actin monomers linking to form F-actin (fibrous
actin). Two strands ofF-actin are spirally coiled around one another, to form a super
helix that is characteristic of the actin filament (Hedrick et al. 1994).
Tropomyosin constitutes approximately 5 % ofmyofibrillar protein and lies in
close contact with the actin filament. A strand of tropomyosin lies alongside each groove
of the actin super helix, and a single molecule extends the length of seven G-actjn
molecules in the actin filament (Greaser 1986).
Troponin constitutes about 5 % ofmyofibrillar proteins and is also present in the
grooves of the actin filament, where it lies astride the tropomyosin strands. Troponin
units show a periodicity along the length of the actin filament. There is one molecule of
troponin for every seven or eight G-actin molecules along the actin filament (Bechtel
1986).
Among the cytoskeletal proteins, titin is the most abundant, compromising about
10 % of the myofibrillar protein. It extends longitudinally in each half of the sarcomere.
The portion of titin in the A band is. inelastic, while that in the I band is elastic. It is
bound to the outside shaft of the thick filament. Titin provides the scaffold for alignment
of the filaments during myofibril and sarcomere formation. In mature myofibrils, it
maintains the ordered structure and integrity ofmyofibrils within the sarcomere. Nebulin
comprises approximately 4 % of the myofibrillar protein. It is located close and parallel
to the thin filament. Nebulin extends longitudinally along the entire length of the thin
filament from the A band to the Z disk. In developing muscle, it plays a role in the
organization of thin filaments during myofibril formation. In mature muscle, it serves as
a template for assembly and/or a scaffold for stability of thin filaments. It also may
function in anchoring thin filaments to the Z disk (Hedrick et al. 1994; Murphy 1998).
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2.1.2 The Mechanism of Muscle Contraction
Muscle contraction involves four of the myofibrillar proteins: actin, myosin,
tropomyosin, and troponin. Actin and myosin are the contractile proteins, which form the
cross-bridges, and at this point this protein complex is called actomyosin. Tropomyosin
and troponin regulate the contraction process (Cunningham 2002). Muscle contraction is
initiated by a stimulus that arrives at the surface of the muscle fiber (the sarcolemma).
Contraction is initiated by a nerve action potential, which results from the release of
acetylcholine. Contraction begins with formation of cross-bridges between the thick and
thin fibers, causing shortening of the sarcomere. Tension then develops in these cross-
bridges and pull the two arrays of thin filaments and their attached Z disks toward each
other. As a result the thin and thick filaments slide past each other with changes in the
degree of interlocking between these filaments. The maximum force developed by a
muscle is related to the number of cross-bridges that can be formed and to the degree of
interlocking between the filaments (Figure 2.3)(Bhagavan 1992; Guyton and Hall 1996).
Relaxed muscle has very low levels of calcium ions (Ca2l in the sarcoplasmic
fluid that bathes the myofibrils. Typical concentrations are less than 10-7 MIL of free
Ca2+. However, total concentration of Ca2+ in skeletal muscle is more than 1000 times
this level (greater than 10-4 MIL), nearly all ofwhich is bound in the sarcoplasmic
reticulum. For muscle to remain in the relaxed state, it must also have a relatively high
concentration ofadenosine triphosphate (ATP). Most of the ATP is found in the form of
a magnesium ion (Mg2+) complex. The Mg2+-ATP complex must be present in order to
prevent formation of cross-bridges between actin and myosin. When the sarcoplasmic
Ca2+" concentration is low (less than 10-7 M), and the Mg2+-ATP concentration is high,
troponin and tropomyosin inhibit cross-bridge formation between the actin and myosin
filaments (Figure 2.3) (Smith et ale 1983; West 1991; Hedrick et ale 1994).
When the action potential is transmitted from the sarcolemma to the interior of the
fiber along the T tubules, it causes bound Ca2+ to be released from the sarcoplasmic
reticulum into the sarcoplasm. Increased free Ca2+ concentration in the sarcoplasm is the
trigger that initiates the contractile mechanism. It order to do so; it is necessary to
increase the concentration of free Ca2+ to about 10-6 or 10-5 MIL (a 10- to 100-fold
increase). When free Ca2+ is released into the sarcoplasm, it is bound by troponin. This
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CONTRACTION PHASE
Resting state
1
Motor nerve action potential arrives at motor end plate
1
Acetylcholine released, sarcolemma and membranes depolarized
(Na+ flux into fiber)
!
Action potential transmitted via T-tubules to SR
. !
Caz+released from SR terminal cisternae into sarcoplasm
!
Caz+ bound by troponin
1
Myosin ATPase activated & ATP hydrolyzed
1
Tropomyosin shift from actin binding site
!
Actin-myosin crossbridge formation
1
Repeated formation & breaking of crossbridges resulting in sliding of filaments and
sarcomere shortening
RELAXATION PHASE
Cholinesterase released and acctylcholine breakdown
1
Sarcolemma & T-tubules repolarized
! I
SR Ca2+ pump activated & Ca2+returned to SR terminal cisternae
1
Actin-myosin crossbridge formation terminated
1
Return of tropomyosin to actin binding site
1
Mg2+ complex formed with ATP
1
Passive sliding of filaments
. 1
Sarcomeres retwn to resting stale
Figure 2.3. Flow diagram ofmuscle contraction-relaxation cycle (adapted from Hedrick
et ai. 1994).
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relieves the inhibition that tropomyosin exerts on cross-bridge formation between actin
and myosin because the calcium-activated troponin interacts with tropomyosin, causing it
to shift its position along the actin filament. The shift by tropomyosin allows the myosin
heads to form cross-bridges between the myosin and actin filaments. These cross-bridges
develop a contractile force, and the actin filaments in each half of the sarcomere are
pulled toward the center of the sarcomere. During contraction, the length of individual
actin and myosin filaments does not change. Rather, the filaments slide along each other,
pulling the Z disk closer to the myosin filaments, thereby decreasing sarcomere length
(Figure 2.3) (Hedrick et al. 1994; Guyton and Hall 1997).
Muscle contraction requires energy in addition to that normally consumed by the
resting muscle. This energy is derived from ATP by a reaction catalyzed by the enzyme
myosin ATPase, in which ATP is hydrolyzed to adenosine diphosphate (ADP) and
inorganic phosphate (Pi). The enzyme system responsible for this reaction is located in
the head of the myosin molecule. The activity of the myosin ATPase is greatly enhanced
by Ca2+ released into the sarcoplasm. Thus, increased free Ca2+ concentration in the
sarcoplasm promotes cross-bridge formation between actin and myosin filaments, and
simultaneously increases ATP splitting, yielding the required chemical energy. Cross-
bridges between actin and myosin convert chemical energy into mechanical energy and
initiate filament sliding, thus generating a contractile force (Figure 2.3) (Hedrick et al.
1994; Murphy 1998).
Relaxation of skeletal muscle is defined as the reestablishment of the resting state.
This state is reestablished when the intracellular free Ca2+ concentration in the
sarcoplasm is 10-7 M (or less), and a relatively high concentration of ATP. Intracellular
free Ca2+ concentration in the sarcoplasm is returned to a low level by the action of the
sarcoplasmic reticulum, which removes the excess Ca2+ from the sarcoplasmic fluid and
binds it in an inactive form. Bound Ca2+ is then transferred to the terminal cisternae for
storage and subsequent release when the next stimulus arrives. When free Ca2+
concentration in the sarcoplasm decreases, the actin-myosin cross-bridges are broken and
troponin releases the Ca2+ it had bound during the initiation of contraction. As troponin
releases Ca2+, it is again able to inhibit the formation of cross-bridges by allowing
tropomyosin to regain its original protective position over the cross-bridge site. In the
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resulting absence of cross-bridges, tension is not generated and the stretching imposed by
elastic components in the muscle causes the filaments to slide passively over one another
(West 1991; Cunningham 2002).
2.1.3 Post-Mortem Changes and Meat Quality
When the animal is slaughtered, muscle tissue undergoes a series of chemical and
biochemical changes. These changes are associated with the stoppage of circulation and
the switch fronl aerobic to anaerobic metabolism. Some of the most notable changes
include a decline in temperature, depletion of available energy, decline in pH,
accumulation of metabolites such as lactic acid, a rise in the relative ionic strength, and a
decrease in the ability of cellular systems to maintain control of the redox conditions
within the cell (Hedrick et al. 1994; Huff-Lonergan et al. 1995). These biochemical
changes have a profound effect on the conversion of muscle to meat, with tenderness
being one aspect ofmeat quality that can be affected either positively or negatively
(Lawrie 1991).
2.1.3.1 Rigor Mortis
Several hours after death, all the muscles of the body go into a state of contracture
called rigor mortis. Rigor mortis is due to formation ofpermanent cross-bridges in
muscle between the actin and myosin filaments. This is the same chemical reaction that
forms actomyosin during muscle contraction. This rigidity is caused by loss of all the
ATP, which is required in the living animal to cause separation of the cross-bridges from
actin and myosin filaments during the relaxation process. The muscles remain in rigor
until the muscle proteins are destroyed by autolysis caused by enzymes released from the
lysosomes (Guyton and Hall 1996) and/or by proteolytic enzymes (Goll et al. 1998).
The difference between living and rigor mortis is that relaxation is impossible in the latter
state, as no energy is available for breaking the actomyosin bonds (Hedrick et al. 1994).
Rigor mortis is comprised of three phases. These include: a) the delay phase, that
corresponds to the period in which muscle is relatively extensible and elastic; b) the onset
phase, where muscle begins to lose extensibility, and c) the completion phase, which
corresponds to depletion of creatine phosphate and as a result ATP can no longer be
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regenerated from ADP, and the muscle becomes relatively inextensible (Dayton et al.
1981.; Greaser 1986; Lawrie 1991).
Two main enzyme systems present in skeletal muscle are implicated as being
responsible for the postmortem proteolytic degradation ofmyofibrillar proteins. The first
is the calpain-calpastatin (neutral proteases) system (Etherington 1984; Goll et al. 1998;
Geesink and Koohmaraie 1999). The second is the cathepsin-cystatins (acidic proteases)
system (Penny and Ferguson-Pryce 1979; Johnson et al. 1990) present only in the
lysosomes of muscle fibers. It has been observed that cathepsins are not released from
lysosomes even after electrical stimulation and extended post-mortem storage (Hedrick et
al. 1994). Without their release, these enzymes cannot degrade myofibrillar proteins
(Calkis and Siderman 1998). Muscle proteins would have to be endocytosed into
lysosomes for proteolysis. This is almost impossible in post-mortem muscle because
endocytosis is an active process requiring energy (Lawrie 1991). Thus, the calpain
enzyme system is considered the most likely system responsible for the proteolytic
changes in myofibrillar proteins during postmortem storage and consequently the most
important system involved in meat tenderness (Koohmaraie et al. 1987; Kendall et al.
1993; Huff-Lonergan et al. 1996; Go11 et al. 1998).
2.1.3.2 The Proteolytic Calpain Enzyme System
The calpain system is comprised, principally, of three proteins: 1) ~-calpain, a
proteolytic enzyme that requires micromolar concentrations (3 to 50 ~M) of ionized Ca
(Ca2+) for a half-maximal rate ofproteolytic activity; 2) m-calpain, a proteolytic enzyme
that requires nearly millimolar concentrations (400 to 800 ~M) of ionized Ca for a half-
maximal rate ofproteolytic activity; and 3) calpastatin, an enzyme responsible for
inhibition of the two calpains (Dayton et al. 1981; Hedrick et al. 1984; Geesink and
Koohmaraie 1999).
The two calpains are both cysteine proteases (i.e. they have a sulfhydryl group at
their active site) with a pH optima of7.2 to 8.2. These enzymes are intracellular in
nature. Within the muscle cell, these enzymes are found in the cytoplasm and associated
with subcellular organelles, primarily the cytoskeleton (myofibrils in skeletal muscle),
but also with the plasma membrane, mitochondria, and nuclei. The calpains are
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expressed in a single isofonn. Calpastatin is a multiheaded inhibitor that can be
expressed in several different isofonns having one, three, or four inhibitory domains
(Lawrie 1991; Huff-Lonergan et al. 1996; Goll et al. 1998).
Nonnally calpains degrade myosin, the major muscle protein, very slowly causing
few cleavages in the light and heavy chain. Undernatured actin, the second most
abundant protein in skeletal muscle myofibrils, is not cleaved. However, the calpains
rapidly cleave troponin T, desmin, vinculin, talin, spectrin, nebulin, and titin. They act
more slowly on troponin I, filamin, C-protein, dystrophin, and tropomyosin, and cleave
a-actinin and M protein very slowly (Hedrick et al. 1984; Goll et al. 1998).
lTltrastructurally, incubation with the calpains results first in loss of the N2 line,
and then in complete loss ofZ-disks leaving a gap in the middle of the sarcomere as well
as loss ofperiodicity in the I-band area, likely due to troponin and tropomyosin
degradation. Alpha-Actinin is a major Z-disk protein, but is degraded slowly by the
calpains. The loss of the Z-disk structure is caused by release of a-actinin from the Z-
disk in an almost intact fonn. Calpains cleave relatively few peptide bonds in each
protein and leave large polypeptide fragments rather than reducing the protein to small
peptides and amino acids. Nevertheless, these cleavages to the structural myofibrils are
of fundamental importance to the break down of the sarcomere structural integrity, which
will result in a significant reduction in the postmortem rigidity, and eventually in a more
tender meat (Goll et al. 1991, 1998).
It has been observed that the calpain enzymes not only need Ca to be activated but
that their rate of activity is closely regulated by the amount of available Ca. That means
that higher concentrations of Ca will induce higher proteolytic activity and consequently
improvements in meat tenderness (Koohmaraie et al. 1988a,b; Swanek et al. 1997).
2.2 Calcium
Calcium (Ca) is a white silvery, alkaline earth metal, which does not occur in free
state. However, Ca is associated with other minerals widely distributed in nature.
Calcium is the fifth most abundant element on the earth and the most abundant cation in
the animal body, comprising 1 to 2 % of the total weight. Approximately 99% of the Ca
in the body is found in the bones and teeth, with the remaining 1 % widely distributed in
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various soft tissues. Calcium has a very close interrelationship with phosphorus,
parathYroid hormone, calcitonin and vitamin D3 and its metabolites (Underwood 1981;
West 1991; Bhagavan 1992).
2.2.1 Importance of Calcium
Calcium is essential for nerve impulse transmission, muscle contraction, blood
coagulation, the secretion of hormones and neurotransmitters, cell growth, motility,
replication, as an activator of a number of enzymes, and for cell membrane integrity
(Rodan 1973; Smith et al. 1983; Wasserman 1989). Calcium levels both intra- and extra-
cellular are tightly regulated. Abnormally low or high levels either in the cell or in the
plasma can induce metabolic disorders (i.e. hypocalcemia or hypercalcemia, respectively)
that can seriously affect not only animal performance but the well-being of the animal
(Guyton and Hall 1997).
2.2.2 Forms of Calcium
Total Ca in serum and extracellular fluid is divided into three forms: a) ionized
(Ca2+), which comprises approximately 50% of the total, b) protein-bound Ca, which
represents approximately 450/0 of the total, and c) Ca that is complexed to anions such as
citrate, bicarbonate, phosphate or lactate. This latter form of Ca comprises approximately
5% of the total. The protein-bound Ca2+is bound principally to negatively-charged sites
of albumin with smaller amounts bound to globulins. The protein-bound form of Ca2+ is
dependent on serum parathYroid hormone (PTH). Alterations in blood pH will change
the concentration of the ionized Ca. As the pH of serum becomes more acidic, the
concentration of the ionized Ca will increase. This is caused by the competition of H+ for
binding to the negatively-charged sites on serum proteins. The ionized and complexed
Ca2+ comprise the ultrafilterable fraction of Ca2+ and represents the fraction that is
present in the glomerular filtrate (Rosol et al. 1995; Rosol and Capen 1997; Guyton and
Hall 2000).
The concentration of total Ca in the serum in most mammalian species is
approximately 2.5 mM or 10 mg/dl, with a range between 2.2 to 2.6 mM or 8.8 to 10.4
mg/dl. The concentration of ionized Ca in serum is approximately 1.2 mM or 4.8 mg/dl,
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with a range between 1.2 to 1.6 mM or 4.8 to 6.4 mgldl (Copp 1973; Bell et al. 1976;
Ganong 1987; West 1991; Rosol et al. 1995; Rosol and Capen 1997).
2.2.3 Calcium Homeostasis
The concentration of Ca in the extracellular fluid is regulated by the hormones
parathyroid hormone (PTH), calcitonin, vitamin D3 and its metabolites. These hormones
are highly sensitive to variations in plasma Ca. They can act alone or in concert to
promote intestinal Ca absorption, bone Ca resorption, and renal Ca reabsorption to
achieve plasma Ca homeostasis (Goff 1989).
2.2.3.1 Intestinal Calcium Absorption
The absorption of Ca occurs in all segments of the small intestine although the
efficiency of absorption follows the order: duodenun > jejunum> ileum. It also occurs in
the colon and cecum. However, it seems that most of the Ca is absorbed in the ileum.
This is due to the long resident time of the ingesta in this segment as compared to the
duodenum and jejunum (Wasserman 1989).
Two transport processes are responsible for the absorption of Ca by the intestinal
cells. The first is an active process, transcellular, energy-requiring, and regulated by
vitamin D3 (1,25(OH)2D3). This process saturates at an intracellular Ca concentration of
about 2 to 5 mM. The second absorption mechanism is a passive diffusion-like process
that is non-saturable. This method appears to be paracellular (i.e. absorbed between cells
rather than through them). The rate of Ca absorption by the passive process is directly
related to the intraluminal concentration ofCa (Wasserman 1989; Hunt and Groff 1990).
The absorption of Ca across the intestine occurs in three phases. The first is the
transport of Ca from the intestine throughout the brush border into the epithelial cell.
Then the intracellular Ca is transported to the basal-lateral surface, and finally Ca is
transported across the basal-lateral membrane into the blood stream (Spirichev and
Sergeev 1988).
The first step is the transfer ofCa across the brush border membrane. Much of
the Ca accumulated by the brush border vesicles is bound to components on the inner
surface of the membrane. The rate of entry ofCa across the brush border membrane
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allows a concentration gradient and is positively affected by 1,25(OH)2D3 (Figure2.4).
The Ca-binding proteins (CaBP) located in the cytosol of the epithelial cells are
translocated to the brush border region. These proteins are responsible for the uptake of
Ca in the cell. The sequestering of Ca by the CaBP and other organelles such as the
endoplasmic reticulum, mitochondria and Golgi apparatus in the cytosol is very important
in order to maintain epithelial cell integrity (Spirichev and Sergeev 1988; Wasserman
1989).
The second step is the transfer ofCa through the cytosol. The translocation of Ca
from the brush border membrane to the basolateral membrane is largely regulated by the
action of 1,25(OHhD3 through the formation of the CaBP, which is responsible for
binding Ca and forming the complex Ca-CaBP. It is this complex which transverses the
cell cytoplasm to the basolateral melTlbrane, where the Ca is released (Figure 2.4)
(DeLuca 1980; Wasserman 1989; Rhoades and Tanner 1995).
The third step is the transfer across the basolateral membrane. Extrusion ofCa
from the cell is the function of an ATP-dependent active Ca transport system, and also
occurs by Na-Ca exchange (Smith et al. 1983; Wasserman 1989).
2.2.3.2 Bone Calcium Resorption
Bone, besides its structural function serves as a source of readily available Ca and
phosphate. This Ca pool is important for maintenance of Ca homeostasis. The
deposition ofCa in bone and the mobilization of it to the extracellular fluid is under the
control of several hormones (PTH, vitamin D, calcitonin, growth homlone, insulin,
thyroxine, estrogen and testosterone, and the glucocorticoids) and hormone like factors
(somatomedins, prostaglandins). A process that is very complex (Smith et al. 1983;
Strand 1983).
Bone is composed ofbone cells called osteoblasts, osteocytes and osteclasts and
extracellular matrix. Osteoblasts are located on the bone surface and are responsible for
osteoid synthesis. Osteoids are secreted into the space adjacent to the bone. Eventually,
new osteoid becomes mineralized, and in the process, osteoblasts are surrounded by
mineralized bone, losing their ability to form bone and as such become quiescent. At this
point they are called oesteocytes. Osteoclasts are cells responsible for bone resorption.
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Figure 2.4. Molecular mechanisms of action of the hormonal form of vitamin D
(1,25(OH)2D) on the active transport of calcium across the intestinal epithelial cells.
DBP = Vitamin D Binding Protein
CABP = Calcium Binding Protein
(Adapted from Rosol and Capen 1997).
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They are large, multinucleated cells located on bone surfaces. Osteoclasts promote bone
resorption by secreting acid and proteolytic enzymes into the space adjacent to the bone
surface. Bone resorption is two-step event. First, osteoclasts create a local acidic
environment that increases solubility of surface bone mineral. Second, proteolytic
enzymes secreted by osteoclasts degrade the organic matrix ofbone. The result is a flux
ofCa and phosphate into and out ofbone, which reflects a turnover ofbone mineral and
changes in bone structure. This phenomenon called remodeling is a beneficial adaptive
process that allows bone to be reshaped to meet changing nlechanical demands placed on
the skeleton. It also allows the body to store or mobilize Ca rapidly in order to maintain
Ca homeostasis (Strand 1983; West 1985; Bhagavan 1992; Rhoades and Tanner 1995).
There are two independent but interacting homeostatic systems affecting bone Ca.
One is the system that regulates ionized plasma Ca, through the readily exchangeable
bone Ca pool. In the operation of this system, about 500 mM ofionized Ca per day
moves into and out of the readily exchangeable pool in bone. The other system is the one
concerned with bone remodeling by the constant interplay ofbone resorption and
deposition. This latter system takes more time to respond but constitutes a larger source
ofCa than the readily exchangeable Ca pool (Ganong 1987; Endres et ale 2001).
2.2.3.3 Renal Calcium Reabsorption
Reabsorption occurs in both the proximal and distal tubules and in the loop of
Henle of the kidneys. Reabsorbable or filterable Ca comprises 60% of the total Ca in
plasma and consists of ionized Ca and Ca bound to filterable anions such as bicarbonate
or citrate. The remaining 400/0 of the total Ca circulates bound to proteins and thus is not
filterable by the glomerular tubules. Ordinarily, only about 1% of filtered Ca is
eventually excreted in the urine, with the remaining 990/0 reabsorbed. Active transport
mechanisms are involved in the uptake from the proximal and distal tubules.
Approximately 60% of filtered Ca is reabsorbed in the proximal tubule, 30% from the
loop of Henle, and 9% from the distal tubule. The remaining 1% is excreted in the urine.
Calcium excretion is regulated by the kidney primarily at the distal tubule. PTH
stimulates Ca absorption in the distal tubule, thus promoting Ca retention and lowering
excretion (Bhagavan 1992; Rhoades and Tanner 1995; Guyton and Hall 1997).
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2.3 Hormonal Regulation of Calcium
2.3.1 Vitamin D
Vitamin D is a group of fat-soluble compounds collectively known as the
calciferols. There are two main fonns of vitamin D. These are vitamin D2 and D3. The
metabolism of the two fonns of vitamin D in the body is identical (Figure 2.5) (DeLuca
and Schnoes 1983; Solvstan 2000).
Vitamin D3 is also called cholecalciferol or activated dehydroxycholesterol. This
type of vitamin D is naturally synthesized by the body, and consequently is the main
source for the animal and also the main fonn from animal food (Rhoades and Tanner
1995). Vitamin D2or ergocalciferol is produced in plants (primarily yeast) by ultraviolet
irradiation of the sterol ergosterol (DeLuca et al. 1977). Vitamin D2 differs from D3 only
in a double bound between carbons 21 and 22 and a methyl group on carbon 24 (Figure
2.5) (Smith et al. 1983). Vitamin D2 is used to supplement milk, cereals, and bread in the
United States, Canada and Mexico (Holick 2000).
Vitamin D functions in Ca and bone metabolism in amphibians, reptiles, birds and
mammals through the active metabolite 1,25-dihydroxyvitamin D (l,25(OH)2D2 and
1,25(OH)2D3) (Solvesten 2000). The 1,25(OH)2D is considered a hormone (secosteroid
hormone with a disrupted B ring) because it modifies the function of target tissues or
organs (Figure 2.5) (Glerup and Eriksen 2000).
Vitamin D is stored in adipose tissue from which it can be released into the
circulation. The main function of vitamin D is to maintain serum Ca levels in the normal
range to support metabolic functions involving Ca (Holick 2000). Specifically, vitamin
D regulates calcification and mobilization of Ca from bone, Ca absorption from the
intestine, and Ca reabsorption from kidneys (Figure 2.6) (DeLuca 1979; Glerup and
Eriksen 2000).
2.3.1.1 Synthesis of Vitamin D3
During exposure to sunlight, the high-energy ultraviolet (UV) radiation penetrates
the skin, where they are absorbed by epidermal and dermal stores of7-dehydro-
cholesterol (provitamin D3). Provitamin D3 then, undergoes bond cleavage between
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Figure 2.5. Structures for vitamin D3 (cholecalciferol) and vitamin D2
(ergocholecalciferol). Pathways for conversion of vitamin D3 into its hormonal form:
1,25(OHhD3 (Adapted from Rhoades and Tanner 1995).
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Figure 2.6. The effect ofvitamin D3 (l,25(OHhD3) on calcium metabolism (Adapted
from Rhoades and Tanner 1995).
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carbons 9 and 10 to fonn a 9-10-secosteroid known as previtamin D3. This compound is
biologically inert and is thennodynamically unstable and spontaneously rearranges to
fonn vitamin D3(Figure 2.5). At a physiological temperature of 37°C, this process takes
approximately 24 h to reach completion, although, it has been found that it could be
completed in only 4 h (DeLuca 1979, 1980; Holick 2000).
Vitamin D3from the diet is absorbed in the ileum of the small intestine passively
as it is dependent on bile salts for solubilization (West 1991). It is transported by the
small intestine in free fonn, predominantly in association with chylomicrons. During the
metabolism of chylomicrons, vitamin D3is transferred to a binding protein in plasma
called vitamin D binding protein (DBP). Vitamin D3is not stored in the liver but is
distributed between the various organs, depending on their lipid content (Rhoades and
Tanner 1995). The nonnal circulating concentration ofvitamin D3for humans and cattle
ranges from approximately less than 0.2 to 20 ng/ml, with a half-life of22 h (DeLuca
1979; Rhoades and Tanner 1995).
After entering the circulation, vitamin D3is activated by undergoing two different
hydroxylation reactions, each in a different tissue. In the liver, vitamin D3 is
hydroxylated at carbon 25 to yield the major circulating fonn ofvitamin D3, 25-
hydroxyvitamin D3 (25(OH)D3), also called calcidiol (Wasserman 1989). This
hydroxylation occurs in the endoplasmic reticulum, catalyzed by the hepatic enzyme 25-
hydroxylase. This first hydroxylation does not appear to be tightly regulated (Smith et al.
1983; Ganong 1987). Circulating concentrations of25(OH)D3in plasma are normally
between 10 to 50 ng/ml, with a half-life of 15 days (DeLuca 1979; Rhoades and Tanner
1995). This metabolite appears to be approximately five times more potent in regulating
Ca homeostasis than vitamin D3(DeLuca 1979; Smith et al. 1983; Rhoades and Tanner
1995).
In the kidneys, 25(OH)D3 is hydroxylated at carbon 1 to form the hormonal form
of vitamin D3, 1,25-dihydroxyvitamin D3 (1 ,25(0H)2D3), also called calcitriol
(Wasserman 1989). This hydroxylation is catalyzed by the mitochondrial enzyme 1a-
hydroxylase located in the proximal tubules. This step is considered to be the most
significant point of vitamin D metabolism. The main factors involved in the regulation of
its activity are PTH (positive feedback), low levels ofCa and P (positive feedback), and
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levels of 1,25(OH)2D3 (negative feedback) (DeLuca 1979; Weiser 1984; Spirichevand
Sergeev 1988; Wassennan 1989; Guyton and Hall 1997). Specific honnones such as
growth honnone, estrogens, androgens, prolactin, and insulin may also influence the
activity of this enzyme (Bhagavan 1992). Normal plasma concentration of 1,25(OHhD3
is approximately 10 to 60 pglml, with a half-life of 15 h (Rhoades and Tanner 1995).
This metabolite is considered to be 500 to 1000 times more biologically active than
vitamin D3 (Rhoades and Tanner 1995; Glerup and Eriksen 2000).
The major excretory route for vitamin D and its metabolites is the bile, with little
excreted in the urine. Vitamin D metabolites may undergo conjugation in the liver prior
to excretion in feces (Smith et al. 1983; Bhagavan 1992).
2.3.1.2 Role of Vitamin D3 in Intestinal Calcium Absorption
The small intestine in the absence ofvitamin D3 will absorb about 10-15% ofthe
dietary Ca. In the presence of 1,25(OH)2D3, this amount will increase to approximately
30% (Holick 2000). During periods ofrapid growth, pregnancy and lactation, the
increased Ca demand results in increased 1,25(OH)2D3 plasma concentrations, which in
turn will increase the efficiency of Ca absorption from intestine (West 1991; Holick
2000).
The 1,25(OHhD3 stimulates absorption of Ca2+ and phosphorus (Pi) across
intestinal epithelial cells by active transport mechanisms. The 1,25(OHhD3, enters the
circulation and is bound to a vitamin D3 plasma binding protein (DBP; Gcprotein,
Transcalciferin; MW of 56,000) and a-globulin (Weiser 1984; Bhagavan 1992). When
the complex reaches the small intestine, the 1,25(OH)2D3 dissociates from the DBP and
enters the intestinal epithelial cell by facilitated diffusion. It then binds to a highly
specific cytosolic receptor. Binding is followed by activation of the receptor and
translocation of the 1,25(OH)2D3-receptor complex to the nucleus, where it binds to
chromatin. This results in increased mRNA synthesis and increased activity ofRNA
polymerase II. A subsequent increase in the synthesis of two specific intestinal proteins
occurs. The first is a Ca ATPase, and the second is calbandin, the specific Ca-binding
protein (CaBP), both of which are essential for the active absorption ofCa (Smith et al.
1983; Weiser 1984; Rhoades and TannerI995). Mammalian intestinal mucosa contains a
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CaBP (MW 9,0(0) that binds 2 moles of Ca2+ per mole ofprotein (Bhagavan 1992).
Typically, there is a lag of several hours in Ca2+ absorption and is associated with
increased synthesis and concentrations of a soluble CaBP in the cytoplasm of the
intestinal mucosal cells as a result of 1,25(OH)2D3 action in intestine (Smith et al. 1983;
Weiser 1984).
2.3.1.3 Vitamin D3 Toxicity
Toxic effects of vitamin D3are mediated through its hypercalcemic and
hypercalciuric actions. The symptoms are the same independently of the type of vitamin
D that causes the intoxication. They include anorexia, nausea, vomiting, polyuria,
polidipsia, constipation, weakness, muscle pain, changes in mental status, fatigue,
confusion, difficulty in concentration, drowsiness, apathy, and eventually coma.
Metastatic calcification of the soft tissues may develop. One of the most apparent
symptoms is nephrocalcinosis, causing a gradual decline in kidney function (Pennington
1976; Hunt and Groff 1990; Guyton and Halll996; Glerup and Eriksen 2000).
2.3.2 Parathyroid Hormone (PTH)
ParathYroid hormone (PTH or parathormone) is an 84-amino acid peptide
produced by the parathYroid glands. There are two pairs ofparathYroid glands, located in
the dorsal surface of the left and right lobes of the thYroid gland. The parathYroid glands
are highly sensitive to changes in the concentration of circulating Ca, specifically plasma
concentrations of ionized Ca (Ganong 1987; Goff 1989; Bhagavan 1992).
The parathYroid glands respond within minutes to slight changes in blood Ca
levels. A small decline in blood Ca stimulates the release of large amounts of PTH
(Figure 2.7). If the plasma Ca concentration decreases below normal, PTH acts
principally on the kidneys, in which it stimulates Ca reabsorption in the thick ascending
limb and distal tubules. This reduces the loss of Ca in the urine and increases plasma Ca
concentration. Only a few grams ofCa are conserved, but this is often sufficient to return
blood Ca to normal. PTH also inhibits phosphate reabsorption in the proximal tubule,
leading to increased urinary phosphate excretion and a decrease in plasma phosphate.
This decrease in phosphate is important with regard to Ca homeostasis. At normal
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Figure 2.7. The effect ofparathyroid hormone (PTH) on calcium metabolism (Adapted
from Rhoades and Tanner 1995).
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plasma concentrations, Ca and phosphate are at or near chemical saturation levels. If
PTH was to increase both Ca and phosphate levels, they would simple crystallize in bone
or soft tissues as calcium phosphate, and the necessary increase in plasma Ca
concentration would not occur. Thus, the effect ofPTH to lower plasma phosphate is an
important part of its role in regulating plasma Ca. In the event of a larger Ca drain,
continued secretion of PTH stimulates the activity of the 1a-hydroxylase enzyme, which
is essential in the formation of the 1,25(OHhD3, which functions to promote the
absorption of Ca from the intestine. In bone, PTH stimulates the development and
activity ofbone osteoclasts, cells that reabsorb bone matrix, and release Ca into the
blood. The action ofPTH to promote bone resorption is augmented by 1,25(OH)2D3
(Figure 2.7) (Rhoades and Tanner 1995; Cunningham 2002).
2.3.3 Calcitonin
Calcitonin or thYrocalcitonin is a 32-amino acid peptide produced by the
parafollicular cells (C-cells) of the thYroid gland. Hormones of the gastrointestinal tract,
especially gastrin, promote calcitonin secretion. Since the net effect of calcitonin is to
promote Ca deposition in bone, stimulation of calcitonin secretion by gastrointestinal
hormones provides an additional mechanism facilitating Ca uptake into bone after
ingestion of a meal (Rhoades and Tanner 1995; Guyton and Hall 1996).
When plasma Ca concentration increases above normal levels, the parfollicular
cells increase the synthesis and secretion of calcitonin (Fig. 2.8). The main target organs
of calcitonin are the kidneys and bone. In the kidneys, calcitonin decreases tubular
reabsorption ofCa and phosphate. This leads to an increase in urinary excretion ofboth
Ca and phosphate and ultimately to decreased levels ofboth ions in the plasma. In bone,
calcitonin opposes the action ofPTH on osteoc1asts by inhibiting their activity. This
leads to decreased bone resorption and an overall net transfer of Ca from plasma into
bone, thus decreasing Ca levels in plasma and returning it to normal. Calcitonin has little
or no effect on the gastrointestinal tract (Figure 2.8) (Rosol and Capen 1997;
Cunningham 2002).
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2.4 Acid-Base Balance
The ability of the animal to maintain a constant composition of the extracellular
fluid is essential for the maintenance of life. Normal metabolic activities require a very
close regulation of the volume, ionic composition, and pH of the extracellular fluid
(Smith et ale 1983). The pH of the body fluids is maintained within narrow limits (7.35
to 7.45). This is necessary for the maintenance ofprotein structure and function, which is
an essential condition for normal metabolism. Hydrogen ions (H+) have a profound
effect on metabolic events largely through interaction with cellular proteins. These
interactions result in altered protein configuration and thus altered protein function. Most
enzymatic reactions need to be carried out under optimum pH, and changes in H+
concentration can have a negative effect on the rate and extent of the reaction, thus
influencing homeostasis. Without adequate control systems in place the metabolic
functions of the cells would either cease or become so active within a few minutes that
the cells would die. Such activity can lead to acidosis in which coma and death are the
final results, or to alkalosis in which tetany or convulsions result (Guyt<;>n 1956; Carlson
1997).
Metabolic processes, however, result in the production of relatively large amounts
of carbonic, sulfuric, phosphoric, and other acids. These products ofmetabolism are
transported to the excretory organs (lungs and kidneys) via the extracellular fluid without
producing any appreciable change in pH. This transportation and subsequent excretion is
accomplished by the combined functions of the buffer system of the blood and by
respiratory and renal regulatory mechanisms (Heusel et ale 2001).
Acid-base balance refers to the homeostatic maintenance ofacids and bases
within the body to achieve a physiological constant pH of approximately 7.40 ± 0.1.
Acid-base balance involves an accounting of the carbonic (H2C03, HC03-, col-, and
C02) and noncarbonic acids and conjugate bases in terms of input (intake plus metabolic
production) and output (excretion plus metabolic conversion) over a given period of time.
The acid-base status of the body fluids typically is assessed by the measurements of
plasma pH and pC02 as the bicarbonate/carbonic acid system is the most important
buffering system of the plasma (Strand 1983; West 1991; Heusel et al. 2001).
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Figure 2.8. The effect of calcitonin on calcium metabolism (Adapted from Rhoades and
Tanner 1995).
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2.4.1 Regulation of the Acid-Base Homeostasis
The three most important systen1s involved in pH regulation are the chemical
buffers of the blood and tissues, the respiratory system, and the kidneys. Removal of the
acids formed by active tissues is crucial because the excess of acid or alkali can
contribute to metabolic disorders such as acidosis or alkalosis (Smith et al. 1983;
Bhagavan 1992; Guyton and Hall 2000):
a) The buffer systems: A buffer pair is the combination of a weak acid and its
conjugate base that resists a change in H+ concentration. Examples of
conjugate buffer pairs include H2C03 and HC03-and Hb02 (oxyhemoglobin)
and Hb- (deoxygenated hemoglobin). Proteins can buffer as Zwitter ions
because of the presence ofNH3+(amino) groups, which can act as an acid
(donate H+) and the presence of a carboxylic group (COO), which can act as a
base (accept H+). These systems react within a fraction of a second,
preventing sudden changes in pH (Example: HA~ H+ + A).
b) The respiratory control: An increase in H+ concentration in the body fluids
directly affects the respiratory center of the medulla to increase the rate of
pulmonary ventilation. A decrease in H+ concentration decreases the rate of
pulmonary ventilation. Pulmonary ventilation is stimulated as much as by
increased H+ concentration in the body fluids as by increased C02
concentration. They both can act independently or in concert to affect the rate
and depth ofrespiration. However, they can neutralize each other as well. In
general, H+ concentration can stimulate the ventilatory rate to 5 times normal,
while CO2 can stimulate the ventilatory rate to 10 times normal. The major
purpose of the respiratory control is to prevent excessive accumulation of C02
in the body and subsequent acidosis. Large quantities of C02 are removed
from the body fluids and as a result the H+ concentration returns toward
normal. In alkalosis the opposite effect occurs. The respiratory system takes
approximately 1 to 3 min to respond after sudden changes in H+ concentration
have occurred.
c) The kidneys control: The kidneys regulate the extracellular fluid H+
concentration through three basic mechanisms: 1) secretion ofH\ 2)
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reabsorption of filtered bicarbonate ions, and 3) production ofnew
bicarbonate. An increase in the H+ concentration to above nonnal (acidosis)
causes increased reabsorption ofbasic compounds from the tubular fluid; a
decrease in the H+ concentration to below nonnal (alkalosis) causes increased
reabsorption of acidic compounds from the tubules. Thus, the kidneys
eliminate the excess of acid or base through their ability to change the
composition of the urine, by excreting either acidic (larger amounts ofH+) or
basic (larger amount ofbicarbonate) urine. This system usually takes hours or
days to respond, and is considered the most powerful acid-base balance
regulatory system.
2.4.2 Disturbances of the Acid-Base Balance:
Nonnal blood pH ranged from 7.35 to 7.45 (corresponding to 35 to 45 nM of
H+/L). Values below 6.80 (160 nM ofH+/L) or above 7.70 (20 nM ofH+/L) are seldom
compatible with life. A large amount of acid is produced everyday, and most of the
organic acids are produced by incomplete oxidation ofproteins, carbohydrates and fats,
and in some conditions (e.g. intoxication, diseases, etc.), which should be eliminated
from the body. Failure to elinlinate or neutralize, leads to disorders in the acid-base
balance (Kaneko 1989; Bhagavan 1992).
Disorders in the acid-base balance are classified according to their cause and the
direction of the pH change. Acidemia is defined as an arterial blood pH of less than 7.35.
Alkalemia is when the arterial blood pH is greater than 7.45. Acidosis and alkalosis
refers to pathological states that can lead to academia or alkalemia (Autran de Morais and
DiBartola 1993, 1994).
Acid-base disorders are divided in two types: respiratory and metabolic. These
can be further classified as respiratory acidosis, respiratory alkalosis, metabolic acidosis,
or metabolic alkalosis. However, more than one type ofpathological process can occur
simultaneously, given rise to a mixed acid-base disturbance, in which the blood pH may
be low, high, or within the nonnal interval (Bhagavan 1992; DiBartola 2000; Guyton and
Hall 2000; Heusel et al. 2001):
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a) Respiratory acidosis: If breathing is slow and shallow, the alveoli is not able
to rid itself of the C02 that diffuses from the blood. Therefore, the
concentration of CO2rises in the alveoli, causing the C02 to build up in the
body fluids. As the quantity of dissolved C02 in the body fluids increases, the
concentration of carbonic acid, bicarbonate ion, and H+ also increases (C02+
H20!::; H2C03 !::; H+ + HC03-). Therefore, the body fluids become more acid
and the pH falls, causing acidosis. In respiratory acidosis pe02 is increased.
b) Respiratory alkalosis: If breathing is rapid and deep, the C02 concentration
in the alveoli falls very low and there is increased diffusion of C02 from the
blood through the pulmonary membrane into the alveoli. Therefore, the
concentrations of dissolved carbon dioxide, carbonic acid, bicarbonate ion,
and H+ are depressed. The pH of the body fluids rises resulting in alkalosis.
In respiratory alkalosis pC02 is increased.
c) Metabolic acidosis: Normal metabolic processes produce considerable
amounts ofnonvolatile acids. Some acids are ingested and absorbed from the
gastrointestinal tract into the blood. Generally, the acidic salts oforganic
compounds are absorbed, and the organic portions of the compounds are then
metabolized into water and C02, leaving the acid radical behind causing an
increase in H+ concentration, thus leading to acidosis. Acidosis due to
retained CO2 is also a type ofmetabolic acidosis, because CO2 is derived from
metabolism. Thus, the term metabolic acidosis usually refers to the acidosis
causes by acid that cannot be excreted by the respiratory system but instead
must be excreted by the kidneys. Metabolic acidosis can result from: 1)
failure of the kidneys to excrete metabolic acids normally formed in the body,
2) formation of excess quantities ofmetabolic acids in the body, 3) addition of
metabolic acids to the body by ingestion or infusion of acids, and 4) loss of
base from the body fluids. In metabolic acidosis, pC02 and plasma
bicarbonate are decreased while the anion gap (difference between
unmeasured anions and unmeasured cations) can be increased.
d) Metabolic alkalosis: When there is an excess retention ofbicarbonate or loss
ofH+ from the body, the result is alkalosis. When large quantities of alkaline
34
drugs are ingested or alkaline salts of organic compounds an excess quantity
of alkali can occurs in the body fluids, or when excessive quantities of
hydrochloric acid are lost from the stomach. Metabolic alkalosis is not nearly
as common as metabolic acidosis.
There is a close association between blood gases and acid-base metabolism.
Appropriate electrodes allow the determination ofpartial pressure of oxygen (pOz),
partial pressure of carbon dioxide (pCOz), and pH in a single blood sample. From these,
the bicarbonate concentration [HC03-], COz content, base excess, and oxygen saturation
can be calculated and the general acid-base status evaluated (Lasker 1981).
2.5 Importance of Normal Plasma Calcium Levels
Concentration of Ca in plasma under normal conditions is maintained in a very
close range by the interaction of several factors, among them are the amount and form of
Ca and phosphorus (P) in the diet, the Ca:P ratio, the physiological state of the animal
and the functioning of the Ca-regulating hormones (PTH, vitamin D3 and calcitonin). If
any of these factors is altered it can affect the Ca homeostasis in the animal. The most
apparent effect is in decreasing (hypocalcemia = < 8 mg/dl) or increasing (hypercalcemia
= > 10 mg.dl» plasma Ca levels, which can cause adjustments in the Ca homeostatic
mechanisms or, depending on severity, specific metabolic disorders (Kaneko et al. 1997).
In hypocalcemia, the nervous system becomes progressively more excitable because of
increased neuronal membrane permeability. The peripheral nerve fibers become so
excitable that they begin to discharge spontaneously, initiating nerve impulses that pass
to the peripheral skeletal muscles, where they elicit tetanic contraction. In severe
hypocalcemia, the spasm ofthe skeletal muscle increase, particularly the muscles of the
extremities and the larynx. Laryngospasms can become so severe that the airway is
obstructed, and death by asphyxia results (Guyton 1956; Underwood 1981; Ganong
1987). In hypercalcemia, the nervous system is depressed, and reflex activity of the
central nervous system becomes sluggish. This induces depression in the contractility of
the muscular walls of the gastrointestinal tract causing constipation and lack of appetite.
In severe cases, calcium phosphate crystals can precipitate forming renal stones,
damaging renal function, and inducing calcification ofblood and soft tissues (West 1991;
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Guyton and Hall 1997). The most common of these two metabolic dysfunctions in animal
production is hypocalcemia, which induces the metabolic disease known as parturient
hypocalcemia or milk fever. Hypocalcemia « 8 mg of total Ca/dl) occurs because Ca
leaves the extracellular fluid pool to enter the mammary gland faster than it can be
replaced by intestinal Ca absorption or bone Ca resorption. The disease is characterized
by recumbence, which can damage nerves and muscles, and also by paralysis of the
smooth muscle, which causes loss of the eructation reflex, resulting directly or indirectly
in bloat or secondary pneumonia caused by inhalation ofrumen contents, then comma
and eventually death (Allen and Sansom 1985).
2.6 Approaches Used to Increase Plasma Calcium Levels
The most common approaches used to increase plasma Ca and reduce the
likelihood ofmilk fever have been the administration ofmassive doses ofvitamin D,
manipulation of dietary Ca, and acidification ofprepartal diets.
2.6.1 Administration of Vitamin D
Vitamin D has been used to prevent parturient hypocalcemia in dairy cows for
many years (Hibbs and Pounden 1955). For example, vitamin D2 has been supplemented
at levels of 20 to 30 million IV (MIV) daily for a maximum of 7 days starting 3 to 8 days
prepartum with positive results in reducing the incidence ofmilk fever (Hibbs and
Conrad 1976). Feeding vitamin D3at levels of 10,000, 50,000, or 250,000 ill daily
approximately two weeks prepartum tended to increase plasma Ca concentration reducing
the incidence ofmilk fever (McDermott et ale 1985).
Reinhardt and Conrad (1980) conducted an experiment in which vitamin D3at the
level of 10 MIV via intramuscular injection was administrated to pregnant non-lactating
Holstein and Jersey cows 5 to 7 days prior to parturition. The injection was combined
with a high Ca diet (130 g Ca and 35 g P/d) or with a high phosphorus diet (45 g Ca and
70 g P/d). Administration of vitamin D3 resulted in a 150 % rise (in both treatments) in
circulating 1,25(OH)2D3 24 h post-injection. By day 1 prepartum the 1,25(OH)zD3 levels
returned to pre-injection levels. The levels of 1,25(OH)2D3 in the plasma ofcontrol cows
did not change until parturition at which time the hormone increased from 100-200 pg/ml
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to 600 pg/ml. This was followed by a decrease to 200 pg/ml by day 2 post-partum.
These researchers concluded that injection of 10 Mill of vitamin D3overrode the tightly
controlled kidney 1a-hydroxylase enzyme resulting in overproduction of 1,25(OHhD3.
Littledike and Horst (1982) studied the effect of large parenteral doses (15 to 17.5
Mill) ofvitamin D3 on plasma Ca, vitamin D3 and 25(OH)D3, and 1,25(OHhD3
concentrations in Jersey cows. The results showed a significant increase in all the
compounds. None of the vitamin D3treated cows showed signals ofmilk fever.
However, 22 % of the control cows developed clinical signs ofmilk fever. Pregnant
cows injected with vitamin D3developed signs of toxicity. Ten out of 17 cows died,
showing evidence ofmetastic calcification. Those researches concluded that due to the
extreme toxicity ofvitamin D3 and the low margin of safety in doses tllat effectively
prevent milk fever, they did not recommend the use ofmassive doses ofvitamin D3 as a
means to prevent milk fever when injected several weeks prepartum.
2.6.2 Manipulation of Dietary Calcium
2.6.2.1 Low Calcium Diets
One of the most effective means to prevent milk fever is to avoid excessive
dietary Ca in the prepartum diet (Allen and Sansom 1985; Horst 1986; Horst et al. 1994).
This approach is based on stimulation of the Ca homeostatic mechanisms of the animal.
Low Ca in the diet will induce lower Ca plasma levels, this lower plasma Ca level will be
sensed by the parathyroid glands and synthesis and secretion of PTH will be increased.
This increase in circulating PTH will stimulate higher activity of the renal enzyme 1a-
hydroxylase and thus greater synthesis of 1,25(OHhD3, which in turn will stimulate
higher Ca absorption from the intestine, Ca reabsorption from kidneys and Ca resorption
from bone (Goff 1989).
It has been found that low Ca diets effectively increase the concentration of
circulating 1,25(OHhD3, and the efficiency of intestinal Ca absorption. Ramberg et al.
(1984) found that when dietary Ca in dairy cows dropped below 50 to 60 gld, the
efficiency of intestinal Ca absorption increased. When dietary Ca was 10 to 15 gld, the
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animals depended almost solely on bone Ca resorption to maintain nonnal plasma Ca
levels.
Goings et al. (1974) prevented parturient paresis in dairy cows by feeding a low
Ca diet (8 g ofCa daily per 450 kg body weight) for about 14 days prepartum. Changes
in plasma Ca and PTH occurred within 4 days of initiation of the feeding of the low Ca
diet. Calcium concentration reached a minimum (8.3 mgldl) approximately 36 h after
initiation of feeding the low Ca diet. Calcium concentration then slowly rose (9 mgldl)
until approximately 50 h after the minimum. These workers concluded that Ca
homeostatic mechanisms were effectively sensitized by the low Ca diet.
Yarrington et al. (1977) investigated the effect of feeding a low (9.5 g CaJd and
25 g P/d) or nonnal (25 g CaJd and 25 g P/d) Ca diet on Ca homeostatic mechanisms.
Feeding started 70 days prior to the calculated date ofparturition. The specific activity of
intestinal and renal CaBP, percentage ofbone surfaces undergoing resorption, urinary
hydroxyproline, and plasma PTH concentrations were higher 1 day postpartum for cows
fed the low Ca compared to the control diet. Urinary hydroxyproline excretion 1 day
postpartum was increased 553 % above prepartum values for cows fed the low Ca diet
compared to 345 % for the control cows. Serum Ca remained within nonnallinlits in the
cows fed the low Ca diet. Plasma PTH concentrations increased with the approach of
parturition in both groups of cows. Calcitonin activity in the thYroid gland was greater in
the cows fed the low Ca diet and ultrastructurally, secretory granules were more
numerous in thYroid C-ce1ls. These workers concluded that Ca homeostasis in cows fed
the low Ca diet prepartum was more under the fine control ofPTH-mediated bone
resorption with the approach ofparturition. Thus, greater reliance on bone Ca
mobilization than on intestinal Ca absorption may be a significant factor in the prevention
ofparturient hypocalcemia from low Ca diets.
Green et al. (1981) characterized the changes in vitamin D metabolites ofplasma
in dairy cows fed a high (80 gld) or low (8 gld) Ca diet for approximately 14 days before
parturition. Plasma Ca concentration decreased after initiation ofeither diet, but cows
fed the low Ca diet tended to have lower prepartum but greater peripartal plasma Ca
concentrations. Magnesium concentrations in plasma were not affected. Prepartum
1,25(OH)2D3 in plasma tended to be greater in cows fed the low Ca diet. It was
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concluded that the changes observed in plasma of the cows fed the low Ca diet were
associated with mobilization of the Ca homeostatic mechanisms several days before the
Ca demand of initiation of lactation.
Kichura et al. (1982) investigated the effect of feeding diets with different
combinations of Ca and phosphorus (P) to cows for about 4 weeks prepartum. Low Ca
diets had greater concentrations ofplasma 1,25(OH)2D3 and hydroxyproline prepartum,
greater plasma Ca concentration at parturition, and less incidence ofparturient paresis.
These workers concluded that low Ca diets, regardless of dietary P intake, seemed to
activate Ca homeostatic mechanisms before parturition by stimulating both intestinal Ca
absorption and bone Ca resorption.
2.6.2.2 Calcium Supplements
Oral administration of large amounts of Ca salts to force Ca into the blood by
passive diffusion can also be used to increase blood Ca concentration during the
periparturient period. The Ca salts used has traditionally been calcium chloride (CaCh)
and calcium propionate (Goff and Horst 1993). The CaCh solutions and gel preparations
are a soluble concentrated (36 %) and rapidly absorbed source of Ca (54 g of Ca).
However, CaCh solutions and gels have several disadvantages. Aqueous solutions of
CaCh and some gel products are very caustic and cause ulceration of the mouth and
digestive mucosa of some cows. All CaCh products reduce blood pH, and excessive oral
CaCh can induce metabolic acidosis (Horst et al. 1994, 1997).
Calcium propionate can be formed into a thick paste. It effectively raises plasma
Ca concentration, although its effect is not as rapid as with CaCho Its activity however, is
more sustained (Goff and Horst 1993). In contrast to CaCh, calcium propionate does not
affect blood pH. Furthermore, the propionate could serve as a gluconeogeneic precursor
at a time when the animal is in a negative energy balance. Calcium propionate has the
disadvantage ofbeing only 21.5 % Ca, thus requiring larger volumes of the preparation to
be given orally (Horst et al. 1997).
Goff et al. (1996) conducted an experiment to test the efficiency of a calcium
propionate paste as an aid to prevent milk fever. Two or three calcium propionate tubes
(37 g ofCa) were given at calving and again at 12 h after calving to Jersey and Holstein
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cows. For the Jersey herd, calcium propionate treatment (2 tubes) reduced the incidence
of milk fever from 50 % in control animals to 29 % in treated cows. Plasma obtained 24
h after calving from treated cows had higher Ca (7.23 mgldl) than plasma from control
(6.87 mgldl) cows. No effect was observed on the Holstein herd. However, calcium
propionate reduced the number of cows with subclinical hypocalcemia « 7.5 mgldl of
plasma Ca) in both herds. The conclusion was that calcium propionate was beneficial in
reducing subclinal hypocalcemia and in reducing the incidence ofmilk fever.
Dhiman and Sasidharan (1999) carried out a study to determine the effectiveness
of CaCh supplements such as gels and drench in increasing blood serum Ca
concentrations in periparturient dairy cows. Treatments were inert gel, gel containing
CaCh and vitamins, gel containing CaCh and minerals, and drench containing CaCh and
vitamins. The results showed that oral supplements of CaCh as gel or drench increased
the blood Ca levels in periparturient dairy cows. These researchers concluded than an
increased supply ofCa through oral supplements of CaCh may prevent milk fever in
cows that are marginally hypocalcemic.
2.6.3 Supplementation of Anionic Salts
Manipulation of the acid-base balance has successfully been used as a nutritional
tool to increase plasma Ca levels in periparturient dairy cows and so reduce the incidence
ofmilk fever (Block 1984, 1994; Block and LeClerc 1989; Tucker et ai. 1992; Horst et
ai. 1997; Goff and Horst 1998). It is recognized that acidification of the diets improves
Ca homeostasis by increasing the proportion ofdietary Ca absorbed from the intestines,
as well as the rate ofmobilization ofCa from the skeleton. This effect seems to be
mediated by increases in the rate ofproduction of 1,25-dihydroxyvitamin D3 and the
I
responsiveness of tissues to parathyroid hormone (Abu Damir et ai. 1994; Vagnoni and
Oetzel 1998). Anionic salts, including magnesium sulfate, ammonium chloride, and
calcium chloride, generally induce a mild compensated metabolic acidosis which is
characterized by extensive Ca excretion in urine (hypercalciuria), which in turn may be
responsible for stimulation of the vitamin D/Ca homeostatic mechanisms. It has been
observed that plasma hydroxyproline concentrations increase suggesting that bone
resorption may be stimulated because of the role ofbone in buffering systemic acidosis.
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In these studies, Ca absorption from intestine has been reported to be increased,
decreased or unchanged (Block 1984; Goff et al. 1991; Detzel 1993; Vagnoni and Detzel
1998).
Alterations in dietary cation-anion balance will influence acid- base status of the
animal. The degree depends on the quantity of the ion entering the system. Since anions
are considered acidogenic and cations alkalogenic, their content in a diet is commonly
used as a measure of its alkalinity or acidity. The dietary cation-anion balance (DCAB)
is defined as the sum in milliequivalents (mEq) of the cations, sodium (Na) and
potassium (K), minus the sum of the anions, chloride (CI) and sulfur (S), and expressed in
the fonnula: [Na + K) - (CI + S]. Thus, a positive DCAB means an alkaline diet while a
negative DCAB means an acidic diet. Calculation of the DCAB ofa diet requires using
the equivalent weights of the electrolytes because acid-base balance is affected by
electrical charge rather than mass. Dne equivalent weight is equal to the molecular
weight divided by the valence (Block 1984; LeClerc and Block 1989; Detzel 1993;
Perhson et al. 1999).
2.7 Manipulation of Plasma Calcium to Improve Beef Tendemess
It is generally accepted that proteolysis ofmyofibrillar proteins is a major
contributor to tenderization ofbeef during the postmortem period. Among the proteolytic
enzymes found in muscle tissue, the neutral proteases known as the calpain enzyme
system appears to be, at least partially, responsible for these changes. Calpains depend
on Ca for activity, and their activity is directly related to the concentration of Ca (the Jl-
and m-calpains require 3-50 and 400-800 JlM of Ca to be activated, respectively). These
enzymes degrade principally the proteins of the Z disk, resulting in changes in structural
and physical characteristics ofmuscle tissue, resulting in more tender meat. It has been
hypothesized if intracellular Ca levels ofmuscle fibers can be increased, the activity of
these enzymes postmortem will be increased. Two main approaches have been used to
increase Ca concentration in muscle: a) postmortem treatment, in which calcium chloride
is injected to meat cuts, and b) premortem treatment, in which vitamin D3 is
supplemented to live animals in order to increase Ca concentration in plasma and
subsequently in muscle.
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2.7.1 Calcium Chloride Injection
It was found that incubation ofbovine longissimus muscle slices obtained 12 h
postmortem, in a buffer solution containing calcium chloride (CaCh), accelerated
myofibrillar proteolysis. These changes occurred within the first 24 h of incubation. No
beneficial effect was observed with the same buffers containing Ca chelators (10 mM
EGTA or 10 mM EDTA)(Koohmaraie et al. 1988a). Because none of the treatments
affected lysosomal enzyme activities (cathepsin B, H and L) and because there was a
decrease in calpains activity, these researchers concluded that a) postmortem
tenderization was mediated by Ca, and b) that the calcium-dependant proteases (calpains)
were responsible for postmortem tenderization. In a subsequent study, Koohmaraie et al.
(1988b) infused lamb carcasses (through carotid artery) with 0.3 M CaCl2 immediately
after death. Infusion of CaCh resulted in acceleration of the postmortem tenderization
process. These workers concluded that Ca is important to increase the activity of the
calpain enzymes, which are responsible for myofibrillar proteolysis. In another study,
Koohmaraie et al. (1989) examined the effect of infusing different concentrations and
ionic strengths ofCaCh to ovine carcasses. It was observed that 0.3 M CaCh gave the
best response in increasing the activity of the calpains. Enzyme activity was maximum
during the first 24 h after infusion. Shear force values were reduced 50 % in carcasses
treated with CaCh compared with untreated carcasses on day 1.
Subsequently, CaCh infusions were extended to beef carcasses (Koohmaraie and
Whipple 1990; Morgan et al. 1991b), and to specific muscle cuts (Wheeler et al. 1991;
Wheeler and Koohmaraie 1992), or by marination of subprimal meat cuts (Whipple and
Koohmaraie 1992).
It was concluded from these studies that: 1) injection ofCaCh represents an
effective way to increase intracellular Ca levels ofmuscle, 2) the external Ca stimulates
higher activity of the calpain enzyme system, 3) which results in greater myofibril protein
degradation, and 4) increased myofibrillar degradation is associated with reduced shear
force values, an indication ofmore tender meat.
There are some disadvantages in the use of this technique in commercial practice.
These include: 1) CaCh at the concentrations of 0.3 M has proved to be the most
adequate infusion dose (Koohmaraie et al. 1989), however, at this concentration CaCh
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tends to produce bitter and off-flavors (Morgan et at. 1991b); 2) manipulation of
carcasses or meat cuts for CaCh infusion represents a significant increase in labor and
facilities as well as a safety issue with respect to preparation and administration of
solution. The risks and expenses associated with this method outweigh its advantages.
Methods to increase the concentration of Ca in muscle while the animal is still
alive, could potentially be of interest to the beef industry. In this case, Ca will be
distributed throughout the muscles of carcass such that the improvement in meat
tenderness will be on the whole carcass (systemic distribution) and not just in some meat
cuts. Moreover, the need for increased labor and/or facilities will be eliminated.
2.7.2 Vitamin D3 Supplementation on Beef Tenderness
Owens et at. (1998) stated that the supplementation ofhigh levels ofvitamin D3
(5 million ill or more per head per day) for approximately 5 to 10 days to finishing steers
prior to slaughter could result in improved beef tenderness. These authors suggested that
the improved beef quality was a result ofhigher activation of the Ca-activated enzymes,
the calpains. The rationale is that higher levels of vitamin D3 in plasma will induce the
synthesis of the hormonal form of vitamin D3 (1,25(OH)2D3), which will act upon the
epithelial cells to improve the efficiency of Ca absorption, as well as on kidneys and bone
to increase the rate of Ca reabsorption and resorption, respectively. All these actions will
induce greater plasma Ca levels, however, as plasma Ca is maintained in a very close
range, the excess of Ca in plasma is mobilized to other tissues, among them muscle. It is
hypothesized that this excess of Ca in muscle will stimulate higher activity of the
proteolytic calpain enzymes, which dissolve myofibrillar proteins in the Z-disk of the
sarcomere. The result is an improvement in beef tenderness.
The first research in this area was carried out by Swanek et at. (1997), in which
two experiments were reported. Beef steers were supplemented in trial 1 with 5 million
IV (MIV) ofvitamin D3 (D3) per day for 5 days immediately prior to slaughter. In trial 2
the cattle were supplemented with 7.5 Mill D3 per day for 10 days prior to slaughter. In
trial 1, total Ca in plasma Ca increased from 9.23 to 10.39, a 12.6 % increase. Shear
force values of steaks from treated animals were reduced by 6.6 % and the number of
unacceptable tough steaks by 21.8 % at 7 days postmortem. In trial 2, shear force values
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were reduced by 18 % at 7 days postmortem aging, and the number of tough steaks was
reduced by 23.3 and 22.5 % at 14 and 21 days ofpostmortem aging. These workers
concluded that an increase in activity of the proteases associated with the calpain system
could be responsible for the improvement in beef tenderness. In subsequent work,
supplementation of steers was carried out at levels of 0, 2.5, 5, and 7.5 MID D3 per day
for 10 days (Swanek et al. 1999). Blood ionized Ca increased linearly between days 6
and 13. The 7.5 MID D3treatment had blood Ca levels that were 40 to 50% greater than
those from control animals. The 5 Mill D3treatment resulted in greater muscle Ca
concentration than from control muscle tissue. Sensory panelists rated samples from
vitamin D3 supplemented steers as more tender than the unsupplemented steers (Swanek
et ai. 1999).
Montgomery et ai. (1998) administered to beef steers 0,5 or 7.5 Mill ofvitamin
D3 (via boluses) per day for 9 days. Cattle were slaughtered 2 days later. Vitamin D3
treatment increased plasma (30 and 40 % for the 5 and 7.5 Mill D3, respectively) and
muscle Ca (30 % for the 5 Mill D3) concentration. The two levels ofyitamin D3 were
equally effective in reducing shear force values (approximately 15 % reduction at 14 days
postmortem). In a subsequent report, Montgomery et al. (2000) using the same levels of
supplemental vitamin D3than in previous work, found that concentrations ofvitamin D3
and 25(OHhD3 increased in plasma, liver and muscle in direct relationship with the
amount ofvitamin D3 supplemented. In contrast, 1,25(OH)2D3 was not affected. These
workers also found higher proteolytic activity (greater activity of the calpain enzyme
system, in particular fl-calpain) in muscle tissue from vitamin D3 treated steers than from
controls. However, this proteolytic activity was higher from the 5 MID D3than for the
7.5 Mill D3 treatment. This suggests that 5 MID D3per day for at least 5 days represents
a potential method to increase beef tenderness and consumer acceptance.
Karges et ai. (1999a) supplemented beef yearling steers with 0, 5, 7.5, 15 and 75
Mill D per day. It was observed that feed intake was significantly depressed in an
inverse relationship with the amount ofvitamin D supplemented. In a subsequent work
Karges et ai. (1999b) supplemented finishing steers with 0 or 6 Mill ofvitamin D (in
pellets) for either 4 or 6 days. It was found that tenderness was numerically increased as
a result ofvitamin D supplementation. In a subsequent study, it was found that plasma
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Ca concentration increased by vitamin D supplementation and was increased to a greater
degree by feeding vitamin D for 6 than for 4 days (Karges et al. 1999c). It was observed
that calpastatin activity at 0 or 24 h was not affected by vitamin D supplementation.
Karges et al. (2001) conducted an experiment to determine the effect of vitamin D3
supplementation on plasma Ca concentration, carcass traits, and tenderness. Vitamin D3
was fed to beef steers at 0 or 6 MIU daily for 4 or 6 days. The results showed a
significant increase on plasma Ca concentration, a decrease in shear force values, no
difference in palatability traits, a delayed pH decline, and an increase in water holding
capacity in meat from the supplemented steers. These researchers concluded that
supplementation ofvitamin D at levels of 6 MIU appears to represent a reliable method
to increase plasma Ca concentration, improve tenderness and the water holding ,capacity
ofbeef.
Scanga et al. (2001) carried out an experiment to develop a recommendation for
the optimum dose and duration of administration ofvitamin D3 for purposes of improving
beef tenderness. Beefheifers were supplemented with vitamin D3(via boluses) at 1, 2 (2
plus 75 g ofCaC03), 3,4 (4 plus 75 g ofCaC03), or 5 Mill daily for 2,4,6, or 8 days
prior to slaughter. The results showed that hot carcass weight, dressing percentage,
USDA Yield Grade, or USDA marbling score were not affected. Total serum Ca
concentrations were increased as a result ofvitamin D3 supplementation. Surprisingly,
the 1 Mill D3 treatment had the highest serum Ca concentration (13.3 vs 12.7 mgldl for
the 5 MIU D3 treatments). There were no differences in shear force values or in
tenderness of cooked steaks (at 75 or 85°C) from supplemented cattle. These results do
not agree with previous research. These workers concluded that more work needs to be
carried out to determine the impact ofvitamin D3 on beef tenderness.
From this review, is clear that supplementation ofvitamin D3 to beef cattle can
result in increased plasma Ca concentration, and subsequently in higher muscle Ca
concentrations. This intracellular Ca can stimulate greater activity of the calpains,
enhancing beef tenderness. However, as pointed out by Owens et al. (1998), high levels
ofvitamin D3 supplementation present two main disadvantages, the first has to do with
animal welfare and animal performance; and the second with food safety and public
health. Feeding high levels ofvitamin D3 depresses feed intake (Berry et al. 2000). This
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affects animal performance, and prolonged high dietary doses can cause vitamin D3
toxicity characterized by muscle weakness, renal and cardiovascular failure and death
(DeLuca 1980; Spirichev and Sergeev 1988). Montgomery et al. (2000) found that
supplementation ofhigh levels (5 or 7.5 MIU/hd/d) of vitamin D3 induced significant
increases in vitamin D3 and 25(OH)D3 concentrations in plasma, muscle, liver and
kidney. Thus, meat containing high levels ofvitamin D3 can potentially induce vitamin
D3 toxicity in consumers, characterized by anorexia, nausea, formation ofrenal stones,
and calcification of soft tissues (Glerup and Eriksen 2000). It is clear that
supplementation ofhigh levels (5 MIU/hd/d or more) ofvitamin D3 represents a viable
method to increase plasma Ca levels to a point where improvements in beef tenderness
has been observed (Swanek et al. 1997, 1999; Montgomery et al. 1998, 2000; Karges et
al. 1999a,b,c, 2001). However, high levels of vitamin D3 also represent high risks in
animal and human health. It would be of value to minimize the risks by feeding lower
levels ofvitamin D3or to augment the effects ofvitamin D3 feeding via other methods of
dietary manipulation ofplasma Ca levels. Such practices might include a designated
period prior to slaughter where dietary Ca levels are reduced as common with dairy cows
prior to calving or manipulation of the dietary cation-anion balance combined with lower
levels of vitamin D3 feeding. This approach may increase plasma Ca levels to a point
where beef tenderness is ultimately improved, without using levels ofvitamin D3 that risk
toxicity.
2.8 The Objectives of the Research Project
The general objectives of the present thesis were to evaluate:
a) The effects of feeding graded levels of vitamin D3 on total and ionized serum Ca
concentrations and on feed intake of cattle fed diets common to Western Canada.
b) How graded levels ofvitamin D3 affect circulating concentrations of vitamin D3
and its metabolites and subsequently Ca homeostatic mechanisms.
c) The effects ofmanipulation ofdietary Ca levels on the response of serum Ca
levels to vitamin D3 supplementation.
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d) If dietary Ca manipulation coupled with anionic salt supplementation could be a
suitable method to increase serum Ca concentrations as a result of vitamin D3
supplementation.
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CHAPTER III
Effect of Supplemental Vitamin D3 on Feed Intake and on Serum Calcium
Concentrations of Steers fed Barley Grain-Based Finishing Diets
3.1 Introduction
Beef is greatly appreciated and consumed in many countries in the world.
However, its consumption can be limited by several factors, among them, its perceived
quality. In particular, tenderness and consistency constitute one of the most important
issues in the beef industry (Boleman et ale 1997).
Tenderness is considered to be the single most important component in meat
quality, as evidenced in the relationship between the price of a cut and its estimated
tenderness (Karges et al. 1999b). Furthermore, inadequate tenderness can cause valuable
losses to the beef industry (Smith et ale 1995).
Tenderness is related to postmortem proteolysis (Boehm et. ale 1998), and it has
been widely hypothesized to be the result of degradation of the myofibrillar proteins near
the Z-disks (Kendall et ale 1993). The calpain proteolytic system plays a key role in the
postmortem proteolysis that leads to increased tenderness (Geesink and Koohmaraie
1999). This proteolytic system consists of two isoenzymes that are activated by Ca with
differing sensitivities. The f..l-calpain isoenzyme requires a micromolar order ofCa2+ and
m-calpain a millimolar order ofCa2+ for activation. The third enzyme is called
calpastatin, which has the function to inhibit the activity of the calpains (Kendall et ale
1993; Geesink and Koohmaraie 1999).
It has been shown that calcium chloride infusion to pre-rigor beef can improve
tenderness (Koohmaraie et al. 1989). This work led to the theory that manipulation of
plasma Ca levels in the living animal, prior to slaughter, would also lead to an
improvement in tenderness. Increases in muscle Ca concentration could be achieved by
increasing Ca concentration in plasma (Montgomery et ale 1998) because Ca
concentration in the extracellular fluid is maintained within a narrow range (8 to 10
mgldl), and any excess is immediately diverted to other tissues or excreted (Rosol et ale
1995). This homeostatic mechanism is controlled by the calciotrophic hormones:
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parathyroid hormone (PTH), calcitonin and vitamin D3 in its hormonal form (l,25-
dihydroxyvitamin D3) (DeLuca 1979; Cunninghanl 2002).
Vitamin D3has been used to regulate Ca homeostasis in the event ofmetabolic
diseases such as rickets and osteomalacia (Guyton 1956), or to prevent milk fever
(Higgins 1955). In both cases, vitamin D3 has effectively increased plasma Ca
concentration. Recently, high levels ofvitamin D3have been supplemented to beef cattle
at the end of the finishing period with the purpose of increasing plasma Ca, and
subsequently in muscle, with the expectation that excess Ca in muscle can increase
calpain activity and so, enhance meat tenderness.
Swanek et al. (1997, 1999) conducted several trials to evaluate the effect of
supplemental vitamin D3on beef tenderness. In one of the trials the steers were
supplemented with 5 million IV (Mill) ofvitamin D3 (D3) per day for 5 days
immediately prior to slaughter, which resulted in an increase of 12.6 % in plasma Ca,
leading to a reduction of 6.6% in shear force values and a 21.8% decrease in the number
of unacceptably tough steaks. In a second trial, steers were supplemented with 7.5 Mill
D3 per day for 10 days prior to slaughter. Plasma Ca was increased approximately 34 %,
which resulted in a reduction of 18.0 % in shear force values and 23.3 % in the nUITlher of
unacceptably tough steaks. These authors concluded that the observed improvement in
tenderness could be due to increased activity of the calpain system.
Montgomery et al. (1998,2000) studied the effects ofhigh levels of vitamin D3
supplementation on plasma and muscle Ca concentration and subsequently on beef
tenderness. Vitamin D3 treatments were 5 and 7.5 Mill D3 per day for 9 days, with the
cattle slaughtered 2 days later. Plasma and muscle Ca concentrations were significantly
increased in treated steers, although, the 5 MID level produced a higher muscle Ca
concentration than the 7.5 Mill treatment. As a result, muscle shear force values were
lowered. These workers concluded that 5 MID D3per day for 10 days before slaughter
may be an effective way to improve beef tenderness.
Karges et al. (l999b) supplemented finishing steers with 6 Mill D3 per day for 4
or 6 days prior to slaughter. They found that vitamin D3 supplementation reduced the
number ofunacceptable steaks. However, supplementation tended to decrease feed
intake and hot carcasses weights.
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It can be concluded from the results of these studies, that the supplementation of
high levels of vitamin D3 (5 MIU or more per day) for 5 to 10 days prior to slaughter can
increase Ca concentration in plasma and muscle, resulting in an improved meat
tenderness. However, there are two concerns with the use ofhigh levels of vitamin D3.
The first has to do with food safety (Owens et al. 1998). High levels of vitamin D3 can
result in high residual levels in meat and other edible tissues (Montgomery et al. 2000
and in press). The second has to do with animal performance, as high supplemental
levels tend to depress feed intake (Owens et al. 1998; Karges et al. 1999a,b; Scanga et al.
2001), a situation that can affect carcass characteristics (Berry et al. 2000).
In the face of these potential problems, it is of interest to determine the response
ofplasma Ca to lower levels of supplemental vitamin D3. It is also of interest to examine
the relationship between supplemental vitamin D3 levels and serum Ca using diets
common to Western Canada.
Therefore, the objective of this study was to investigate the effects of feeding
graded levels (1.25, 2.5 and 5 MIU/hdJd for seven days) ofvitamin D3 on serum total and
ionized Ca levels and on feed intake ofcattle fed diets common to Western Canada.
3.2 Material and Methods
3.2.1 Experimental Design
3.2.1.1 Adaptation Period (days Al to A33)
Fifteen Angus steers (452 ± 28 kg) were housed in individual pens (3.6 x 3.6 m)
with automatic water bowls in the Livestock Research Barn of the Department ofAnimal
and Poultry Science at the University of Saskatchewan. Animals were cared for
according to the guidelines of the Canadian Council ofAnimal Care. The cattle were
adapted to the experimental diet for 33 days. The ration consisted of75 % concentrate
(barley grain base) and 25 % barley silage (as fed) meeting the nutritional requirements
for this type ofcattle according to the National Research Council (NRC 1996) (Table
3.1).
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Table 3.1 Ingredient composition and fonnulated nutrient levels of the experimental
diet.
Item
Total mixed diet:
Concentrate
Barley silage
Concentrate:
Barley grain
Canola meal
Tallow
Limestone
Rumensin Z
Vitamin Y
Salt
Fonnulated composition x:
Digestible energy, Mcal/kg W
Crude protein, %
Calcium, %
Phosphorus, %
Ca:P
DM (0/0)
87.2
12.8
87.8
3.9
5.5
1.2
0.6
0.4
0.6
3.60
13.15
0.52
0.36
1.48
Z Premix: Monensin (20% active) mixed with barley grain.
Y Premix: Vitamin A (416,650 IU/kg) and vitamin D (83,333 IU/kg).
x Nutrient Requirements of Beef Cattle. National Research Council (1996).
W Predicted TDN x 4.4 Mcal/kg (Weiss et al. 1992).
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Feed was offered twice a day (0700 and 1600 h), with orts collected and weighed
everyday before the morning feeding. Individual maximum voluntary intake were
estimated from day A20 to A26. Then, voluntary intake was then restricted to 85% from
days A27 to A33 to allow for cattle to even their intake and consume all feed offered.
Initial blood samples were obtained by jugular venipunture on days A17, A24 and
A31 at approximately 1300 h. These samples served as the pre-treatment control
samples. Blood samples were collected into 7ml-draw evacuated (Vacutainer®) tubes
without anticoagulant, blood was then allowed to clot at room temperature for
approximately 2 h. They were centrifuged at 3500 rpm for 15 min. The serum was used
for the determination of total and ionized Ca concentrations.
3.2.1.2 Supplemental Period (days SI to S7)
During this period, the diet and the feeding pattern were the same as in the last
week ofthe adaptation period (feed restriction to 85%, two feedings a day). Feed intake
was monitored daily, with orts collected and weighed everyday before the morning
feeding.
The steers were randomly assigned to one of the following vitamin D3
supplemental treatments: 1.25, 2.5, and 5 Mill of vitamin D3per steer per day, for seven
consecutive days, with five steers per treatment.
The vitamin D3 supplementwas prepared from the vitamin D3premix containing
500,000 IU per gram (Rhone-Poulenc Canada Inc.), using ground barley as a carrier. The
vitamin D3 supplement was formulated to have a final concentration of 13.0 Mill D3 per
kg of supplement. This supplement was analyzed (New Jersey Feed Laboratory, Inc.)
and the actual concentration was 13.13 ±0.15 MIU D3per kg. The total daily amount of
vitamin D3 supplement assigned per steer per day was equally divided and supplied at
each feeding. The supplement was top-dressed onto the ration and thoroughly mixed by
hand before delivering into the feed bunk.
Daily blood samples (from day 81 to 87) were obtained and processed from each
steer, under the same protocol as in the previous period.
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3.2.1.3 Withdrawal Period (days WI to W8)
Once vitamin D3 supplementation ended, the steers were maintained for five days
under the same experimental conditions to evaluate post-treatment effects. Immediately
after the bleeding on day W5, the cattle were shipped back to the feedlot.
During this period, feed was offered without restriction according to their
individual daily consumption. Similarly, feed intake was monitored daily with orts
collected and weighed before every morning feeding.
Blood samples were obtained from day WI to W5 in the metabolism barn, and on
day W8 at the feedlot. Blood sampling was carried out under the same protocol as in
previous periods.
3.2.2. Laboratory Analyses
3.2.2.1 Total Calcium Determination
Total Ca in serum was determined by indirect potentiometry utilizing a Ca ion
selective electrode in conjunction with a sodium reference electrode under the
SYNCHRON LX System (Beckman Coulter, Inc., Fullerton, CA. USA). Total Ca was
calculated from free Ca once the molar ratio between free and total Ca concentrations
was constant. To achieve a constant molar ratio between total and free Ca, a buffered
solution (which contains strong Ca complexing agents) was used. The ratio was one part
serum to 21 parts buffered solution (LX ISE Electrolyte Buffer Reagent: Tris). The high
molar strength buffer served to establish a constant activity coefficient for Ca ions. The
electrode was then calibrated to standard concentration values, and unknowns calculated.
3.2.2.2 Ionized Calcium Determination
Ionized Ca in serum was determined by the use of an ion selective electrode
(Radiometer ABL 700 Series Analyzer. Copenhagen). The analyzer measures the
differential in voltage between a reference electrode and a Ca ion-selective electrode in a
solution. The potential established by the unknown solution is compared with the
potential developed by a standard solution ofknown ionic strength and ion composition.
Three electrodes are seated in a temperature-controlled module (37°C). The serum
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sample moves along the sample path by peristaltic pumps. The pH of the serum was
measured by a pH glass and reference electrode, adjusting ionized Ca values to pH 7.4
(Gases Ionized Calcium. Operator's Manual. Ciba-Corning 634 Ionized CaJpH system).
3.2.3 Statistical Analysis
The data was analyzed using the Analysis of Variance Technique including
Repeated Measures Analysis using the General Linear Model procedure of SAS (SAS
1989) to compare treatments within days and over time (across the experimental periods).
The following model for the repeated measures analysis was used:
Model: Yijk = J..l + ai + 'tij + Ok + (a8)ij + Sijk
where:
Yijk = is the response at time k on animal j in treatment i.
J..l = is the overall mean.
ai = is a fixed effect of treatment i.
'tij = is a random effect of animal j in treatment i.
Ok = is a fixed effect of time k.
(ao)ij = is a fixed interaction effect of treatment i with time k.
Sijk = is the random error at time k on animal j in treatment i.
Single degree of freedom contrasts:
A = Pre-treatment control value vs the 1.25 MID treatment.
B = Pre-treatment control value vs the 2.5 Mill treatment.
C = Pre-treatment control value vs the 5.0 MID treatment.
3.3 Results and Discussion
3.3.1 Feed Intake (DMI)
Voluntary individual intake calculated from day A18 to A24 of the adaptation
period averaged 10.89 ± 1.42 kg ofDM (Table 3.2 and Figure 3.1). Feed intake was then
restricted to 85% ofad libitum for days A25 to A31. The aim was to eliminate as much
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as possible any daily fluctuation. Variation in intake during the supplemental period
could then be considered a direct effect of treatment.
Vitamin D3 supplementation depressed (P<0.05) feed consumption from day 6 of
supplementation (S6) to approximately day 3 of the withdrawal period (W3) for all the
treatments. Minimum intake values were attained on day WI, and they represented an
18.7,27.7, and 36.7 % reduction (P<0.05) in feed consumption with respect to the
average pre-treatment value for the 1.25, 2.5 and 5.0 Mill treatments, respectively. No
differences (P>0.05) among treatments were detected. Feed intake tended to recover
after supplementation, however, intakes were still lower than pre-treatment values, 4 days
after supplementation (Table 3.2 and Figure 3.1).
Repeated measures analysis indicated that feed intake was depressed (P<O.OOOI)
over time as a result ofvitamin D3 supplementation with no differences between
treatments (Table 3.2). This depression in intake as a result ofvitamin D3
supplementation has been acknowledged in other studies. Karges et al. (1999a)
conducted an experiment to detennine the effect ofhigh levels ofvitamin D3
supplementation on feed intake. Yearling steers were supplemented with 5, 7.5, 15 and
75 Mill D3, per day for 12 days. Feed consumption began to be depressed on days 2, 4,
5, and 6 for the 75, 15, 7.5 and 5 Mill treatments, respectively. These workers concluded
that depression in intake as result ofhigh levels of vitamin D3 was a dose-response effect.
In the present experiment this tendency was also observed, even with lower doses of
supplementation.
In another study, Karges et al. (1999b) restricted intake to 90% of ad libitum
intake when supplementing 6 MID D3 to finishing steers for 4 or 6 days. Intake
decreased 11.7 and 14 % on days 4 and 6 of supplementation, respectively. In the current
study, restriction was slightly higher (85%) but the depression observed was much higher
in the 5 Mill treatment (36.7 %).
Montgomery et al. (in press) supplemented feedlot steers with 0.5, 1,2.5, 5 and
7.5 Mill D3 for 9 days before slaughter. Feed intake was linearly decreased during the
last 3 days of supplementation, with only the 2.5, 5 and 7.5 Mill doses negatively
affecting ADG and feed intake. In the present study, even the 1.25 Mill D3 treatment
depressed intake. Similar results were observed by Berry et al. (2000).
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Table 3.2. Effect of supplementing high levels of vitamin D3 for seven consecutive days
on feed intake (DMI) of finishing Angus steers (452 ±30 kg BW).
DMI (kg)
Vitamin D3 Level (MID/hd/d) Contrast Z
Days 1.25 2.5 5.0 8EM A B C
Group 1 2 3
Adaptation Period Y:
A 10.26 11.78 10.63 0.69
85% 8.72 10.01 9.03
Supplemental Period x:
81 8.69 9.86 9.00 0.61 0.4552 0.2067 0.8251
82 8.69 9.78 9.00 0.60 0.4552 0.2742 0.8251
83 8.43 8.80 8.97 0.81 0.2556 0.4446 0.7980
84 8.50 9.28 8.79 0.63 0.3032 0.8784 0.6494
85 8.39 9.12 7.53 0.63 0.2333 0.8750 0.0715
86 7.84 7.10 6.70 0.89 0.0479 0.0002 0.0080
87 7.75 7.74 6.34 0.74 0.0362 0.0066 0.0026
Withdrawal Period Y:
W1 7.07 7.13 5.70 0.82 0.0026 0.0002 0.0003
W2 7.80 8.28 6.63 0.84 0.0428 0.0807 0.0065
W3 8.34 7.43 7.13 0.87 0.2083 0.0012 0.0269
W4 8.87 8.30 8.08 0.69 0.6229 0.0887 0.2220
Repeated Measures Analysis:
P values
Treatment 0.5787
Time <0.0001
Time x treatment 0.0926
Z Contrasts:
A = Control restricted vs the next experimental day in 1.25 MID treatment.
B = Control restricted vs the next experimental day in 2.5 Mill treatment.
C = Control restricted vs the next experimental day in 5 MID treatment.
Y Feed intake ad libitum.
x Feed intake restricted to 85% ofad libitum.
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Figure 3.1. Effect of supplementing high levels ofvitamin D3 on feed intake (DMI) of
finishing Angus steers (452 ± 30 kg BW), during pre-treatment (A), treatment (Sl to S7)
and post-treatment (WI to W4) periods.
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DepressIon of feed intake of feedlot animals as a result of supplementing high
levels of vitamin D3 appears not to be related to palatability factors. This conclusion is
based on the observation that vitamin D3has been administered by top-dressing the diet
(Karges et ai. 1999a; Montgomery et ai. in press), as pellets (Karges et ai. 1999b,c), and
by intraruminal boluses (Montgomery et ai. 1998, 2000). In all cases, a significant
depression in feed consumption was observed. This decline in consumption has been
directly related to the amount of vitamin D3 supplemented. That is, higher levels of
supplementation induced higher levels of depression. It is likely that vitamin D3
supplementation causes metabolic (alteration of the normal acid-base balance) or
physiological changes (Owens et ai. 1998), which could be responsible for the reduced
intake of the supplemented cattle.
The depression in feed intake observed in the present study influenced the total
amount ofvitamin D3consumed. Total vitamin D3 consumption averaged 96.1 % (1.20
Mill/d), 90.3 % (2.26 MID/d) and 89.4 % (4.48 Mill/d) for the 1.25,2.5 and 5 Mill
treatments, respectively.
3.3.2 Total and Ionized Serum Ca
Serum levels of the three pre-treatment control samples for total and ionized Ca
concentrations were 10.61 ± 0.35 and 5.12 ± 0.15 mgldl, respectively (Tables 3.3 and 3.4
and Figures 3.2 and 3.3). Normal Ca concentration in blood ranges from 9.0 to 11.0
mgldl and from 4.8 to 6.4 mg/dl, for total and ionized Ca, respectively (Guyton 1956;
Copp 1973; Smith et ai. 1983; Rosol and Capen 1997). Thus, the total and ionized serum
Ca concentrations found in the present experiment appeared to be in good agreement with
the normal ranges reported in the literature.
In this study, it was found that supplementation ofvitamin D3 did not influence
(P>O.05) total Ca concentrations relative to the control period during the first three days
of supplementation. For the 2.5 and 5 Mill treatments, total Ca concentration was
increased (P<O.OOOI) from day 4 of supplementation (S4) until day 5 of the withdrawal
(W5) period. Even the concentration on day W8, while decreased was still higher
(P<0.05) than pre-treatment control values. In contrast, total Ca concentrations for the
1.25 Mill treatment were not different (P>0.05) from pretreatment values throughout the
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Table 3.3. Effect of supplementing high levels of vitamin D3 on total serum Ca
concentrations of finishing Angus steers (452 ±30 kg BW).
Total Ca (mgldl)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days 1.25 2.5 5.0 8EM A B C
Group 1 2 3
Adaptation Period:
AID 10.59 10.90 10.66 0.12
A24 10.34 10.68 10.60 0.19
A3l 10.26 10.80 10.68 0.13
Average: 10.61 ± 0.35
Supplemental Period:
81 10.38 10.66 10.61 0.08 0.2666 0.7986 1.0000
82 10.40 10.80 10.89 0.10 0.3021 0.3085 0.1946
83 10.60 10.98 11.02 0.16 0.9682 0.0526 0.0600
84 11.04 11.58 11.47 0.18 0.0337 <0.0001 0.0001
85 10.77 11.45 11.25 0.21 0.4267 <0.0001 0.0036
86 10.93 11.33 11.30 0.21 0.1137 0.0002 0.0016
87 10.99 11.70 11.98 0.21 0.0584 <0.0001 <0.0001
Withdrawal Period:
WI 10.96 11.63 11.94 0.26 0.0823 <0.0001 <0.0001
W2 10.78 11.55 . 12.21 0.29 0.4041 <0.0001 <0.0001
W3 10.85 11.67 12.29 0.23 0.2342 <0.0001 <0.0001
W4 11.03 11.42 12.25 0.22 0.0370 <0.0001 <0.0001
W5 10.98 11.52 12.43 0.27 0.0695 <0.0001 <0.0001
W8 10.52 11.15 11.35 0.24 0.6907 0.0048 0.0008
Repeated Measures Analysis
P values
Treatment 0.0041
Time <0.0001
Time x treatment 0.0003
Z Contrasts:
A = Control restricted vs the next experimental day in 1.25 Mill treatment.
B = Control restricted vs the next experimental day in 2.5 Mill treatment.
C = Control restricted vs the next experimental day in 5 MID treatment.
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Figure 3.2. Effect of supplementing high levels ofvitanlin D3 on total serum Ca
concentrations of finishing Angus steers (452 ±30 kg BW), during adaptation (AI to
A3I), supplemental (81 to 87), and withdrawal (WI to W8) periods.
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Table 3.4. Effect of supplementing high levels of vitamin D3 on ionized serum Ca
concentrations of finishing Angus steers (452 ± 30 kg BW).
Ionized Ca (mgldl)
Vitamin D3 Level (MID/hd/d) Contrasts Z
Days 1.25 2.5 5.0 8EM A B C
Group 1 2 3
Adaptation Period:
AiD 5.08 5.18 5.16 0.05
A24 5.05 5.25 5.22 0.08
A3i 4.91 5.16 5.05 0.05
Average: 5.12±0.15
Supplementation Period:
8i 5.01 5.21 5.17 0.05 0.2359 0.3518 0.6912
82 4.91 5.17 5.19 0.07 0.0280 0.6051 0.5562
83 5.13 5.39 5.34 0.07 0.9160 0.0053 0.0845
84 5.15 5.38 5.37 0.07 0.7155 0.0067 0.0484
85 5.08 5.36 5.39 0.06 0.6801 0.0134 0.0308
86 5.26 5.46 5.55 0.08 0.1392 0.0006 0.0008
87 5.14 5.66 5.58 0.09 0.7809 <0.0001 0.0004
Withdrawal Period:
Wi 5.19 5.61 5.74 0.16 0.4266 <0.0001 <0.0001
W2 5.21 5.73 5.90 0.14 0.3337 <0.0001 <0.0001
W3 5.22 5.70 5.89 0.14 0.2552 <0.0001 <0.0001
W4 5.39 5.63 6.03 0.14 0.0038 <0.0001 <0.0001
W5 5.26 5.59 6.00 0.16 0.1392 <0.0001 <0.0001
W8 4.82 5.25 5.30 0.18 0.0015 0.1729 0.1579
Repeated Measures Analysis
P values
Treatment 0.0040
Time <0.0001
Time x treatment 0.0070
Z Contrasts:
A = Control restricted vs the next experimental day in 1.25 MID treatment.
B = Control restricted vs the next experimental day in 2.5 Mill treatment.
C = Control restricted vs the next experimental day in 5 MID treatment.
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Figure 3.3. Effect of supplementing high levels of vitamin D3 on ionized serum Ca
concentrations of finishing Angus steers (452 ±30 kg BW), during adaptation (AI to
A3I), supplemental (81 to 87), and withdrawal (WI to W8) periods.
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the experiment (Table 3.3 and Figures 3.2).
Parallel changes were observed in regard to ionized Ca. However, increments
were significant (P<0.05) from day S4 to W5, for the 2.5 and 5 Mill treatments. On day
W8, ionized Ca concentrations returned to normal levels for all treatments. The 1.25
Mill treatment had similar (P>0.05) serum ionized Ca levels as the pre-treatment control
value throughout the experiment (Table 3.4 and Figure 3.3).
The repeated measures analysis indicated a significant effect of time, treatment
and time by treatment interaction for total and ionized Ca, which is illustrated in Figures
3.2 and 3.3. While total and ionized serum Ca concentrations increased over time for all
the treatments, they did so to a greater extent for the 5 MID treatment.
Maximum total Ca concentrations were 11.03, 11.67 and 12.43 mg/dl, which represented
an increase in 4.0, 10.0 and 17.2 % with respect to the adaptation period, for the 1.25 (on
day W4), 2.5 (on day W3) and 5.0 (on day W5) Mill treatments, respectively (Table 3.3
and Fig. 3.2). Maximum ionized Ca concentrations were 5.39,5.73 and 6.03 mg/dl,
which represented an increase of5.3, 11.9 and 17.8 % with respect to the pre-treatment
control value for the 1.25 (on day W4), 2.5 (on day W2) and 5.0 (on day W4) Mill
treatments, respectively (Table 3.4 and Figure 3.3).
Comparing these results with the literature, the total Ca concentration found with
the 5 Mill treatment was higher than the 10.39 mg/dl reported by Swanek et al. (1997)
who also supplemented 5 Mill D3 to finishing steers for 5 days. This difference can be
explained firstly, by the number of days of supplementation (7 vs 5) and, secondly,
because the steers in their study were sacrificed immediately after supplementation
without a withdrawal period. In the present study, maximum values were attained during
the withdrawal period. In a subsequent study, Swanek et al. (1999) reported a plasma Ca
value of 12.39 mg/dl, when 5 MID D3 was supplemented for 7 days. Results that are in
agreement with this study. Increments of approximately 2 mg/dl in total Ca
concentration as a result of 5 MID D3 supplementation have also been reported by
Montgomery et al. (1998 and 2000) and Karges et al. (1999a,c).
The ratio of ionized to total Ca is given in Table 3.5. This ratio is very important
as it indicates the proportion of total Ca available to tissues for metabolic purposes
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Table 3.5. Effect of supplementing high levels of vitamin D3 on the ionized to total
serum Ca ratio of finishing Angus steers (452 ± 30 kg BW).
Ionized to Total Ca Ratio (%)
Vitamin D3Level (MIUlhdld) Contrasts Z
Days 1.25 2.5 5.0 8EM A B C
Group 1 2 3
Adaptation Period:
A1D 48.07 47.59 48.42 0.36
A24 48.86 49.14 49.29 0.41
A31 47.90 47.80 47.28 0.41
Average: 48.26 ± 0.86
Supplementation Period:
81 48.23 48.87 48.72 0.37 0.9595 0.3016 0.4798
82 47.22 47.86 47.69 0.47 0.0594 0.4979 0.3803
83 48.39 49.15 48.44 0.44 0.8088 0.1321 0.7865
84 46.68 46.53 46.79 0.30 0.0046 0.0040 0.0253
85 47.18 46.93 47.95 0.66 0.0496 0.0259 0.6297
86 48.10 48.20 49.19 0.66 0.7728 0.9192 0.1558
87 46.85 48.38 46.57 0.60 0.0113 0.8383 0.0104
Withdrawal Period:
W1 47.37 48.19 48.09 0.48 0.1066 0.9084 0.7894
W2 48.40 49.57 48.30 0.54 0.7947 0.0276 0.9531
W3 48.18 48.82 47.90 0.60 0.8782 0.3427 0.5763
W4 48.89 49.30 49.22 0.58 0.2489 0.0798 0.1438
W5 47.88 48.51 48.21 0.37 0.4830 0.6786 0.9390
W8 45.75 47.16 46.63 1.43 <0.0001 0.0638 0.0138
Repeated Measures Analysis
P values
Treatment 0.5366
Time <0.0001
Time x treatment 0.8810
Z Contrasts:
A = Control restricted vs the next experimental day in 1.25 Mill treatment.
B = Control restricted vs the next experimental day in 2.5 Mill treatment.
C = Control restricted vs the next experimental day in 5 Mill treatment.
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(Guyton 1956; Rosol et al. 1995; Guyton and Hall 1997). It can be seen that by day 4 of
supplementation, the ratio for all treatments was reduced and was also lower on day S7
for the 1.25 and 5 MID treatments. During the withdrawal period there were no
differences in this ratio relative to pre-treatment values. This indicates that during the
supplementation period, total Ca increased at a relatively greater rate than ionized Ca thus
reducing the ratio, with the situation reversed during the withdrawal period.
The rise in total and ionized Ca levels observed in this study has important
implications for the beef industry. Other workers have observed that high levels of
vitamin D3 supplementation induced higher plasma Ca concentrations, which in tum
produced higher muscle Ca concentrations (Montgomery et al. 1998, 2000 and in press;
Karges and Morgan 1999; Swanek et al. 1999). This excess ofCa in muscle is though to
stimulate higher activity of the calpain proteolytic enzyme system (m-calpain, !J.-calpain),
which leads to more tender beef (Koohmaraie 1992, 1996; Zamora et al. 1998).
Swanek et al. (1997) supplemented 5 Mill D3 for 5 days and observed a rise in
plasma Ca of 12.6 %. This increase in Ca was enough to reduce shear force values by
6.6% and the number of tough steaks by 21.8 % (seven days postmortem aging). In this
study, supplementation of 5 Mill D3/hd/d increased total Ca to levels where
improvements in shear force values and tenderness have been observed by Swanek et al.
(1999) and Montgomery et al. (2000).
The results of this study showed that the rise in serum Ca is related to the level of
vitamin D3 supplementation. Minimal increases were seen with the 1.25 MID treatment,
in contrast the greatest increases were seen with the 5 MID treatment. To more fully
understand the response of serum Ca to vitamin D3 supplementation and to possibly
manipulate the response, it is necessary to more fully understand the biological
mechanism that leads to this rise including the role of the calciotrophic hormones such as
parathyroid hormone, calcitonin and vitamin D3 and its major metabolites.
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3.4 Conclusions
The results of this study showed that feed intake was depressed as a result of
vitamin D3 supplementation, and the depression followed an inverse relationship with the
amount of vitamin D3 supplemented. Intake recovery was observed only after
supplementation ended, with the rate of recovery being related to the degree of
depression. From these observations and from other studies in which vitamin D3 was
intraruminally administered, it was concluded that the depression in feed intake when
high levels of vitamin D3 are supplemented is possibly due to metabolic or physiological
alterations and not to palatability factors.
The levels of supplemental vitamin D3 used in this study have been shown to be
an effective way to increase serum Ca concentrations in beef steers fed with a common
barley grain-based feedlot finishing diet. The observed increments in serum Ca were in
direct relationship with the amount ofvitamin D3 supplemented, that is, higher levels
produced larger increments.
Interestingly, the maximum increments in total and ionized serum Ca
concentrations from supplemented steers were found not during the supplemental but
during the withdrawal period. This post-treatment rise may result from alterations in the
hormonal control ofCa metabolism, a phenomenon that deserves further investigation.
The results of this study where barley grain-based finishing rations were fed have
important implications for the beef.industry in western Canada. The rise in serum Ca
obtained in this study with the 5 Mill treatment is similar to that noted by other workers
who with com-based diets have noted a considerable improvement in beef quality,
notably a reduction in shear force values. If this can be achieved for Canadian beef,
particularly at lower levels ofvitamin D3 supplementation, then it is possible that such
dietary manipulation of Ca homeostasis may become a common management tool.
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CHAPTER IV
Effect of Supplementing High Levels of Vitamin D3 on the Homeostatic
Control of Serum Calcium in Finishing Steers
4.1 Introduction
Calcium (Ca) plays a key role in many physiological processes including
structural (bones and teeth); in contraction of skeletal, cardiac, and smooth muscles; in
transmission ofnerve impulses; blood clotting; hormone secretion and enzyme activity
(Guyton and Hall 1996). Approximately 99 % of the total Ca in the body is deposited in
bone and teeth; 0.9 % is sequestered in the plasma membrane and endoplasmic reticulum
of cells and the remaining 0.1 % in the extracellular fluid. Total serum Ca concentration
is about 10 mg/dl, with approximately 50 % of it in the ionized form (Ca2+), which is the
biologically active form ofCa (Rhoades and Tanner 1995; Rosol and Capen 1997).
Fluctuations in the normal Ca concentration can cause important metabolic
alterations. For example, slight increases in Ca concentration in the extracellular fluid
(hypercalcemia) can cause progressive depression of the nervous system; conversely,
slight decreases in Ca concentration (hypocalcemia) cause the nervous system to become
more excited (Guyton and Hall 1996). Therefore, maintenance of a constant Ca
concentration, despite variations in intake and excretion, is one of the primary
honleostatic functions of the body. The metabolism of Ca is regulated, fundamentally, by
the interaction of three hormones: parathYroid hormone (PTH) which is secreted by the
parathYroid glands; calcitonin (CT), secreted by the C-cells of the thYroid gland; and
vitamin D3in its hormonal form, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), produced in
the kidneys (Hunt and Groff 1990; Horst et aI. 1997).
PTH is highly sensitive to declines in plasma Ca concentration, even a small
decline will stimulate the release of large amounts of this hormone. Calcitonin, on the
other hand, is secreted when Ca concentration is higher than normal, although, it seems to
be less sensitive than PTH to changes in Ca concentration (Goff 1989; Bhagavan 1992).
Vitamin D3, from skin and that from the diet which is absorbed in the small
intestine (duodenum) enters the lymphatic circulation. It is rapidly taken up by the liver,
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where it is hydroxylated to 25-hydroxyvitamin D3 (25(OH)D3), which constitutes the
nlajor circulating fonn of vitamin D3. Subsequently, it undergoes a second hydroxylation
in the kidney to fonn the steroid honnone 1,25(OHhD3, whose main function is to
increase the efficiency ofCa absorption from the intestine. The 1,25(OH)2D3 stimulates
the synthesis of Ca-binding protein in the intestinal epithelial cells, which results in the
active transport ofCa from the intestine. However, the metabolic conversion of
25(OH)D3 to 1,25(OH)2D3 is regulated by PTH, and is dependent upon dietary Ca levels,
plasma Ca and P concentrations, and circulating 1,25(OH)2D3 levels (DeLuca 1980;
Spirichevand Sergeev 1988; Wassennan 1989; Host et al. 1994).
It has been observed that large amounts of vitamin D3 (more than 10 million IV in
a single dose) effectively increased plasma Ca concentrations in dairy cattle (Reinhardt
and Conrad 1980; Littledike and Horst 1982). This effect has been observed in beef
cattle with quantities around or higher than 5 million IU per head per day (Owens et al.
1998). Indeed, supplementation of feedlot animals with 5 to 7.5 MIU D3per day for 5 to
10 days has resulted in increases in plasma Ca concentration (Swanek et a11999;
Montgomery et al. 2000; Karges et al. 2001). Similar results were noted in the first trial
of this study. Increases in plasma Ca levels of approximately 2 mgldl as noted in the
above studies have been shown to increase intracellular Ca concentration in myofibrils.
For instance, supplementation of 5 MIV D3 to finishing steers for 7 or 9 days increased
muscle Ca concentration by 43 % (Swanek et al. 1999) and 34 % (Montgomery et al. in
press), respectively. In both studies, improvements in beef tenderness were observed.
In the previous experiment (Chapter III), it was found that serum Ca
concentration was effectively increased as a result ofhigh levels (2.5 and 5 MIU/d) of
vitamin D3 supplementation when fed to steers on a common western Canadian feedlot
diet. Total and ionized serum Ca concentrations exhibited very similar patterns, that is,
increasing simultaneously as a result ofvitamin D3 supplementation. This rise in total
and ionized Ca is hard to explain in light of the tight regulatory control mechanisms that
govern Ca levels in blood (Guyton 1956; DeLuca and Shnoes 1983; West 1991; Kaneko
et al. 1997). To this point none of the previous studies have attempted to understand
from a honnonal point of view what is the underlying reason for the observed increases
in serum Ca when high levels of vitamin D3 are fed.
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Understanding the hormonal control of serum Ca levels is of interest, as it will
help to explain how supplementation ofvitamin D3influences this parameter and
ultimately beef tenderness. As such, the objective of this study was to evaluate the effect
of supplementing high levels of vitamin D3 (0, 2.5 and 5 MIU per day for seven
consecutive days) on the following parameters (during supplemental and post-treatment
periods):
1) Total and ionized serum Ca concentrations, and the ionized to total Ca ratio;
2) Vitamin D3 and 25-hydroxyyitamin D3plasma concentrations;
3) Parathyroid hormone and calcitonin serum concentrations;
4) Feed intake.
4.2 Material and Methods
4.2.1 Experimental Design
4.2.1.1 Adaptation Period (days Al to A18)
Fifteen Hereford steers (607 ±12 kg BW) were housed in individual pens (3.6 x
3.6 m) with automatic water bowls in the Livestock Research Bam of the Department of
Animal and Poultry Science at the University of Saskatchewan. Animals were cared for
according to the guidelines of the Canadian Council ofAnimal Care. The cattle were
adapted to the experimental diet for 18 days. The diet consisted of 750/0 concentrate
(barley grain base) and 25% barley silage (as fed), meeting the requirements for this type
of cattle according to the National Research Council (1996) (Table 4.1).
The steers were fed twice a day (0800 and 1600 h), with orts collected and
weighed every day before the morning feeding. Individual maximum voluntary feed
intake was measured from days A5 to All. Subsequently, feed was offered at this level
from days A12 to A18, with the objective to level out intake before vitamin D3
supplementation and so be able to measure its effect on feed intake.
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Table 4.1. Ingredient composition and formulated nutrient levels of the experimental
diet.
Item
Total mixed diet:
Concentrate
Barley silage
Concentrate:
Barley grain
Canolameal
Tallow
Limestone
Rumensin Z
Vitamin Y
Salt
Formulated composition x:
Digestible energy, Mcallkg W
Crude protein, %
Calcium, %
Phosphorus, %
Ca:P
DM(%)
87.2
12.8
89.4
3.9
3.9
1.2
0.6
0.4
0.6
3.60
13.30
0.52
0.36
1.49
Z Premix: Monensin (20% active) mixed with barley grain..
Y Premix: Vitamin A (416,650 IUlkg) and vitamin D (83,333 IUlkg).
x Nutrient Requirements ofBeef Cattle. National Research Council (1996).
W Predicted TDN x 4.4 Mcallkg (Weiss et al. 1992).
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4.2.1.2 Supplemental Period (days SI to S7)
The steers were randomly assigned to one of the following supplemental
treatments: 0, 2.5, or 5.0 million IV (MIV) of vitamin D3per steer per day for seven
consecutive days, with five steers per treatment.
The vitamin D3 supplement was prepared from a vitamin D3 concentrate
containing 500,000 ill per gram (Rhone-Poulec Canada Inc.), using ground barley as a
carrier. This supplement was formulated to have a final concentration of 13.0 Mill D3
per kg of premix.
The total daily amount of supplement per steer per treatment was equally divided
and supplied at each feeding. The supplement was top-dressed to the ration and
thoroughly mixed by hand before delivering it into the feed bunk.
During this peliod, daily blood samples (81 to 87) were obtained by jugular
venipunture, from all the steers, at approximately 1300 h. Three sets of samples were
taken. For the first and second sets, blood was collected into 7ml-draw evacuated
(Vacutainer®) tubes without anticoagulant. The blood obtained was allowed to clot at
room temperature for approximately 2 h. Then, one set was centrifuged at 3500 rpm for
15 min, and the serum obtained was immediately used to determine total and ionized Ca
concentrations. The second set was centrifuged at 3000 rpm for 10 min at -4°C, then the
serum was collected and transferred to 1.7 ml centrifuge clear vials and stored at -70°C
until analysis for PTH and calcitonin concentrations. For the third set, blood was
collected into 7 ml-draw vacutainer tubes with anticoagulant (lOO U8P units of lithium
heparin), which were placed in crushed ice immediately after withdrawal, and
approximately 2 h later centrifuged at 3000 rpm for 10 min at -4°C, then the plasma was
collected and transferred to 1.7 ml centrifuge clear vials and stored at -70°C until
analysis for vitamin D3 and 25(OH)D3 concentrations.
4.2.1.3. Withdrawal Period (WI to W9)
Once the vitamin D3 supplementation period ended, the steers were maintained
for a further five days under the experimental conditions to evaluate post-treatment
effects, then the steers were shipped back to the feedlot. Feed was offered without
restriction and was monitored daily with orts collected and weighed before every
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morning feeding. Daily blood samples were obtained from day WI to W5, and a final
sample on day W9, under the same protocol as described previously.
4.2.2 Laboratory Analyses
4.2.2.1 Total and Ionized Calcium Determinations
Serum samples were analyzed for total and ionized Ca as described in Chapter III.
Briefly, total Ca was determined by indirect potentiometry utilizing a Ca ion selective
electrode (Radiometer ABL 700 Series Analyzer. Copenhagen, Denmark).
4.2.2.2 Parathyroid Hormone (PTH) Determination
Serum concentrations ofPTH were analyzed by a two-site immunoradiometric
assay (IRMA)(Intact PTH- ParathYroid Hormone. Nichols Institute Diagnostics). Two
different goat polyclonal antibodies to human PTH, purified to be specific to two
different regions of the PTH molecule were used. One antibody bound the mid-region
and C-terminal PTH 38-84, this antibody was immobilized onto plastic beads. The other
antibody bound the N-terminal PTH 1-34, this was radiolabeled for detection. Further
details on the assay are provided in the Appendix A.
4.2.2.3 Calcitonin Hormone Determination
Calcitonin (thYrocalcitonin) concentrations in serum were determined by a double
-antibody radioimmunoassay (Double Antibody Calcitonin. Diagnostic Products
Corporation DPC®, Los Angeles, CA. USA). This is a sequential competitive
radioimmunoassay procedure. The samples were first pre-incubated with anti-calcitonin
antiserum. 125I-Iabeled calcitonin competed with calcitonin in the sample for antibody
sites. After incubation for a fixed period of time (18 h), separation ofbound from free
was achieved by the PEG-accelerated double-antibody method. Finally, the antibody-
bound fraction was precipitated and counted by a gamma counter. Calcitonin
concentration in the samples was read from a calibration curve. Further details of the
assay are provided in Appendix B.
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4.2.2.4 Vitamin D3 and 25-Hydroxyvitamin D3 Determinations
Plasma concentrations of vitamin D3 and 25-hydroxyvitamin D3 25(OH)D3 were
determined using reverse-phase high-performance liquid chromatography (HPLC).
These two compounds were extracted from plasma samples by using acetonitrile (1 :2
ratio). Solutions were thoroughly mixed (vortexed) for a fixed period of time (30 sec),
then centrifuged. The supernatant from control animals underwent a second extraction
with chloroform and hexane and evaporation under nitrogen and then reconstitution with
acetonitrile. The supernatant from treated steers was subjected to only the first
extraction. Supernatants were filtered and transferred to injection vials. Samples were
introduced to the HPLC using an autosampler (WatersTM. Millipore Co. Milford, MA.
USA). Samples were analyzed with a reverse-phase column (Phenomenex C18 3J.l 15 x
4.6 mm) and acetonitrile as the mobile phase under isocratic conditions. The metabolite
25(OH)D3 was eluted first and vitamin D3minutes later. The absorbance of these
analytes (peak area) was computed and integrated by the software Millennium 2010
(MillenniumTM. Millipore Co. Milford, MA. USA). Calibration curves were used to
calculate concentrations from the experimental samples. Further details of the assay are
provided in Appendix C.
4.2.3 Statistical Analysis
The feed intake and blood sample data were analyzed using the Analysis of
Variance Technique including Repeated Measures Analysis using the General Linear
Model procedure of SAS (SAS 1989) to compare treatments within days and over time.
The following model for the repeated measures analysis was used:
Model: Y ijk = Il + Ui + 'tij + 8k + (U8)ij + Sijk
where:
Yijk = is the response at time k on animal j in treatment i.
Jl = is the overall mean.
Ui is a fixed effect of treatment i.
'tij = is a random effect of animal j in treatment i.
8k = is a fixed effect of time k.
(a8)ij = is a fixed interaction effect of treatment i with time k.
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Sijk = is the random error at time k on animal j in treatment i.
Single degree of freedom contrasts:
1) Control versus the average response of the two vitamin D3 treatments.
2) Comparison between the 2.5 and 5 MID D3treatments.
4.3 Results and Discussion
4.3.1 Feed Intake (DMI)
Feed intake during the adaptation period averaged 8.99 ± 1.21 kg ofDM. Intake
from control animals was maintained without change throughout the supplemental and
withdrawal periods. During the first days of the supplementation period, feed intake was
not different (P>O.05) between control and supplemented steers, with the exception on
the second day of supplementation (S2) where it was highly depressed (P<O.05) in the 5
Mill treatment, but it recovered the following day. The trend over time was to reduce
(P<O.05) feed intake as supplementation advanced with no difference (P>O.05) between
levels of supplementation. Feed intake tended to recover after supplementation ended,
following an inverse relationship with the level of vitamin D3 supplenlented, although it
had not fully recovered four days post-treatment. Minimum intakes were attained
towards the end of the supplemental period, which represented a decrease of 18.2 and
37.2 % relative to control animals for the 2.5 and 5 Mill treatments, respectively (Table
4.2).
Repeated measures analysis indicated a highly significant effect of time
(P<O.OOOl) and the interaction of time by treatment (P<O.OOOl), but no treatment effect
(P=O.0992). The interaction indicates that over time the depression in feed intake was
greater with the 5 Mill treatment (Table 4.2).
Depression of feed intake as a result ofhigh levels ofvitamin D3 supplementation was
evidenced in the previous study (Chapter III) and this response has also been observed in
other studies (Owens et al. 1998). The degree of depression seems to be directly related
to the amount ofvitamin D3 supplemented (Karges et at. 1999a). As discussed in the
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Table 4.2 Effect of high levels ofvitamin D3 supplementation on dry matter intake
(DMI) of finishing Hereford steers (607 ± 12 kg BW).
DMI (kg)
Vitamin D3Level (MIUlhd/d) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Adaptation Period:
A 9.20 8.66 9.11 0.57
Supplemental Period:
81 8.57 7.46 8.94 0.65 0.6482 0.1348
82 8.80 8.92 4.42 0.76 0.0405 0.0012
83 8.36 8.70 7.75 0.76 0.8853 0.3969
84 8.31 8.01 6.95 0.81 0.4172 0.3751
85 7.98 6.53 5.98 0.77 0.0939 0.6251
86 8.52 6.88 5.35 0.77 0.0259 0.1889
87 8.72 7.43 5.72 0.59 0.0120 0.0649
Withdrawal Period:
W1 8.49 7.82 6.65 0.70 0.1656 0.2559
W2 8.83 8.80 6.62 0.57 0.0665 0.0744
W3 9.06 8.31 6.42 0.58 0.0358 0.0411
W4 8.98 8.54 6.94 0.60 0.1181 0.0849
Repeated Measures Analysis:
P value
Treatment 0.0992
Time <0.0001
Time x treatment <0.0001
Z Contrast:
C vs D = Control vs the average ofthe two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3 treatments.
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previous experiment, the depression in intake appears to be not related to palatability
factors, because decreases in feed consumption has been observed independently of the
vitamin D3 route of administration. That is, with top-dressing (Karges et al. 1999a;
Montgomery et al. in press), with pellets (Karges et al. 1999a,b,c; 2001), or by oral
boluses (Montgomery et al. 1998, 2000).
The vitamin D3 supplement was formulated to have a final concentration of 13.0
Mill per kg. Analysis of the supplement indicated an actual concentration of 12.90 ±
0.46 Mill D3 per kg (New Jersey Feed Laboratory Inc. Trenton, New Jersey). As the
supplement was added to the daily ration, vitamin D3 consumption was directly related to
daily feed intake. As such, the average vitamin D3 consumption for the 2.5 and 5 Mill
treatments were 85.4 % (2.14 Mill/d) and 68.38 % (3.41 MID/d) of the targeted intakes,
respectively.
4.3.2 Total and Ionized Ca Concentrations
Total and ionized serum Ca concentrations on the first day of supplementation
were 10.11, 10.18 and 10.26 mgjdl and 4.92,5.08 and 5.06 mgjdl for the 0,2.5 and 5
Mill treatments, respectively, with no difference (P>0.05) between treatments (Tables
4.3 and 4.4 and Figures 4.1 and 4.2).
These initial concentrations, as well as the range from 9.90 to 10.19 mgjdl for
total and 4.78 to 5.11 mgjdl for ionized Ca from control animals during the whole
experiment were in the normal range for cattle of9.0 to 11.0 and 4.8 to 6.4 mgjdl for total
and ionized plasma Ca concentrations, respectively (Guyton 1956; Copp 1973; Rosol and
Capen 1997).
Total and ionized serum Ca concentrations were increased (P<O.OOOl) as a result
of vitamin D3 supplementation. Contrast analysis indicated that Ca serum concentrations
in supplemented animals were higher (P<0.05) than from controls, from day 83 to W5
and from 84 to W9 for total and ionized Ca, respectively. Conversely, differences due to
treatments (2.5 vs 5 MID) were only evident (P<0.05) during the withdrawal period
(from day W2 to W9), with highest levels achieved in the 5 Mill treatment (Tables 4.3
and 4.4 and Figures 4.1 and 4.2).
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Table 4.3. Effect ofhigh levels of vitamin D3 supplementation on total serum Ca
concentrations of finishing Hereford steers (607 ± 12 kg BW).
Total Ca (mgldl)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days o 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 10.11 10.18 10.26 0.16 0.5819 0.7324
82 10.17 10.40 10.46 0.14 0.1503 0.7526
83 10.02 10.34 10.53 0.14 0.0273 0.3595
84 10.10 10.42 10.74 0.15 0.0274 0.1601
85 10.19 10.68 10.91 0.09 0.0002 0.1507
86 10.06 10.73 10.98 0.09 <0.0001 0.0694
87 9.96 10.66 10.90 0.11 <0.0001 0.1408
Withdrawal Period:
WI 9.98 10.84 11.28 0.14 <0.0001 0.0503
W2 10.09 10.77 11.61 0.26 0.0046 0.0402
W3 10.02 10.79 11.90 0.28 0.0021 0.0150
W4 10.18 11.02 12.12 0.27 0.0013 0.0148
W5 9.90 10.70 12.11 0.19 <0.0001 0.0002
W9 10.04 9.82 10.34 0.12 0.7563 0.0090
Repeated Measures Analysis:
P value
Treatment 0.0002
Time <0.0001
Time x treatment <0.0001
ZContrast:
C vs D = Control vs the average of the two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 MIU D3 treatments.
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Figure 4.1. Effect ofhigh levels ofvitamin D3 supplementation (0,2.5 and 5 Mill per
day for seven consecutive days) on total serum Ca concentrations of finishing Hereford
steers (607 ± 12 kg BW), during supplemental (81 to 87) and withdrawal (WI to W9)
periods.
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Table 4.4. Effect ofhigh levels of vitamin D3 supplementation on ionized serum Ca
concentrations of finishing Hereford steers (607 ± 12 kg BW).
Ionized Ca (mgldl)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days o 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 4.92 5.08 5.06 0.07 0.1 011 0.8741
82 4.78 4.94 4.95 0.08 0.1102 0.8892
83 4.92 5.06 5.14 0.07 0.0662 0.4973
84 4.87 5.02 5.11 0.05 0.0124 0.2275
85 4.95 5.12 5.19 0.04 0.0025 0.2666
86 5.03 5.27 5.34 0.07 0.0062 0.5128
87 5.04 5.28 5.42 0.06 0.0019 0.1558
Withdrawal Period:
WI 5.07 5.34 6.38 0.52 0.2345 0.1800
W2 5.06 5.26 5.78 0.15 0.0321 0.0326
W3 5.11 5.34 5.97 0.15 0.0115 0.0107
W4 5.06 5.36 5.98 0.14 0.0045 0.0095
W5 5.03 5.24 5.97 0.12 0.0016 0.0008
W9 5.07 4.67 4.99 0.08 0.0369 0.0174
Repeated Measures Analysis:
P value
Treatment 0.0007
Time <0.0001
Time x treatment 0.0094
Z Contrast:
C vs D = Control vs the average of the two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 MIU D3treatments.
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Figure 4.2. Effect ofhigh levels ofvitamin D3 supplementation (0,2.5 and 5 MID per
day for seven consecutive days) on ionized serwn Ca concentrations of finishing
Hereford steers (607 ± 12 kg BW), during supplemental (81 to 87) and withdrawal (WI
to W4) periods.
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It is important to note that maximum Ca concentrations were achieved four days
after the end of the vitamin D3 supplemental period (W4), and were reached the same day
for total and ionized Ca for the 2.5 and 5 MID treatments (Tables 4.3 and 4.4 and Figures
4.1 and 4.2).
The maximum rise in total and ionized serum Ca in response to vitamin D3
supplementation was similar (11.67 vs 11.02 and 12.43 vs 12.12 mgldl for total and 5.73
vs 5.36 and 6.03 vs 5.98 mgldl for ionized Ca) for the 2.5 and 5 Mill treatments in the
previous and present study of this series, respectively. Maximum total Ca concentration
of 12.12 mgldl achieved in the present study with the 5 Mill D3 treatment for seven
consecutive days, was higher than the reported by Swanek et aZ. (1997) (10.39 mgldl), at
the same level of supplementation. The difference in values may be due to a lower
period of supplementation (5 days), and the fact that the steers in their study were
slaughtered immediately after supplementation. In a subsequent study, Swanek et aZ.
(1999) supplemented 5 Mill D3 for seven days, and found a final plasma Ca
concentration of 12.39 mgldl, which was very close to the value found in the present
experiment.
Montgomery et al. (1998) administered 5 Mill D3 to finishing steers for eight
days and reported that plasma Ca concentrations were increased fronl 9 to 11 mgldl. In
absolute terms, their final plasma Ca concentration was lower than that found in the
current experiment, even though vitamin D3 was supplemented by intraruminal boluses.
However, the magnitude of the increase was similar as Ca concentration was increased by
approximately 2 mgldl in both studies (from 9 to 11 and from 10.11 to 12.12 mgldl,
respectively). Karges et aZ. (1999a,b) reported a similar rise in plasma Ca when 5 or 6
Mill D3 were supplemented to steers for twelve (13 mgldl) or six days (12.12 mgldl),
respectively. It is important to note that the rise in total and ionized Ca levels in serum in
this study were similar to that of the studies where this increase has been associated with
improved meat quality (Swanek et aZ. 1997, 1999; Karges et aZ. 1999a,b, 2001;
Montgomery et aZ. 1998, 2000).
Ionized to total Ca ratios are presented in Table 4.5. There were no differences in
the ratio between the two vitamin D3 treatments. There was, however, a decrease in the
ratio due to supplementation with vitamin D3 from day S5. A reduction in this ratio
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Table 4.5 Effect ofhigh levels ofvitamin D3 supplementation on serum ionized to total
Ca ratio of finishing Hereford steers (607 ± 12 kg BW).
Ionized to Total Ca Ratio (%)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 48.65 49.92 49.34 0.36 0.0460 0.2746
82 46.98 47.46 47.33 0.49 0.5050 0.8527
83 49.13 48.95 48.79 0.36 0.5709 0.7595
84 48.23 48.17 47.60 0.39 0.4787 0.3155
85 48.59 47.94 47.60 0.34 0.0769 0.4934
86 50.00 49.14 48.57 0.36 0.0224 0.2866
87 50.60 49.52 49.67 0.36 0.0395 0.7717
Withdrawal Period:
W1 50.81 49.31 48.65 0.37 0.0016 0.2279
W2 50.20 48.80 49.73 0.41 0.0871 0.1383
W3 51.00 49.42 50~15 0.44 0.0454 0.2666
W4 49.73 48.62 49.31 0.43 0.1746 0.2747
W5 50.81 48.99 49.25 0.49 0.0150 0.7084
W9 50.49 47.55 48.24 0.38 0.0001 0.2242
Repeated Measures Analysis:
P value
Treatment 0.0081
Time <0.0001
Time x treatment 0.0001
Z Contrast:
C vs D = Control vs the average ofthe two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3treatments.
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indicates that total Ca was increasing at a relative faster rate than ionized Ca. This
phenomenon was also observed in the previous experiment of this series with the
exception that the ratio returned to nonnal values by the end of the withdrawal period.
Total content ofCa in the extracellular fluid is found in the following forms:
approximately 50 % is free or ionized Ca, 45 % is bound to proteins, and the remaining 5
% is complexed (Rosol et al. 1995; Rosol and Cappen 1997).
4.3.3 Parathyroid Hormone (PTH) Concentrations
Serum PTH concentrations of the experimental steers on day Sl were: 147.07,
149.84 and 199.60 pg/ml for the 0, 2.5 and 5 MID treatments, respectively. Values that
were not statistically different (P>0.05). Over the course of the supplemental period,
PTH values fell in all (supplemented and unsupplemented) steers (Table 4.6 and Figure
4.3).
Values for the control steers reached a plateau on day S5, however, for the treated
steers they continued to decrease through the supplemental and withdrawal periods. The
lowest PTH values attained were 80.75, 19.35 and 8.31 pg/ml on day W5, W5 and W4
for the 0,2.5 and 5 MID treatments, respectively, which represented a decrease of 45.0,
87.0 and 96.0 % with respect to their initial values (day S1) for each group (Table 4.6 and
Figure 4.3).
Contrast analysis indicated that supplemented animals had lower (P<0.05) PTH
values than control animals from day S6 to W9. However, no differences (P>0.05)
between levels of supplementation during supplemental or withdrawal periods were
identified, with the exception of day S3 and S4, where the 5 Mill treatment had the
lowest levels ofPTH (Table 4.6 and Figure 4.3).
PTH hormone appears to be the principal honnone involved in the minute-to-
minute regulation of Ca concentration in blood. It is produce by the chief cells of the
parathyroid glands (Rosol and Capen 1997). The parathyroid glands respond to minor
fluctuations in Ca concentration by rapidly altering the rate ofhonnonal secretion and
more slowly by altering the rate ofhonnonal synthesis (Rosol et al. 1995). PTH controls
plasma Ca concentrations by acting at the glomerular level to increase the reabsorption of
Ca by stimulating the development and activity ofbone osteoclasts, and by stimulating
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Table 4.6. Effect ofhigh levels ofvitamin D3 supplementation on serum parathyroid
honnone (PTH) concentrations of finishing Hereford steers (607 ± 12 kg BW).
PTH (pgldl)
Vitamin D3 Level (MIUlhdld) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 147.07 149.84 199.60 22.21 0.3295 0.1391
82 216.35 224.56 139.38 51.64 0.5967 0.2661
83 181.60 216.84 66.03 32.14 0.3277 0.0061
84 129.93 123.87 36.88 22.49 0.0971 0.0181
85 109.65 108.11 57.00 24.67 0.3875 0.1687
86 120.59 42.89 20.82 16.14 0.0007 0.3529
87 117.39 33.01 14.54 15.99 0.0004 0.4300
Withdrawal Period:
W1 94.65 19.21 16.99 9.65 <0.0001 0.8734
W2 141.71 46.35 18.71 26.44 0.0056 0.4741
W3 118.57 24.87 23.31 16.69 0.0006 0.9483
W4 116.06 29.41 8.24 20.19 0.0020 0.4767
W5 80.75 19.35 10.86 8.24 <0.0001 0.4807
W9 131.19 60.32 43.76 13.64 0.0005 0.4074
Repeated Measures Analysis:
P value
Treatment 0.0013
Time <0.0001
Time x treatment 0.0014
Z Contrast:
C vs D = Control vs the average of the two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3treatments.
84
300.0 I----------------------;::========:::::::;l
-+-OMIU 03
--'-2.5 MIU 03
___ 5.0 MIU 03
250.0
51 52 53 54 55 56 57 W1 W2 W3 W4 W5 ~
-50.0 ..J.- ----'
Experimental Days
Figure 4.3. Effect ofhigh levels ofvitamin D3 supplementation (0,2.5 and 5 Mill for
seven days) on serum parathyroid hormone (PTH) concentrations of finishing Hereford
steers (607 ± 12 kg BW), during supplemental (81 to S7) and withdrawal (WI to W4)
periods.
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the synthesis of:the hormonal form of vitamin D3, which acts on intestinal tissue to
increase the efficiency ofCa absorption (Goff 1989; Guyton and Hall 1996). When Ca
plasma reaches levels above normal, PTH secretion is reduced, and in acute
hypercalcemia the parathYroid glands can suffer hypoplasia (Guyton and Hall 1997). It
would appear, therefore, that the reduced levels of PTH in serum were a metabolic
adjustment to reduce the high levels ofCa in serum caused by vitamin D3
supplementation.
4.3.4 Calcitonin Concentrations
8erum calcitonin concentrations of the experimental steers were determined on
days 81, 83, 86, WI, W3 and W5 (Table 4.7). On the first day of the supplemental
period there was no difference (P>O.05) in calcitonin concentrations between control and
supplemented steers, however, there was (P<O.05) between the 2.5 and 5 Mill treatment
(Table 4.7). On the third day of supplementation the situation was inversed, that is, there
was a difference (P<O.05) between control and supplemented steers, but not between
vitamin D3 treatments. From the end of the supplementation period (86) and throughout
withdrawal period, there were no differences (P>O.05) between control and vitamin D3
treatments.
Calcitonin secreted by the parafollicular cells, or C cells of the thYroid gland has
the function to reduce blood Ca concentration (Rosol et aI. 1995). This is achieved by
increasing urinary Ca excretion, by decreasing absorption from bone osteoclasts
(imnlediate effect), and by preventing the formation ofnew osteoclasts (prolonged effect)
(Goff 1989; Guyton and Hall 1997). However, even though serum Ca concentrations
were significantly increased by vitamin D3 supplementation, and PTH dec~eased,
calcitonin concentrations were not significantly altered throughout the whole experiment.
Rosol et al. (1995) pointed out that the function of calcitonin in inhibiting osteoclastic
bone resorption is transitory, because the osteclasts rapidly become refractory to its
effect. For this reason, the calcitonin regulatory nlechanism is considered weaker than
the PTH system because its effect only lasts a few hours to a few days (Rhoades and
Tanner 1995). This may explain why serum Ca concentrations from supplemented steers
were increased and reached high levels for a prolonged period of time, because calcitonin
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Table 4.7. Effect ofhigh levels ofvitamin D3supplementation on serum calcitonin
hormone concentrations of finishing Hereford steers (607 ± 12 kg BW).
Calcitonin (pg/ml)
Vitamin D3Level (MIU/hd/d) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 354.02 381.94 297.64 15.94 0.4799 0.0028
83 278.16 381.52 339.68 22.48 0.0112 0.2128
86 296.36 323.34 352.68 23.27 0.1697 0.3902
Withdrawal Period:
WI 318.62 309.08 281.72 30.86 0.5505 0.5425
W3 289.16 312.46 347.60 19.54 0.1133 0.2275
W5 332.04 310.42 328.08 22.99 0.6578 0.5970
Repeated Measures Analysis:
P value
Treatment 0.4222
Time 0.2246
Time x treatment 0.0071
Z Contrast:
CvsD = Control vs the average of the two vitamin D3treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3 treatments.
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appears not to playa key role in controlling plasma Ca levels as the PTH and
1,25(OHhD3system does in ruminants.
4.3.5 Vitamin D3 and 25-Hydroxyvitamin D3 Concentrations
Plasma vitamin D3concentrations from the experimental steers on the first day of
supplementation (81) were: 4.92, 6.70 and 11.51 ng/ml for the 0, 2.5 and 5 Mill
treatments, respectively. Vitamin D3concentrations from control animals ranged from
2.71 to 8.20 ng/ml throughout the experiment, with an average of4.23 ± 1.47 ng/ml
(Table 4.8 and Figure 4.4). This average was close to the nonnal values of 1 to 3 ng/tTlI
reported for dairy cattle (McDennott et al. 1985; Horst 1986); or the 3.1 ng/ml for
finishing beef cattle (Montgomery et al. 2000)..
Plasma 25(OH)D3concentrations from the experimental steers on day 81 were:
50.13, 50.11, 54.03 and 54.03 ng/ml for the 0,2.5 and 5 MID treatments, respectively.
The 25(OH)D3 concentrations for the control steers ranged from 43.49 to 60.65 ng/ml
throughout the trial, with an average of48.47 ± 4.33 ng/ml (Table 4.9 and Figure 4.5).
This average was in good agreement with the nonnal range of20 to 60 ng/ml for dairy
cattle (Horst and Reinhardt 1982; Littledike and Horst 1982; Horst et al. 1994); or almost
identical to the 48.1 ng/ml reported for finishing steers (Montgomery et al. 2000).
Vitamin D3 and 25(OH)D3 were increased (P<O.OOOI) as a result ofvitamin D3
supplementation, and this response was directly related (P<O.OOOI) to the level of
supplementation, but their responses were different (Tables 4.8 and 4.9 and Figures 4.4
and 4.5). The increase in vitamin D3in plasma fit a bell shaped curve. Values increased
almost immediately once supplementation started, with a maximum located between days
85 and 87, and declining and plateauning on day W3. At this point, vitamin D3
concentration remained elevated relative to control values through the end of the trial
(W9) (Figure 4.4). The increase in 25(OH)D3 concentration was linear from almost the
beginning through the end of the trial with the highest value on day W9 (Figure 4.5). In
contrast, the levels of these compounds in control animals remained constant throughout
the trial (Figures 4.4 and 4.5).
Maximum vitamin D3concentrations were 132.4 and 149.8 ng/ml, which
represented a 32.6- and 36.9-fold increase relative to the control aninlals for the 2.5 and 5
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Table 4.8. Effect ofhigh levels of vitamin D3 supplementation on plasma vitamin D3
concentrations of finishing Hereford steers (607 ± 12 kg BW).
Vitamin D3(ng/ml)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 4.92 6.70 11.51 1.86 0.0914 0.0934
82 4.64 44.27 79.07 12.14 0.0024 0.0656
83 3.03 44.01 107.81 7.11 <0.0001 <0.0001
84 3.28 114.60 132.23 10.60 <0.0001 0.2623
85 4.06 132.43 149.75 10.12 <0.0001 0.2495
86 2.71 90.19 139.99 7.89 <0.0001 0.0008
87 3.99 107.05 148.48 9.32 <0.0001 0.0085
Withdrawal Period:
WI 4.10 103.55 135.22 9.62 <0.0001 0.0383
W2 4.05 61.46 102.24 6.49 <0.0001 0.0008
W3 5.40 33.62 56.40 4.29 <0.0001 0.0027
W4 8.20 60.39 43.80 6.32 0.0001 0.0881
W5 2.44 58.44 51.52 7.49 <0.0001 0.5265
W9 4.23 40.76 51.23 3.10 <0.0001 0.0342
Repeated Measures Analysis:
P value
Treatment <0.0001
Time <0.0001
Time x treatment <0.0001
Z Contrast:
C vs D = Control vs the average of the two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3treatments.
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Figure 4.4. Effect ofhigh levels of vitamin D3 supplementation (0, 2.5 and 5 Mill for
seven days) on plasma vitamin D3 concentrations of finishing Hereford steers (607 ± 12
kg BW), during supplemental (SI to S7) and withdrawal (WI to W4) periods.
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Table 4.9. Effect ofhigh levels of vitamin D3 supplementation on plasma 25-hydroxy
vitamin D3(25(OH)D3) concentrations of finishing Hereford steers (607 ± 12 kg BW).
25(OH)D3 (ng/ml)
Vitamin D3 Level (MIU/hd/d) Contrasts Z
Days 0 2.5 5.0 8EM CvsD 2.5 vs 5.0
Supplemental Period:
81 50.13 50.11 54.03 3.84 0.6870 0.4838
82 48.58 68.56 84.03 7.56 0.0112 0.1738
83 49.84 60.54 120.39 6.95 0.0005 <0.0001
84 46.90 93.33 166.60 8.31 <0.0001 <0.0001
85 46.69 130.65 204.92 7.69 <0.0001 <0.0001
86 43.82 139.34 249.53 9.82 <0.0001 <0.0001
87 48.01 162.78 265.41 10.49 <0.0001 <0.0001
Withdrawal Period:
W1 43.49 178.40 288.77 11.50 <0.0001 <0.0001
W2 44.29 180.41 285.46 15.50 <0.0001 0.0004
W3 49.85 160.92 308.67 11.59 <0.0001 <0.0001
W4 60.65 237.30 325.48 20.98 <0.0001 0.0117
W5 49.34 242.81 297.54 16.82 <0.0001 0.0401
W9 48.47 226.92 335.89 23.69 <0.0001 0.0069
Repeated Measures Analysis:
P value
Treatment <0.0001
Time <0.0001
Time x Treatment <0.0001
Z Contrast:
CvsD = Control vs the average of the two vitamin D3 treatments.
2.5 vs 5.0 = 2.5 vs 5.0 Mill D3treatments.
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Figure 4.5. Effect ofhigh levels ofvitamin D3 supplementation (0, 2.5 and 5 Mill for
seven days) on plasma circulating 25-hydroxyvitamin D3(25(OH)D3) concentrations of
finishing Hereford steers (607 ± 12 kg BW), during supplemental (81 to 87) and
withdrawal (WI to W4) periods.
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Mill treatments, respectively (Table 4.8). Maximum 25(OH)D3 concentrations were
242.8 and 335.9 ng/ml, which represented a 4.9- and 6.9-fold increase relative to the
control animals for the 2.5 and 5 MID treatments, respectively (Table 4.9).
Horst and Reinhardt (1983) conducted an experiment in which nonlactating non-
pregnant dairy cows were injected (single dose) with 15 MID D3. These workers found
an immediate increase in plasma vitamin D3, 25(OH)D3 and 1,25(OHhD3 levels.
Vitamin D3 concentration peaked approximately 10 days after treatment, and then began
to fall through day 35, at which time a plateau was attained, which lasted until the end of
the trial (day 90). The 25(OH)D3 concentration was also immediately increased, peaking
approximately 30 days after treatment, and then began to fall slowly until the end of the
trial. Similarly, 1,25(OH)2D3 had a sharp increase after 12 to 15 days after vitamin D3
injection, and then began to decline. Interestingly, the plasma concentration patterns of
vitamin D3 and 25(OH)D3 found in the current experiment were remarkably similar to
this study, despite the difference in the route ofvitamin D3 administration and in the
amount used.
Montgomery et ai. (2000) supplemented finishing steers with 5 Mill D3 for 9
days and found plasma vitamin D3and 25(OH)D3 concentrations of3.1 and 464.3 ng/ml
and 48.1 and 578.4 ng/ml for control and supplemented steers, respectively. The control
values found in the present trial were in close agreement with this report. However,
differences in maximum plasma vitamin D3(150- vs 37-fold) and 25(OH)D3 (12- vs 7-
fold) values of treated animals were identified. These differences may be due to actual
vitamin D3consumption. These researchers administered vitamin D3 by intraruminal
boluses, while in the present trial vitamin D3was top-dressed to the daily ration, with
depression in feed intake affecting total consumption. Vitamin D3 intake for the 5 Mill
treatment in the present trial was only 68.4 % of the targeted value. However, despite the
differences in vitamin D3 intake, the relationship between vitamin D3 supplementation
and plasma vitamin D3 and 25(OH)D3concentrations were very similar in both studies.
When one considers the metabolic response to supplemental vitamin D3 it is clear
that supplementation caused significant increases in plasma vitamin D3 and 25(OH)D3,
and in total and ionized serum Ca, a reduction in PTH and no effect on calcitonin levels.
In addition feed intake was drastically depressed. This rise in total and ionized serum Ca
93
levels is likely a result of several metabolic signals that ultimately influence Ca
absorption and resorption. It is clear, first, that PTH levels declined rapidly due to a rise
in serum Ca with no detectable affect on calcitonin levels. As discussed, this drop in
PTH is fully consistent with its metabolic function (Guyton and Hall 1996). Mega levels
ofdietary vitamin D3 were found to dramatically increase plasma vitamin D3 levels. It is
obvious that as a result of increased of25(OH)D3levels, the first hydroxylation, which is
carried out in the liver by the 25-hydroxylase enzyme was carried out relatively
unregulated. Again this is consistent with known functions of this enzyme. The rise in
25(OH)D3 levels could increase serum Ca levels in one or two fashions. First, increased
levels of25(OH)D3could stimulate conversion in the kidney to 1,25(OH)2D3 (hormonal
form of vitamin D3), which acts to stimulate Ca binding protein synthesis in intestinal
epithelial cells which then increase active Ca transport across the epithelium. In humans
and many other species, this step is normally a tightly regulated step with 1,25(OH)2D3
levels held in close check (DeLuca et al. 1977; Guyton and Hall 1997). Supporting this
reasoning, Montgomery et al. (2000), did not find significant changes in 1,25(OHhD3
plasma concentrations in steers supplemented with 5 Mill D3 for nine days. The second
possible mechanism for increased serum Ca levels due to vitamin D3 supplementation is
that 25(OH)D3 may override the normal process, by performing the functions of
1,25(OH)2D3 in intestine and bone by virtue of excess of substrate, that is, although the
affinity of the receptors in the target tissues is much higher for 1,25(OH)2D3 than for
25(OH)D3, the excess of 25(OH)D3, as a result of vitamin D3 supplementation, could
bind the receptors and simulate the functions of 1,25(OH)2D3 in kidney, bone and
intestine (Smith et al. 1983; Bhagavan 1992; Rhoades and Tanner 1995).
Finally, it has also been shown in other studies that supplementation with high
levels ofvitamin D3(2.5 and 5 MID) to finishing steers results in significant increases in
plasma vitamin D3and 25(OH)D3 concentrations (Montgomery et al. 2000). These
higher levels of vitamin D3 in plasma will lead to higher concentrations in muscle and in
other organs (liver) and tissues (adipose) as has been demonstrated by Montgomery et al.
(2000 and in press). High levels ofvitamin D3 in edible tissues represent the main
concern with regard to human health (Owens et al. 1998). High residual amounts of
vitamin D3 have been found in meat, from supplemented animals (5 MID/d), even after
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the meat has been cooked (Montgomery et ai. in press). The residual concern is based on
the fact that vitamin D3regulates Ca metabolism and elevated consumption (via meat)
may lead to alteration in the normal nletabolism ofCa in humans, causing, principally,
calcification of the soft tissues and formation ofkidney stones (Hunt and Groff 1990;
Guyton and Hall 1996, 1997). Acute intoxication from vitamin D3includes lost of
appetite, nausea, weakness, hypertension, renal failure, cardiovascular dysfunction and
death, which is the result ofnephrocalcinosis and heart and aortic calcification (Smith et
ai. 1983; Hunt and Groff, 1990; Glerup and Eriksen 2001).
In light of the documented potential for residues ofvitamin D3 in organ and tissues,
it is doubtful if this dietary treatment to improve beef tenderness would ever be approved
by Canadian regulatory agencies. It is therefore of interest to explore alternative
mechanisms to increase serum Ca levels that may work either alone or in combination
with vitamin D3 to improve beef tenderness.
4.4 Conclusions
Vitamin D3supplementation at levels used in this experiment (2.5 and 5
MIU/hd/d for 7 days) caused a significant depression in feed intake, with the degree of
depression and the rate of recovery inversely related to the amount ofvitamin D3
supplemented. Both levels of supplemental vitamin D3 induced significant increases in
total and ionized serum Ca concentrations. The increments were directly related to the
level of supplementation. Maximum serum Ca concentrations were attained several days
after supplementation ended. This suggests that the cascade of events leading to
synthesis of Ca binding protein and subsequently increased Ca absorption were activated,
however the mechanisms require time to fully develop. Vitamin D3 supplementation at
both levels, induced a significant increase in plasma vitamin D3 and 25(OH)D3
concentrations. These two metabolites had different response curves to supplementation.
Plasma vitanlin D3 was increased only during supplementation, whereas 25(OH)D3 was
linearly increased throughout the supplenlental and withdrawal periods. This suggests
that the activity of the 25-hydroxylase enzyme was not tightly regulated, allowing the
conversion ofvitamin D3 to 25(OH)D3.
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The increase in plasma vitamin D3and 25(OH)D3 and subsequently in the total
and ionized serum Ca caused a depression in the normal PTH values, although calcitonin
was not significantly affected. This suggests that the calciotrophic hormone responsible
for the increased Ca levels was 1,25(OH)2D3, either acting by itselfor by the 25(OH)D3
by virtue of excess substrate.
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CHAPTER V
Effect of Feeding a Low Calcium Diet and Vitamin D3 on Calciun1
Metabolism in Finishing Steers
5.1 Introduction
It has been observed that manipulation of dietary calcium (Ca) can directly affect
plasma Ca levels. The efficiency of Ca absorption in the intestine is related to the
amount of Ca in the diet, high levels of Ca reduce the efficiency of absorption and low
levels tend to improve it (Verdaris and Evans 1975). This phenomenon is a response to
maintain Ca homeostasis in the organism. Reduced levels ofCa in the diet results in
lower Ca in the blood, thus the animals' response is to secrete greater amounts of PTH,
which in tum stimulates the kidneys to synthesize 1,25(OH)2D3, whose main function is
to accelerate the active transport of Ca from the intestine, increasing plasma Ca levels
and consequently its availability. Calcium can be absorbed from the lumen of the
intestine by passive diffusion between the intestinal epithelial cells (parecellular
transport) and by active transport across the epithelial cells. Passive diffusion is directly
related to the concentration of Ca ions in the lumen ofthe gut. The active transport of Ca
across the intestinal epithelial cells takes place when dietary Ca is low or when demand is
very high. This process requires 1,25(OH)2D3, which facilitates the active process
through the synthesis of the Ca binding protein (CaBP) which has the function to
transport Ca across the epithelial cell. It appears that the rate of transcellular Ca transport
is directly correlated to the amount of CaBP in the cells. In other words, low Ca diets
stimulate Ca homeostatic mechanisms and the contrary is true for high Ca diets (DeLuca
1980; Goff 1989; Horst et al. 1994).
A common use of this concept is with dairy cows approaching parturition. Such
cows are prone to milk fever. Low Ca diets have been used during the latter stages of the
dry period to increase or at least maintain plasma Ca concentration at parturition and so
reduce the likelihood ofparturient paresis or milk fever (Beitz et al. 1973; Goings et al.
1974; Kichura et al. 1982; Allen and Sansom 1985).
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Goings et al. (1974) fed a low Ca diet (8 g ofCa/d) to dairy cows for 14 (7 to 17)
days prepartum. Plasma Ca concentrations of the cows decreased within four days after
the initiation of feeding the low Ca diet, although minimunl values were reached
approximately 36 h after the initiation of feeding and then slowly rose to pre-treatment
values. An increase in PTH concentration also occurred during the same 4 days. This
feed management was sufficient to prevent parturient paresis in all the treated cows.
These authors made the observation that feeding cows a low Ca diet for at least 7 days
prepartum is likely to stimulate Ca homeostatic mechanisms to the degree that milk fever
can be prevented.
Kichura et al. (1982) conducted an experiment in which dairy cows were fed with
different proportions of Ca and P from four weeks prepartum. They found that cows fed
the low Ca diets regardless of the dietary phosphorus intake, had greater 1,25(OH)2D3
and hydroxyproline concentrations prepartum, and greater plasma Ca concentrations at
parturition, and less incidence ofparturient paresis than cows fed high Ca diets. These
workers concluded that low Ca diets effectively activated the Ca homeostatic
mechanisms before parturition by stimulating both bone resorption and intestinal
absorption ofCa.
In the previous experiments of this study, the basis for high levels ofvitanlin D3
supplementation under western Canadian conditions (Chapter III) and the relationship
between supplemental vitamin D3and Ca homeostatic mechanisms (Chapter IV) were
studied. It was found that the levels of serum Ca concentrations achieved from the 5
MID D3 level were, in both experiments, in the range in which significant improvements
in beef tenderness were reported (Swanek et al. 1997, 1999; Montgomery et al. 1998,
2000; Karges et al. 2001). However, high levels of supplemental vitamin D3 also induce
high levels of residual vitamin D3 in liver and other edible tissues (Montgomery et al.
2000), as well as negatively influencing animal performance (Karges et al. 1999a,b;
Berry et al. 2000). These conditions are the main concerns that limit the utilization of
this practice as a common tool for feedlot producers to improve beef tenderness.
It is possible, however, that feeding a low Ca diet for a set period of time may
induce Ca absorption, reabsorption and resorption mechanisms and thus prime the
response to vitamin D3 supplementation. In such situations it may be possible to feed
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lower levels of vitamin D3yet obtain a significant rise in plasma Ca. Therefore, the
objective of this study was to evaluate the feasibility of using a low Ca diet prior to
vitamin D3 supplementation at one of the three levels: 1.25, 2.5 and 5 MIU/hd/d for 7
days, with the aim to increase serum Ca to higher levels than supplementation of vitamin
D3without dietary Ca manipulation. It was also of interest to determine the effect of
dietary treatment on circulating concentrations ofparathyroid hormone, calcitonin,
vitamin D3, 25(OH)D3and 1,25(OHhD3.
5.2 Material and Methods
5.2.1 Experimental Design
5.2.1.1 Adaptation Period (days Al to A36)
Nineteen Angus steers (522 ± 34 kg BW) were housed in individual pens (3.6 x
3.6 m) with automatic water bowls in the Livestock Research Barn of the Department of
Animal and Poultry Science at the University of Saskatchewan. Animals were cared for
according to the guidelines of the Canadian Council of Animal Care. The cattle were
adapted to the experimental diet for 36 days. The diet consisted of75% concentrate
(barley grain base) and 25% barley silage (as fed), nleeting the requirements for this type
ofcattle according to the National Research Council (1996) (Table 5.1).
The steers were fed twice a day (0800 and 1600 h), with orts collected and
weighed every day before the morning feeding. Individual maximum voluntary feed
intake was measured from day A30 to A36, constituting the pre-treatment feed intake
value.
The experimental steers were bled by jugular venipuncture starting at 1230 h on
the last day of this period (A36). Two sets of samples were taken. For the first, blood
was collected into 5ml-draw evacuated (Vacutainer®) tubes without anticoagulant. The
blood was allowed to clot at room temperature for approximately 2 h, then centrifuged at
3500 rpm for 15 min, the serum obtained was immediately used to detennine total and
ionized Ca concentrations. For the second set, blood was collected into 10 ml-draw
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Table 5.1. Ingr'edient composition and formulated nutrient levels of the experimental
diets.
Item
Normal Ca diet
DM(%)
Low Ca diet
DM(%)
Total mixed diet:
Concentrate 89.6 89.6
Barley silage 10.4 10.5
Concentrate:
Barley grain 88.1 89.5
Canola meal 7.3 7.3
Tallow 1.7 1.7
Limestone 1.6 0.0
Rumensin Z 0.4 0.5
Vitamin Y 0.4 0.5
Salt 0.6 0.6
Formulated composition x:
Digestible energy 3.50 3.55
Mcal/kg W
Crude protein, % 12.09 12.24
Calcium, % 0.62 0.14
Phosphorus, % 0.43 0.44
Ca:P 1.43 0.32
Z Premix: Monensin (20% active) mixed with barley grain.
Y Premix: Vitamin A (416,650 IU/kg) and vitamin D (83,333 IU/kg).
x Nutrient Requirements ofBeefCattle. National Research Council (1996).
W Predicted TDN x 4.4 Mcal/kg (Weiss et al. 1992).
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evacuated (BD Vacutainer™) tubes with anticoagulant (sodium heparin), which were
placed on crushed ice immediately after withdrawal, and approximately 2 h later
centrifuged at 3000 rpm for 10 min at ~oC, then the plasma was collected and
transferred to 1.7 ml centrifuge clear vials and stored at -20°C. These plasma samples
were used to determine vitamin D3 and 25-hydroxyvitamin D3 concentrations.
5.2.1.2 Low Ca Diet Period (days Ll to LI0)
The steers were randomly dived into four groups of five steers each. Groups 1,2
and 3 were fed with a low Ca diet (Table 5.1) for ten days. This low Ca diet was
essentially the same as the normal Ca diet but with the main source of Ca (limestone)
withdrawn, resulting in a total Ca content of 0.14 % and a Ca to P ratio of 0.32, in
contrast to 0.62 % and 1.43 for the normal Ca diet, respectively. Group 4 was fed the
normal Ca (control) diet during this period.
Feed was offered and intake monitored as in the previous period. Blood samples
were obtained on days L2, L4, L6, L8 and L10 starting at 1230 h. These blood samples
were collected, processed, stored and analyzed as described for the adaptation period.
5.2.1.3 Supplemental Period (days SI to 87)
All the steers were shifted to the normal Ca diet on day 11 (S1). The steers that
received the low Ca diet (groups 1,2 and 3) were then randomly assigned to one of the
following levels ofvitamin D3 supplementation: 0, 1.25 and 2.5 million ill (Mill) D3 per
steer per day for seven consecutive days. The steers from group 4 (with no low Ca
period) were supplemented with 5 MID D3 per steer per day for seven consecutive days,
the purpose of this group was to serve as a general control (to compare the effect of
dietary Ca manipulation and vitamin D3 supplementation).
The vitamin D3 supplement was prepared from a vitamin D3 concentrate
containing 500,000 ill per gram (Rhone-Poulec Canada Inc.), using ground barley as a
carrier. This supplement was formulated to have a final concentration of 13 Mill D3 per
kg ofpremix. Analysis of the supplement indicated an actual concentration of 14.06
±0.53 Mill D3 per kg (Aventis Animal Nutrition, Inc. Alpharetta, GA. USA). The
corresponding daily total amount of the vitamin D3 supplement was equally divided and
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supplied at each'feeding. The supplement was top-dressed onto the ration and thoroughly
mixed by hand into the feed bunk. Feed intake was restricted to 85 % of the average
voluntary intake during the last 7 days of the low Ca period with the exception of the
control group (0 MIU) to ensure maximum vitamin D3 consumption, with additional
daily adjustments in order to avoid excessive feed refusals. Feed, was supplied and feed
intake monitored daily as described in previous periods.
Blood samples were obtained on day S2, S4 and S6, and these blood samples
were collected, processed, stored and analyzed as described for the adaptation period.
5.2.1.4 Withdrawal Period (days WI to Wll)
Once vitamin D3 supplementation ended, the steers were maintained for a further
six days under the experimental conditions to evaluate post-treatment effects, then the
steers were shipped back to the feedlot. Feed was offered without restriction. The ration
and intake monitoring were the same as in previous period.
The steers were bled by jugular venipunture on days WI, W3, W5 and Wll (at
the feedlot), these blood samples were collected, processed, stored and analyzed as
described for the adaptation period. In addition, on the first day of the withdrawal period
(WI) blood was collected using 10 ml-draw evacuated (BD Vacutainer™) tubes with
anticoagulant (sodium heparin). Samples were placed in crushed ice immediately after
withdrawal and approximately 2 h later centrifuged at 3000 rpm for 10 min at -4°C.
Plasma was then transferred to 50 ml screw conical centrifuge tubes and stored at -20°C.
These plasma samples were used to determine parathyroid hormone (PTH), calcitonin,
and 1,25(OH)2D3 concentrations.
5.2.2 Laboratory Analyses
5.2.2.1 Total and Ionized Ca Determinations
Serum concentrations of total and ionized Ca were determined by indirect
potentiometry utilizing a Ca ion selective electrode, as described in Chapter III.
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5.2.2.2 Parathyroid Hormone (PTH) Determination
PTH concentrations in plasma were determined by immunoradiometric assay
(Coat-A-Count® Intact PTH IRMA, Diagnostic Products Corporation®, Los Angeles,
CA. USA). Coat-A-Count Intact PTH IRMA (1-34) is a solid-phase immunoradiometric
assay emploYing 1251-labeled affinity-purified polyclonal anti-PTH (1-34) antibody in
liquid phase, in conjunction with affinity-purified polyclonal anti-PTH (44-84) antibodies
immobilized to the wall of a polystyrene tube. Intact PTH was captured between the anti-
PTH immobilized on the tube and the radio-labeled anti-PTH. Unbound 1251-labeled anti-
PTH antibody was removed by decanting the reaction mixture and washing the tube,
which reduced the nonspecific binding to a very low level. The PTH concentration was
directly proportional to the radioactivity present in the tube after the wash step. The
radioactivity was counted using a gamma counter, after which the concentration ofPTH
in the sample was obtained by comparing the sample counts-per-minute with those
obtained from standards (calibration curves). Further details of the assay are provided in
Appendix A.
5.2.2.3 Calcitonin Hormone Determination
Calcitonin (thyrocalcitonin) concentrations in plasma were determined by a
double -antibody radioimmunoassay as described in Chapter IV. Further details of the
assay are provided in Appendix B.
5.2.2.4 Vitamin D3 and 25-Hydroxyvitamin D3 Determinations
Concentrations in plasma of vitamin D3 and 25-hydroxyvitamin D3 (25(OH)D3)
were carried out using a reverse-phase high-performance liquid chromatography (HPLC)
assay. These two compounds were extracted from plasma samples by using acetonitrile
(1 :2 ratio). Solutions were thorough!y mixed (vortexed) for a fixed period of time, then
centrifuged. The supernatant was then filtered and transferred to injection vials. Samples
were introduced into the HPLC by an autosampler (Agilent Seriesll00, Waldbronn,
Germany). The samples were analyzed with a reverse-phase column (Prodigy ODS3 5,....
250 x 4.6 mm) and acetonitrile as the mobile phase under isocratic conditions. The
metabolite 25(OH)D3 was eluted first and vitamin D3second. The absorbance of these
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analytes (peak area) was computed and integrated by the software ChemStation (Hewlett-
Packard. Agilent Technologies Waldbornn, Gennany). Calibration curves were used to
calculate concentrations from the experimental samples. Further details of the assay are
provided in Appendix C.
5.2.2.5 1,25-Dihydroxyvitamin D3 (1,25(OHhD3) Determination
Concentrations in plasma of 1,25(OH)2D3 were detennined by radioimmunoassay
(RIA)(1,25-Dihydroxyvitamin D 1251RIA kit. DiaSorin, Stillwater, MN. USA). This
assay consisted of a two-step procedure involving a preliminary extraction and
subsequent purification ofvitamin D (D2 and D3) metabolites from serum using CIsOH
"Extra Clean" cartridges. Following extraction, the treated samples were then assayed
using a competitive RIA procedure. The RIA method is based on a polyclonal antibody
that is specific for both 1,25(OH)2D2 and 1,25(OH)2D3. The sample, antibody and tracer
were incubated for 2 h at 20-25°C. Phase separation was accomplished after a 20 min
incubation at 20-25°C with a second antibody precipitating complex. After centrifugation
and decantation, the bound fraction remaining in the pellet was counted in a gamma
counter. Honnone concentration in the samples was calculated directly from a standard
curve of known concentrations. Further details of the assay are provided in Appendix D.
5.2.3 Statistical Analysis
The data was analyzed using the Analysis ofVariance Technique including
Repeated Measures Analysis using the General Lineal Model procedure of SAS (SAS
1989) to compare treatments within days and over time.
The following model for repeated measures was used:
Model: Yijk = Jl + ai + tij + 8k + (a8)ij + eijk
where:
Yijk = is the response at time k on animal j in treatment i.
Jl = is the overall mean.
ai = is a fixed effect of treatment i.
tij = is a random effect of animal j in treatment i.
8k = is a fixed effect of time k.
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(a8)ij = is a fixed interaction effect of treatment i with time k.
Cijk = is the random error at time k on animal j in treatment i.
Single degree of freedom contrasts:
A = Normal Ca diet versus low Ca diet.
B = Control animals versus the average of vitamin D3treatments.
C = Between 1.25 and 2.5 MID D3treatments.
D = Between 2.5 and 5 MID D3treatments.
5.3 Results and Discussion
5.3.1 Feed Intake (DMI)
Feed intake during the adaptation period averaged 9.67 ± 1.42 kg ofDM, in
which group 4 had a lower (P<0.05) intake than the other three groups, an effect
attributed to differences in live weight, as this group was lighter than the other three.
During the low Ca period (ten days), groups 1,2 and 3 were fed the low Ca diet (0.14 %
Ca and 0.32 Ca to P ratio) and group 4 with the normal Ca diet (0.62 % Ca and 1.43 Ca to
P ratio). Feeding the low Ca diet did not alter (P>0.05) feed intake, with the exception of
days L5 and L6 where intake was higher (P<0.05) than the controls (group 4)(Table 5.2).
These results are in accordance with Verdaris and Evans (1975), who did not find
significant difference in intake of dairy cows when they were fed with a low (0.2 %) or
high (2.1 %) Ca diet.
During the supplemental period (seven days), all the groups were shifted to the
normal Ca diet. Groups 1, 2, 3 and 4 received 0, 1.25, 2.5 and 5 MID D3per steer per
day, respectively. Control animals (group 1) were fed ad libitum, while the vitamin D3
supplemented steers were fed at 85% of ad libitum relative to the average intake from the
previous period, and additionally daily adjustments were performed to avoid excessive
refusals. There was no difference (P>0.05) in feed intake among levels of vitamin D3
supplemented (Table 5.2).
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Table 5.2. Effect of feeding a low Ca diet for ten days prior to vitamin D3
supplementation on feed intake (DMI) of finishing Angus steers (522 ±33 kg BW).
DMI (kg)
Group
Days 1 2 3 4 8EM
Adaptation Period (normal Ca diet ad libitum/:
A
Contrast Z
B C D
A 9.84 10.07 10.21 8.27 0.66
Low Ca Diet Period (ad libitum):
LCa LCa LCa NCa
Li 8.63 9.76 9.11 7.80 0.83 0.1633
L2 7.17 7.65 6.79 7.58 1.34 0.8039
L3 8.49 8.15 8.48 8.10 1.16 0.8378
L4 7.93 8.70 8.29 7.33 0.79 0.2872
L5 9.01 9.95 8.52 6.63 1.02 0.0433
L6 10.10 10.21 8.46 7.62 0.68 0.0208
L7 9.85 9.85 9.45 8.14 0.71 0.0693
L8 8.83 9.70 9.06 7.65 0.76 0.1914
L9 8.29 9.39 8.11 8.44 0.73 0.8524
LiD 8.45 9.23 7.01 6.98 1.17 0.3548
Supplemental Period (normal Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3Level (Mill/hd/d)
o 1.25 2.5 5.0
8i 8.64 6.97 6.58 6.36 1.04 0.7381 0.8535
82 7.69 7.25 6.52 6.48 0.98 0.5103 0.9732
83 8.09 7.06 6.50 6.42 1.01 0.6251 0.9423
84 7.65 6.15 6.24 5.64 1.53 0.9599 0.7395
85 7.57 6.52 6.39 5.52 1.22 0.9215 0.5500
86 6.73 6.28 5.51 5.44 1.32 0.6041 0.9648
87 7.34 6.22 5.58 5.25 1.32 0.6656 0.8359
Withdrawal Period (normal Ca diet ad libitum):
Wi 6.37 7.60 5.37 5.48 1.67 0.9055 0.2448 0.9558
W2 7.64 7.99 5.71 4.93 1.51 0.4083 0.1928 0.6647
W3 8.64 7.83 5.23 3.90 1.68 0.1304 0.1813 0.5060
W4 8.76 7.87 6.07 3.98 1.23 0.0603 0.2043 0.1677
W5 11.23 9.93 6.90 5.38 1.09 0.0070 0.0243 0.2490
Z Contrasts: A = Normal Ca (NCa) diet (group 4) vs low Ca (LCa) diet (groups 1,2 and
3)./ B = Control animals vs vitamin D3 treated steers / C = 1.25 vs 2.5 Mill D3 / D =
2.5 vs 5 Mill D3.
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During the withdrawal period (five days), the normal Ca diet was fed to all steers
ad libitum. No differences (P>0.05) among supplemented and control steers were found,
except on the last day (W5), where consumption from control animals was higher than
from vitamin D3 supplemented steers. Similarly, there was a significant difference
(P<0.05) between the 1.25 and 2.5 MIU, but not between the 2.5 and 5 MID treatments
(Table 5.3).
Minimum intakes were 6.37 (WI), 6.15 (S4), 5.23 (W3) and 3.90 (W3) kg, which
represented a decrease in 10.8, 13.9,26.8 and 45.4 % relative to the average intake on
day 1 of supplementation, for the 0, 1.25, 2.5 and 5 Mill treatments, respectively (Table
5.2). The decline in intake from control animals (group 1) could be due to the handling
of the steers for bleeding. Additional to this effect, supplementation ofvitamin 03
appeared to decrease feed intake, in a direct relationship to the amount supplemented.
This depression in intake has also been noted in other studies (Owens et al. 1998; Karges
et al. 1999a; Berry et al. 2000; Scanga et al. 2001), and in the previous experiments of
this series.
The vitamin D3 concentration of the supplement was 14.06 ±0.53 Mill per kg
(Aventis Animal Nutrition, Inc. Alpharetta, GA. USA). The supplement consumption
averaged 1.27,2.56 and 5.14 Mill D3per day for the 1.25,2.5 and 5 MIU treatments,
respectively. The higher concentration and better adjustment of the daily feed intakes
helped to achieve the targeted consumption.
5.3.2 Total and Ionized Ca Concentrations
Serum total and ionized Ca concentrations in the adaptation period averaged 9.97
± 0.26 and 4.90 ± 0.19 mgldl, respectively. These concentrations and the ranges of9.96
to 10.18 and 4.89 to 5.01 mgldl for total and ionized Ca, respectively, for the control
group during the low Ca period, were within the normal ranges reported for cattle
(Wasserman 1989; Rosol et al. 1995; Rosol and Capen 1997) (Tables 5.3 and 5.4 and
Figures 5.1 and 5.2).
Total Ca concentrations from the low Ca groups (1, 2 and 3) were lower (P<0.05)
than the control group (4), with the exception on days L4 and L10 (Table 5.3). Ionized
Ca concentrations were also lower, with the exception on day L6 (Table 5.4). The
.
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Table 5.3. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3on total serum Ca concentrations of finishing Angus steers (522 ± 33 kg BW).
Total Ca (mg/dl)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A
Contrast Z
B C D
A 9.77 9.89 9.97 10.18 0.13
Low Ca Diet Period (ad libitum) Y:
LCa LCa LCa NCa
L2 9.49 9.75 9.75 10.11 0.15 0.0269
L4 9.51 9.66 9.63 9.96 0.17 0.0952
L6 9.74 9.70 9.83 10.15 0.15 0.0443
L8 9.71 9.86 9.85 10.18 0.12 0.0179
LiO 9.79 9.70 9.86 10.05 0.14 0.1462
Supplemental Period (normal Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
o 1.25 2.5 5.0
S2
S4
86
9.59 9.78 9.87 9.93 0.14
9.91 10.02 10.27 10.60 0.16
9.94 10.50 10.90 11.54 0.15
0.1240 0.6088 0.7699
0.0593 0.2421 0.1622
<0.0001 0.0690 0.0086
Treatment
Time
Time x treatment
Withdrawal Period (normal Ca diet ad libitum):
Wi 9.85 10.46 11.25 12.02 0.20
W3 9.90 10.65 11.50 12.41 0.30
W5 9.78 10.11 11.47 12.10 0.25
Wii 9.60 9.50 10.06 10.62 0.24
Repeated Measures Analysis:
P value
0.0003
<0.0001
<0.0001
<0.0001 0.0108 0.0163
0.0005 0.0514 0.0519
0.0003 0.0012 0.0982
0.1286 0.0952 0.1208
Z Contrasts: A = Normal Ca diet (group 4) vs low Ca diet (groups 1,2 and 3).
B = Control animals vs vitamin D3 treated steers
C = 1.25 vs 2.5 Mill D3
D = 2.5 vs 5.0 Mill D3
Y LCa = low Ca diet; NCa = normal Ca diet
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Figure 5.1. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 (0, 1.25, 2.5 and 5 Mill per day for seven consecutive days) on total serum Ca
concentrations of finishing Angus steers (522 ± 33 kg BW), during adaptation (A), low
Ca (L1 to L10), supplemental (81 to 87) and withdrawal (WI to W11) periods.
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Table 5.4. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3on ionized serum Ca concentrations of finishing Angus steers (522 ± 33 kg).
Ionized Ca (mg/dl)
Group Contrast Z
Days 1 2 3 4 8EM A B C D
Adaptation Period (normal Ca diet ad libitum):
A 4.79 4.99 4.91 4.94 0.10
Low Ca Diet Period (ad libitum) Y:
LCa LCa LCa NCa
L2 4.66 4.78 4.75 5.01 0.08 0.0111
L4 4.64 4.69 4.72 4.89 0.09 0.0563
L6 4.75 4.74 4.82 4.89 0.08 0.1998
L8 4.78 4.82 4.87 4.97 0.06 0.0592
LID 4.75 4.82 4.84 4.96 0.05 0.0144
Supplemental Period (normal Ca diet; D3 treatments fed at 85% of ad libitum):
Vitamin D3Level (MIU/hd/d)
0 1.25 2.5 5.0
82 4.72 4.74 4.73 4.63 0.06
84 4.78 4.82 4.86 4.96 0.08
86 4.67 4.88 4.98 5.34 0.07
Withdrawal Period (normal Ca diet ad libitum):
WI 4.87 5.00 5.29 5.64 0.13
W3 4.75 4.90 5.37 5.90 0.22
W5 4.78 4.98 5.57 6.03 0.18
WII 4.76 4.84 5.04 5.23 0.14
Repeated Measures Analysis:
P value
Treatment 0.0024
Time <0.0001
Time x treatment <0.0001
0.7401 0.9136 0.2223
0.2704 0.6943 0.3793
0.0002 0.2904 0.0015
0.0120 0.1117 0.0707
0.0217 0.1152 0.0909
0.0022 0.0182 0.0694
0.1006 0.2732 0.3244
Z Contrasts: A = Normal Ca diet (group 4) vs low Ca diet (groups 1,2 and 3).
B = Control animals vs vitamin D3 treated steers
C = 1.25 vs 2.5 MIU D3
D = 2.5 vs 5.0 MIU D3
Y LCa = low Ca diet; NCa = normal Ca diet
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Figure 5.2. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 (0, 1.25, 2.5 and 5 Mill per day for seven consecutive days) on ionized serum
Ca concentrations of finishing Angus steers (522 ± 33 kg BW), during adaptation (A),
low Ca (L1 to L10), supplemental (Sl to S7) and withdrawal (WI to W11) periods.
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ionized to total Ca ratio was not altered (P>0.05) during the period of low Ca feeding
(Table 5.5).
During the first four days of the supplemental period, total and ionized Ca
concentrations were not different (P>0.05) between the control and supplemented steers
or within levels of supplementation. However, at the end of this period (86) total and
ionized Ca from treated steers were higher (P<O.OOOI and P=0.0002, respectively) than
controls, and there were also differences (P<0.05) within levels of supplementation. A
response that was in direct relationship to the amount ofvitamin D3 supplemented. The
ionized to total Ca ratio was not different between treated and control steers (Tables 5.3,
5.4 and 5.5 and Figures 5.1 and 5.2).
During the withdrawal period, total and ionized Ca concentrations continued
rising, and were elevated (P<0.05) relative to control animals, increases that followed the
same pattern as in the previous period. However, these differences tended to disappear at
the end of the withdrawal period (Wll). The ratio of ionized to total Ca was not affected
(P>0.05) with the exception of day WI where it was higher (P<O.05) for supplemented
steers (Table 5.5).
Maximum serum Ca values were achieved during the withdrawal period. Total
Ca maximal concentrations were 10.65, 11.50 and 12.41 mg/dl, which represented a 6.8,
15.3 and 24.5 % increase relative to control animals for the 1.25, 2.5 and 5 Mill
treatments, respectively, on day W3 (Table 5.3 and Figure 5.1). Maximal concentrations
for ionized Ca were 5.00,5.57 and 6.03 mg/dl, which represented a 2.0, 13.7 and 23.1 %
increase relative to control animals for the 1.25,2.5 and 5 MID treatments, respectively,
on day W5 (Table 5.4 and Figure 5.2).
Repeated measures analysis indicated a significant effect of treatment (P<O.OOOI
and P=O.0024), time (P<O.OOOI, both) and time by treatment interaction (P<O.OOOl, both)
for total and ionized serum Ca levels, respectively. The nature of these interactions is
illustrated in Figures 5.1 and 5.2.
The maximum serum Ca concentration of 12.41 mg/dl from the 5 Mill D3
treatment was in good agreement with the range ofresults reported by other workers
using the same level of supplementation and where improvements in beef tenderness
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were observed (Swanek et ai. 1997, 1999; Montgomery et ai. 1998, 2000; Karges et ai.
1999b, 2001).
Comparing total and ionized serum Ca concentrations obtained in this experiment
with previous experiments of this study, there was found a remarkable similarity among
levels of supplementation. For example, comparing study 1 with this study, total Ca:
11.67 vs 11.50 mg/dl and 12.43 vs 12.41 mg/dl for the 2.5 and 5 Mill treatments,
respectively. For ionized Ca: 5.73 vs 5.57 mg/dl and 6.03 vs 6.03 mg/dl for the 2.5 and 5
Mill treatments, respectively. Additionally, the ionized to total Ca ratios were very
similar among treatments and experiments, which ranged from 47.7 to 49.2 %.
The ionized to total Ca ratio during the adaptation period averaged 49.40 ± 1.81
%. This ratio is in accordance with the normal physiological relationship between
ionized and total Ca ofapproximately 50:50 (Copp 1973; Coles 1986; Rosol et al. 1995).
This Ca ratio was not affected (P>0.05) either by the low Ca diet or by vitamin D3
supplementation, with the exception on day WI, where supplemented steers had a lower
(P<0.05) ratio than controls, with no difference (P<0.05) amongst treatments (Table 5.6).
No effect (P>0.05) was observed during the withdrawal period (Table 5.6). This
indicates that any change in total serum Ca induced by the low Ca diet or by vitamin D3
supplementation was paralleled, almost immediately by changes in ionized Ca levels.
5.3.3 Vitamin D3and 25-Hydroxyvitamin D3 Concentrations
Vitamin D3 and 25(OH)D3 plasma concentrations from the experimental steers
during the adaptation period averaged 20.76 ± 7.00 and 23.22 ± 5.74 ng/ml, respectively.
The vitamin D3 pre-treatment average value and the range (13.43 to 30.68 ng/ml) from
control animals during the low Ca period were slightly higher than the nonnal range (1 to
6 ng/ml) reported by DeLuca (1979) and Montgomery et ai. (2000), however, this range
was in good agreement with the values «0.2 to 20 ng/ml) reported by Endres and Rude
(2001). The 25(OH)D3 pre-treatment value and the range (15.05 to 20.24 ng/ml) from
control animals were in agreement with the normal range (25 to 35 or 10 to 50 ng/ml)
reported in the literature (DeLuca 1979; Endres and Rude 2001, respectively).
During the low Ca diet period, vitamin D3 concentration was decreased (P<0.05)
in steers fed the low Ca diet relative to those fed the control diet during the first two days
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Table 5.5. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 on ionized to total serum Ca ratio of finishing Angus steers (522 ± 33 kg).
Ionized to Total Ca Ratio (%)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A
Contrast Z
B C D
A 49.05 50.48 49.30 48.53 0.91
Low Ca Diet Period (ad libitum) Y:
LCa LCa LCa NCa
L2 49.10 49.07 48.72 49.56 0.38 0.1860
L4 48.78 48.53 49.00 49.11 0.50 0.5596
L6 48.79 48.87 49.05 48.18 0.52 0.2348
L8 49.23 48.89 49.49 48.83 0.66 0.6246
LID 48.53 49.81 49.11 49.36 0.84 0.8251
Supplemental Period (normal Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hdJd)
o 1.25 2.5 5.0
S2
S4
S6
49.24 48.46 47.91 46.64 0.66
48.24 48.19 47.36 46.79 0.53
47.01 46.48 45.69 46.28 0.70
0.0557 0.5202 0.1725
0.2059 0.2341 0.4368
0.2946 0.3899 0.5452
Treatment
Time
Time x treatment
Withdrawal Period (normal Ca diet ad libitum):
WI 49.44 47.81 47.03 46.87 0.73
W3 47.93 46.07 46.76 47.42 1.28
W5 48.90 49.21 48.50 49.80 0.73
WII 49.58 51.01 50.06 49.22 0.56
Repeated Measures Analysis:
P value
0.6064
<0.0001
0.3259
0.0194 0.4186 0.8717
0.4274 0.6744 0.7054
0.7488 0.4545 0.2081
0.4342 0.2070 0.2849
Z Contrasts: A = Normal Ca diet (group 4) vs low Ca diet (groups 1,2 and 3).
B = Control animals vs vitamin D3 treated steers
C = 1.25 vs 2.5 MID D3
D = 2.5 vs 5.0 Mill D3
Y LCa = low Ca diet; NCa = normal Ca diet
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of this period. However, at the end of this period (LIO), the situation was reversed (Table
5.6 and Figure 5.3). The 25(OH)D3concentrations were similar between treated and
untreated steers, with the exception of the last day of the period (LI0), where the normal
Ca cattle had lower (P<0.05) plasma 25(OH)D3 concentrations than the low Ca diet
groups (Table 5.7 and Figure 5.4). These differences while significant were relatively
small.
During the supplemental period, the supplemented animals showed an increase
(P<O.OOOI) in vitamin D3and 25(OH)D3 concentrations. The response was closely
related to the amount of vitamin D3 supplemented (P<O.OOOI). However, these two
compounds had different response patterns. That is, the vitamin D3 increase resembled a
bell shaped curve, with the midpoint towards the end of the supplemental period. The
25(OH)D3Ievels exhibited a sustained linear increase until the beginning of the
withdrawal period where plateaus were reached (Tables 5.6 and 5.7 and Figures 5.3 and
5.4).
Repeated measures analysis indicated a significant effect of treatment (P<O.OOOI),
time (P<O.OOOI) and time by treatment interaction (P<O.OOOl) for plasma vitamin D3 and
25(OH)D3 concentrations. The nature of these effects is illustrated in Figures 5.3 and 5.4.
Maximum plasma concentrations ofvitamin D3were 103.25, 171.59 and 352.98
ng/ml, which represented a 5-, 8.2- and 13.l-fold increment relative to control animals
for the 1.25, 2.5 and 5 Mill treatments, respectively. Maximum concentrations for
25(OH)D3, were 91.40, 160.87 and 271.62 ng/tnl, which represented a 5.6-, 10.2- and
17.2-fold increase relative to control animals for the 1.25,2.5 and 5 MID treatments,
respectively (Tables 5.6 and 5.7 and Figures 5.3 and 5.4).
Montgomery et al. (2000) supplemented finishing steers with 5 MID D3 for 9
days and found at slaughter that plasma vitamin D3 and 25(OH)D3 concentrations reached
464.3 and 578.4 ng/ml, respectively. In the present study the increases in plasma of these
compounds for the 5 MID treatment were lower than the values reported by Montgomery
et al. (2000). These workers, however, used a different method ofvit~inD3
administration (intraruminal boluses). Nevertheless, the response trends were similar
between the two studies.
115
Table 5.6. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 on plasma vitamin D3concentrations of finishing Angus steers (522 ± 33 kg).
Vitamin D3 (ng/ml)
Group Contrast Z
Days 1 2 3 4 8EM A B C D
Adaptation Period (nonnal Ca diet ad libitum):
A 10.22 22.90 22.47 26.46 1.98
Low Ca Diet Period (ad libitum) Y:
LCa LCa LCa NCa
L2 15.15 21.18 10.68 30.68 2.08 <0.0001
L4 21.01 20.03 10.28 13.89 1.53 0.0848
L6 20.88 17.92 10.27 13.43 3.22 0.4363
L8 28.36 26.26 13.06 19.98 3.22 0.4911
LIO 29.68 22.96 23.95 13.56 2.43 0.0007
Supplemental Period (nonnal Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hdld)
o 1.25 2.5 5.0
82
84
86
28.17 45.38 53.68 131.97
28.79 73.77 141.44 336.17
26.98 80.17 144.63 352.98
3.78 <0.0001
15.14 <0.0001
10.96 <0.0001
0.1226 <0.0001
0.0033 <0.0001
0.0004 <0.0001
Withdrawal Period (nonnal Ca diet ad libitum):
WI 20.79 103.25 171.59 301.25
W3 24.25 86.61 108.20 157.11
W5 27.62 55.87 64.67 104.38
WII 15.22 33.75 36.57 36.52
Repeated Measures Analysis:
13.77
6.85
4.56
4.47
<0.0001
<0.0001
<0.0001
0.0013
0.0015 <0.0001
0.0259 <0.0001
0.1491 <0.0001
0.6251 0.9935
Treatment
Time
Time x treatment
P value
<0.0001
<0.0001
<0.0001
Z Contrasts: A = Nonna1 Ca diet (group 4) vs low Ca diet (groups 1,2 and 3).
B = Control animals vs vitamin D3 treated steers
C = 1.25 vs 2.5 MIU D3
D = 2.5 vs 5.0 Mill D3
Y LCa = low Ca diet; NCa = normal Ca diet
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Figure 5.3. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 (0, 1.25, 2.5 and 5 Mill per day for seven consecutive days) on plasma
vitamin D3 concentrations of finishing Angus steers (522 ± 33 kg BW), during adaptation
(A), low Ca (Ll to LI0), supplemental (81 to 87) and withdrawal (WI to Wll) periods.
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Table 5.7. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 on circulating 25-hydroxyvitamin D3 (25(OH)D3) concentrations of finishing
Angus steers (522 ± 33 kg BW).
25(OH)D3 (nglml)
Group Contrast Z
Days 1 2 3 4 8EM A B C D
Adaptation Period (normal Ca diet ad libitum):
A 18.94 19.16 30.94 22.91 1.38
Low Ca Diet Period (ad libitum) Y:
LCa LCa LCa NCa
L2 18.64 19.55 21.29 20.24 1.45 0.8065
L4 18.12 18.49 21.02 17.97 1.34 0.4264
L6 18.60 18.54 19.71 17.77 1.24 0.4191
L8 18.16 19.01 20.45 20.22 1.69 0.6052
L10 19.18 18.98 25.20 15.05 1.22 0.0006
Supplemental Period (normal Ca diet; D3treatments fed at 85% ofad libitum):
Vitamin D3Level (MIU/hd/d)
o 1.25 2.5 5.0
82 18.05 30.42 36.97 53.04 2.50
84 17.34 48.70 81.40 149.78 3.34
86 16.72 75.42 117.97 218.42 3.99
<0.0001 0.0570 0.0003
<0.0001 <0.0001 <0.0001
<0.0001 <0.0001 <0.0001
Withdrawal Period (normal Ca diet ad libitum):
W1 15.74 84.59 160.86 271.62 7.67 <0.0001 <0.0001 <0.0001
W2 16.26 91.40 148.32 262.13 10.55 <0.0001 0.0008 <0.0001
W3 15.66 81.60 151.83 235.45 11.45 <0.0001 0.0003 <0.0001
W4 17.38 75.28 128.19 171.08 6.95 <0.0001 <0.0001 0.0004
Repeated Measures Analysis:
P value
Treatment <0.0001
Time <0.0001
Time x treatment <0.0001
Z Contrasts: A = Normal Ca diet (group 4) vs low Ca diet (groups 1,2 and 3).
B = Control animals vs vitamin D3 treated steers
C = 1.25 vs 2.5 MID D3
D = 2.5 vs 5.0 MID D3
Y LCa = low Ca diet; NCa = normal Ca diet
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Figure 5.4. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 (0, 1.25, 2.5 and 5 Mill per day for seven consecutive days) on 25-
hydroxyvitamin D3 (25(OH)D3) concentrations of finishing Angus steers (522 ± 33 kg
BW), during adaptation (A), low Ca (Ll to LID), supplemental (81 to 87) and withdrawal
(W1 to W 11) periods.
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5.3.4 1,25-Dihydroxyvitamin D3 (1,25(OHhD3) Concentrations
Plasma 1,25(OH)2D3 concentration was determined immediately after
supplementation period ended (WI). The concentration was 26.83, 62.05, 113.99 and
148.71 pglml for the 0, 1.25,2.5 and 5 MIU treatments, respectively, indicating a
significant (P<O.OOOI) increase in 1,25(OHhD3 concentration with the level ofvitamin
D3 supplementation (Table 5.8).
Increases in 1,25(OH)2D3 concentration as a result of vitamin D3 supplementation
was to some extent unexpected. It has been pointed out that the second hydroxylation of
vitamin D3 in the kidney is a tightly regulated step, as it is controlled principally by Ca
levels in plasma, by PTH, and the level of 1,25(OH)2D3 itself. This control is
accomplished by modulating the activity of the 1a-hydroxylase enzyme. When Ca in
plasma reaches concentrations above normal, PTH is decreased and consequently the
activity of this enzyme is reduced, shutting down the production of 1,25(OH)2D3
(DeLuca and Schnoes 1983; Horst and Littledike 1979; Guyton and Hall 1996). In this
respect, Montgomery et al. (2000) found no increase (20.8 vs 26.83 pglml) in plasma
1,25(OH)2D3 as a result ofvitamin D3supplementation (5 Mill D3 for 9 days).
A possible explanation for the increase in 1,25(OHhD3Ievels observed in this
study is that high levels ofvitamin D3 supplementation induced high levels ofvitamin D3
and 25(OH)D3 in plasma. It is possible that high substrate concentrations, mainly
25(OH)D3, stimulated higher activity of the la-hydroxylase enzyme, by overwhelming
the negative feedback. This would in tum result in higher levels of 1,25(OH)2D3 which
will stimulate the Ca homeostatic mechanisms. It has been observed that ruminants
respond differently to administration of vitamin D3. Intramuscular injection of 10 or
more Mill of vitamin D3 to dairy cows has resulted in elevated levels of 1,25(OHhD3 in
plasma, this higher levels of 1,25(OHhD3 increase the influx of Ca to the extracellular
fluid through the stimulation of Ca reabsorption, resorption and absorption from kidneys,
bone and intestine, respectively, preventing the incidence ofmilk fever (Reinhardt and
Conrad 1980; Littledike and Horst 1982; Goff et al. 1991). Although, no clear
explanation to this phenomenon has been provided in the literature. Nevertheless, Horst
and Reinhardt (1983) pointed out that ruminants appear unique in their response to large
doses ofvitamin D3, suggesting that ruminants lack the tightly controlled 1a-hydroxylase
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Table 5.8. Effect of feeding a low Ca diet for ten days prior to supplementation of
vitamin D3 on circulating calciotrophic hormones concentration of finishing Angus steers
(522 ±33 kg BW) on day 1 of the withdrawal period.
Calciotrophic Hormones (pglml)
Vitamin D3 Level (MIU/hdld) Contrast Z
Day 0 1.25 2.5 5.0 SEM A B C
Parathyroid Hormone (PTH):
WI 74.65 29.44 12.51 5.00 6.40 <0.0001 0.0552 0.3964
1,25-Dyhydroxyvitamin D3:
WI 26.83 62.05 113.99 148.71 12.25 <0.0001 0.0047' 0.0531
Calcitonin:
WI 330.86 384.72 360.69 395.73 29.93 0.1671 0.5358 0.3976
Z Contrasts:
A = Control animals (0 MID) versus supplemented vitamin D3steers.
B = Treatment 1.25 versus 2.5 Mill D3.
C = Treatment 2.5 vs 5 Mill D3.
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enzyme activity that has been observed in other species (monogastrics, including
humans).
5.3.5 Parathyroid Hormone (PTH) Concentration
Plasma PTH concentrations were determined immediately after supplementation
period ended (WI). PTH concentrations were 74.65, 29.44, 12.51 and 5.00 pglml for the
0, 1.25,2.5 and 5 Mill treatments, respectively. There was a significant (P<O.OOOI)
effect of treatment and between the lower and higher level ofvitamin D3 supplementation
(P<0.05), although the 2.5 Mill treatment was similar (P>0.05) to both levels of
supplementation (Table 5.8). PTH concentrations were in agreement with its theoretical
response to high levels of plasma Ca. PTH is essential in protecting against
hypocalcemia and in the maintenance of skeletal integrity (Rosol and Capen 1997).
When Ca concentration in plasma decreases below normal values then the parathyroid
glands secrete larger amounts of PTH, which in tum stimulates the hydroxylation of
25(OH)D3 to form the 1,25(OHhD3. PTH also acts concurrently on Ca reabsorption
from kidneys, resorption from bone and Ca absorption from the intestine (Smith et ale
1983; Rhoades and Tanner 1995), in consequence Ca levels in plasma return normal
levels (West 1991). When Ca concentrations are above normal, the opposite occurs, PTH
concentration is decreased (Bhagavan 1992; Rhoades and Tanner 1995), effect that was
observed in the present experiment.
5.3.6 Calcitonin Hormone Concentration
Calcitonin plasma concentrations were determined immediately after
supplementation period ended (WI). The calcitonin concentrations were 330.85,384.72,
360.69 and 395.73 pglml for the 0, 1.25,2.5 and 5 Mill treatments, respectively, with no
effect (P<0.05) of supplementation (Table 5.8).
Calcitonin concentrations in this experiment were different to the theoretical
trends expected. Calcitonin functions together with the other calciotrophic hormones to
maintain normal plasma Ca levels. When Ca concentrations are above normal, calcitonin
is secreted immediately in order to prevent hypercalcemia (Copp 1973; Rhoades and
Tanner 1995; Guyton and Hall 1997). Even though, vitamin D3 supplementation did
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increase serum Ca concentrations, calcitonin levels were not altered. As discussed in
Chapter IV, Rossol et al. (1995) indicates that calcitonin regulatory mechanism is
considered weaker than the PTH system. This may explain why calcitonin levels were
not significantly affected by vitamin D3supplementation.
In summary, feeding steers with the low Ca diet for ten days tended to decrease
feed intake, plasma vitamin D3, and total and ionized serum Ca concentrations but only
for the first one to two days of feeding. Supplementing steers with vitamin D3 for seven
days resulted in a significant depression in intake, and in PTH levels, and in elevated
levels of total and ionized serum Ca, as well as in plasma vitamin D3, 25(OH)D3, and
1,25(OH)2D3 levels, with no effect on calcitonin levels.
Total serum Ca concentrations were increased by almost 0.5 mg/dl more (11.50 vs
11.02 mg/dl) than in the previous experiment (Chapter IV) for the 2.5 MID treatment. It
is possible to hypothesize that the increased response in the present study for the same
level ofvitamin D3 supplementation was a result of the low Ca diet, which may have
primed the animal to respond to vitamin D3 supplementation. However, it is also possible
that the improved response is in relation to differences in the actual consumption of
vitamin D3. In the previous experiment, the steers fed the 2.5 Mill D3level consumed 84
% (2.1 MID/d) of the total amount targeted, while in the present trial the consumption
was slightly higher than that targeted (2.7 MID/d). In the previous study steers fed the 5
MID D3level consumed approximately 70 % (3.4 MID/d) of the total amount targeted,
while in this experiment consumption was almost exactly on target (5.1 MID/d).
The apparent lack of response of the low Ca diet during the feeding period or in
enhancing the effect ofvitamin D3 on serum Ca concentrations may be due to the
following factors. First, dairy cattle are fed low Ca diets for long periods of time (30 to
80 days); and secondly, and most importantly, low Ca diets usually do not increase
plasma Ca levels during the feeding period, but they prevent sharp drops ofplasma Ca
levels at parturition and/or initiation of lactation, by increasing Ca resorption from bone
and the efficiency of Ca absorption from the intestine. Through stimulation of the
synthesis ofPTH and 1,25(OH)2D3, these diets actually prime the Ca homeostatic
mechanisms of the animal. In this trial, feeding the low Ca diet altered the Ca
homeostatic mechanisms as initial levels of total Ca and vitamin D3 were initially lower
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than nonna!. However, the lack of any major stress, as parturition imposes to the high-
producing cow seems to neglect any advantage from the low Ca diet prior to
supplementation of vitamin D3. It does not appear that feeding a low Ca diet to finishing
steers enhances the serum Ca response of the animals to vitamin D3 feeding.
5.4 Conclusions
Feeding a low Ca diet for ten days prior to vitamin D3 supplementation induced a
decrease in feed intake, total serum Ca and plasma vitamin D3 concentrations during the
first three to four days of feeding, but had no effect on other parameters.
High levels of vitamin D3 (1.25, 2.5 and 5 MIUlhdld for seven consecutive days)
had a significant effect on depressing feed intake and plasma PTH levels. On the other
hand, it significantly increased total and ionized serum Ca, and plasma vitamin D3,
25(OH)D3 and 1,25(OHhD3 concentrations. The degree ofresponse was related to the
level ofvitamin D3 supplementation. However, no effect on the ionized to total Ca ratio
or in calcitonin concentrations were observed.
An interesting finding from this experiment is that supplementation with high
levels of vitamin D3 actually increases the plasma concentration of 1,25(OHhD3 despite
high concentrations of total and ionized Ca in serum. This phenomenon has been also
observed in dairy cows when they have been injected with high amounts of vitamin D3.
These results suggest that in ruminants the activity of the enzyme 1a-hydroxylase is not
as tightly regulated as is in humans and other animals (pigs).
It seemed that the low Ca diet affected the Ca homeostatic mechanisms at least to
some degree, because total Ca and vitamin D3concentrations in blood were lower than
nonnal during the first days of the low Ca period. However, the lack of any considerable
Ca stress such as parturition appears to counteract the potential benefits of feeding a low
Ca diet to finishing steers.
In conclusion, it does not appear that feeding a low Ca diet to finishing steers
enhances the serum Ca response of the animals supplemented with vitamin D3•
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CHAPTER VI
Effect of Low and High Calcium Diets, Anionic Salts and Vitamin D3
Supplementation to Finishing Beef Steers on Calcium and Acid-Base
Homeostasis
6.1 Introduction
It has been observed that feeding low calcium (Ca) diets to dairy cattle induce
higher plasma Ca concentrations at and around parturition. These increased levels have
helped to reduce milk fever problems (Beitz et al. 1973; Green et al. 1981; Horst et al.
1997). However, this effect has only been identified during the periparturient period. It
is postulated that this rise in plasma Ca as a result of low Ca feeding is a response to the
stress induced by the onset of lactation. In the last experiment of this series, there were
no beneficial effects on serum Ca when beef steers were fed a low Ca diet either with or
without vitamin D3 supplementation, likely due to the lack of any significant stress on Ca
metabolism such as the initiation of lactation.
On the other hand, the feeding of acidified diets has increased the levels of Ca in
plasma, which has resulted in considerable reduction in the incidence ofmilk fever
(Block 1984, 1994; LeClerc and Block 1989; Wang and Beede 1992). The proposed
mechanism of action is that a higher proportion of dietary anions in relation to cations
alters the nonnal acid-base status of the animal reducing the pH of the blood and
consequently causing a mild acidosis. This in turn induces Ca excretion in urine
(hypercalciuria). Hypercalciuria may be due to a competitIon between Ca++ and H+ for
binding sites on serum proteins (Moore 1970). Reduced Ca levels in plasma in turn
stimulate the Ca homeostatic mechanisms. Parathyroid honnone (PTH) synthesis is
stimulated and the responsiveness of target tissues to PTH is increased. Similarly,
plasma 1,25(OH)2D3 concentrations increase. As a result, the proportion of dietary Ca
absorbed from intestine and the rate ofCa mobilization from bone are increased, leading
to a correction in plasma Ca concentration. For this reason high Ca diets are
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recommended when feeding acidified diets (Gaynor et al. 1989; Abu Damir et al. 1994;
Horst et al. 1997; Pehrson et al. 1999).
The balance of the bioavailable ions that are not metabolized in the diet influences
the acid-base balance in the animal (Oetzel et al. 1991). The dietary cation-anion balance
(DCAB) is defined as the summation in milliequivalents (mEq) of the cations, sodium
(Na) and potassium (K), minus the sum of the anions, chloride (CI) and sulfur (S) per kg
ofdry matter or per day ([Na+K] - [CI+SJ). Thus, a positive DCAB reflects a cationic
diet conversely a negative DCAB reflects an anionic diet (Block 1984; LeClerc and
Block 1989).
Acidified diets (negative DCAB) have proved to be an important tool to increase
plasma Ca concentration to manage milk fever problems in high producing dairy cows at
and around parturition. Unfortunately, most of the research reported in the literature
express the degree of acidification (DCAB) in terms ofmEq/1 00 g of DM or mEq/kg of
OM or they do not use the above formula. In some cases a derivation of it is used where
for example the researcher does not take into account S or includes absorption factors for
each mineral (Block 1984; OetzeI1993). For this experiment the supplementation of
anionic salts was carried out in terms ofmEq/d and not per kg of OM consumed.
Anionic salts such as magnesium sulfate, calcium sulfate, ammonium sulfate,
magnesium chloride, ammonium chloride and calcium chloride have been used to
formulate acidogenic diets (Oetzel et ai. 1991) with positive results in preventing milk
fever (LeClerc and Block 1989; Goff et ai. 1991; Erdman 1993). In the previous
experiment of this series a low Ca diet was used prior to supplementation of vitamin 03
to finishing steers with the objective to stimulate Ca homeostasis (i.e. increase serum Ca)
and so enhance the effect ofvitamin 03 supplementation. However, this effect was not
apparent, although serum Ca and plasma vitamin 03 concentrations were decreased at the
beginning of the low Ca feeding period, indicating that Ca homeostasis was altered in
some degree. For this reason, the same approach was followed in this experiment.
Feeding of anionic salts appears to be a viable way to pose a Ca stress, because they
increase the amount ofCa excreted via urine.
Moreover, such diets also influence plasma Ca concentrations through an effect
on bone Ca mobilization and intestinal Ca absorption. It is possible that a combination of
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dietary Ca manipulation in conjunction with the feeding of anionic salts and vitamin D3
may increase serum Ca values to the point where beef tenderness has been improved. In
the process, if lower levels of vitamin D3are required to increase serum Ca
concentrations, then the risk ofresidual vitamin D3in edible tissues could be reduced.
The objective of this experiment was to evaluate the effect ofdietary Ca
manipulation (low and high Ca diets), anionic salts (MgS04 and NH4CI) and low levels
of vitamin D3 on circulating concentrations of serum Ca, vitamin D3, 25(OH) D3,
calciotrophic hormones, and in the acid-base regulatory mechanisms of finishing steers.
6.2 Materials and Methods
6.2.1 Experimental Design
An overview of the experimental design is given in Table 6.1.
6.2.1.1 Adaptation Period (days Al to A19)
Twenty Hereford steers (448 ±26 kg BW) were housed in individual pens (3.6 x
3.6 m) with automatic water bowls in the Livestock Research Barn ofthe Department of
Animal and Poultry Science at the University of Saskatchewan. Animals were cared for
according to the guidelines of the Canadian Council of Animal Care. The cattle were
adapted to the experimental diet for 19 days. The diet consisted of75 % concentrate
(barley grain based) and 25 % barley silage (as fed) (Table 6.1). This diet was considered
as the normal Ca diet and was formulated according to the Nutrient Requirements of Beef
Cattle (NRC 1996), which had a total Ca concentration of0.64 % and a C~ to P ratio of
1.3 (Enviro-Test Laboratories. Saskatoon, SK. Canada and Norwest Labs. Lethbridge,
AB. Canada). The dietary cation-anion balance (DCAB) ([Na+K] - [CI+S]) for this diet
was 2.07 mEq/kg ofDM (OetzeI1993).
The steers were fed twice a day (0800 and 1600 h), with orts collected and
weighed before the morning feeding. Individual maximum voluntary feed intake was
measured from day A13 to A19, constituting the pre-treatment feed intake value.
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Table 6.1. Experimental design.
Period
Adaptation
LowCa
No. of Days
19
(AI to A19)
14
(Ll to L14)
Type of Diet
Normal Ca Diet
DCAB=2.07
mEq/kgDM
Ca= 0.64 %
Ca:P = 1.26
Low Ca Diet
DCAB= 1.77
mEq/kgDM
Ca= 0.16 %
Ca:P = 0.31
Supplemental
Anionic Salts Z
Supplemental
Vitamin D3
Supplemental 10 High CaDiet SI to S3: SI to S10:
(SI to S10) DCAB=2.19 -1500 0, 0.6, 1.2 or 2.4
mEq/kgDM (mEq/hd/d) (Mill D3/hd/d)
. Ca=0.84% S4 to S10:
Ca:P = 1.68 -3000
(mEq/hd/d)
Withdrawal 5 High CaDiet
(WI to W5) DCAB = 2.19
mEq/kgDM
Ca= 0.84 %
Ca:P = 1.68
Z -1500 mEq/hd/d = 56.6 g of MgS04+ 56.6 g ofNH4CI
-3000 mEq/hd/d = 113.5 g of MgS04 + 113.5 g ofNH4CI
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Table 6.2. Ingredient composition and formulated nutrient levels of the experimental
diets.
Normal Ca Diet Low Ca diet High Ca Diet
Item DM(%)
Total mixed diet:
Concentrate 89.6 89.6 89.6
Barley silage 10.4 10.4 10.4
Concentrate:
Barley grain 88.1 89.5 87.5
Canola meal 7.3 7.3 7.3
Tallow 1.7 1.7 1.7
Limestone 1.6 0.0 2.26
Rumensin Z 0.4 0.5 0.4
Vitamin Y 0.4 0.5 0.4
Salt 0.6 0.6 0.6
Chemical composition:
Digestible energy, Mcal/kg x 3.47 3.52 3.45
Crude protein, % 16.14 16.35 16.04
Calcium, % 0.64 0.16 0.84
Phosphorus, % 0.51 0.51 0.50
Ca:P 1.26 0.31 1.68
DCAB mEq/kg DM W 2.07 1.77 2.19
Z Premix: Monensin (20% active) mixed with barley grain.
Y Premix: Vitamin A (416,650 IU/kg) and vitamin D (83,333 IU/kg).
x Predicted TDN x 4.4 Mcal/kg (Weiss et al. 1992).
W DCAB: Dietary Cation-Anion Balance: ([Na + K] - [CI + S])(OetzeI1993).
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The experimental steers were bled by jugular venipuncture starting at 1230 h on
the last day of this period (AI9). Four sets of samples were taken. The first set was
collected into 5m1-draw evacuated (Vacutainer®) tubes without anticoagulant. Blood
was allowed to clot at room temperature for approximately 2 h, then centrifuged at 3500
rpm for 15 min. The serum obtained was immediately used to determine total and
ionized Ca concentrations. The second set was collected into 10 ml-draw evacuated
(Vacutainer®) tubes without anticoagulant. Samples were allowed to clot at room
temperature for approximately 2 h and then centrifuged at 3000 rpm for 15 min at -4°C.
The serum was collected and transferred to 1.7 ml centrifuge clear vials and stored at -
20°C until analysis ofparathyroid hormone, calcitonin and 1,25-dihydroxyvitamin D3.
The third set was collected into 10 ml-draw evacuated (BD Vacutainer™) tubes with
anticoagulant (sodium heparin), which were placed in crushed ice inunediately after
withdrawal, and approximately 2 h later centrifuged at 3000 rpm for 15 min at -4°C. The
plasma was collected and transferred to 1.7 ml centrifuge clear vials and stored at -20°C
until analysis ofvitamin D3 and 25-hydroxyvitamin D3 concentrations. The fourth set was
collected into 2 m1 syringes (Pico™50; Radiometer, Copenhagen, Denmark), which were
placed on crushed ice immediately after extraction and within an hour analyzed for pH,
partial pressure of carbon dioxide (PC02), total carbon dioxide (tC02), partial pressure of
oxygen (P02), bicarbonate (HC03), base excess (BE), hemoglobin (tHb), sodium (Na),
potassium (K), chloride (CI) and anion gap (AG) using a blood gas analyzer (Radiometer
288 System, Copenhagen, Denmark).
6.2.1.2 Low Ca Diet Period (days Ll to L14)
The steers were randomly divided into four groups (five steers per group) and fed
with a low Ca diet for fourteen days. The low Ca diet was similar in composition to the
basal experimental diet but the source of additional Ca (limestone) was withdrawn (Table
6.1). The chemical analysis (Enviro-Test Laboratories. Saskatoon, SK. Canada and
Norwest Labs. Lethbridge, AB. Canada) indicated that the complete ration had a total Ca
concentration of 0.16 % and a Ca to P ratio of0.31. The DCAB for this diet was 1.77
mEq/kg ofDM (OetzeI1993). The feeding pattenl and the monitoring of the feed intake
were the same as in the previous period.
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Blood samples from all the steers were obtained on days L7 and L14, which were
collected, processed, stored and analyzed as described for the adaptation period.
6.2.1.3 Supplemental Period (days SI to S10)
Immediately after the low Ca diet period ended, all four groups of steers were
switched to a high Ca diet. The high Ca diet was similar in composition to the basal
experimental diet but with additional amount ofCa (limestone) (Table 6.1). The
chemical analysis (Enviro-Test Laboratories. Saskatoon, SK. Canada and Norwest Labs.
Lethbridge, AB. Canada) indicated that the complete ration had a total Ca concentration
of 0.84 % and a Ca to P ratio of 1.68.
The DCAB for this diet was 2.19 mEq/kg ofDM (Oetzel1993; Norwest Labs.
Lethbridge, AB. Canada). The feeding pattern and the monitoring of feed intake were the
same as in the previous period. During this period, all four groups of steers were
supplemented with anionic salts, including magnesium sulfate (MgS04) and ammonium
chloride (NH4CI). The addition of these salts was such that the DCAB was decreased to
-1500 mEq/hd/d. This was accomplished by adding to the ration 56.57 g of MgS04 and
56.57 g ofNH4CI per steer per day for three days (SI to S3). For the remaining seven
days'ofthe supplemental period (S4 to S10) the DCAB was reduced to -3000 mEq/hd/d
by adding to the ration 113.5 g of MgS04 and 113.5 g ofNH4CI per steer per day. The
total amount of these minerals were equally divided and offered at each feeding by top-
dressing the ration and then mixing it by hand into the feed bunk. Additionally, thiamin
(50 mglhd/d) was added to the diet in the morning feeding to prevent any negative effect
(e.g. polyencephalomalacia) as a consequence of sulfur excess.
Groups 1, 2, 3 and 4 were assigned to the following levels of supplemental
vitamin D3: 0, 0.6, 1.2 and 2.4 Mill per steer per day for 10 consecutive days,
respectively.
The vitamin D3 supplement was prepared from a vitamin D3 concentrate
containing 518,000 ill per gram (Aventis Animal Nutrition Canada Inc. Campbellsville,
Ontario), using ground barley as a carrier. This supplement was fonnulated to have a
final concentration of 13 Mill D3per kg ofpremix. Analysis of the supplement indicated
an actual concentration of 12.66 ±0.21 Mill D3per kg (eN Laboratories. Courtland,
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MN. USA). The daily total amount ofvitamin D3 per steer was equally divided and
supplied at each feeding.
Feed intake was restricted to 85% relative to the average consumption from the
last 7 days of the low Ca period in all the steers, and additional daily adjustments were
carried out to avoid excessive feed refusals and assure maximal consumption ofanionic
salts and vitamin D3. Feeding times and feed intake monitoring were as described in
previous periods.
Blood samples from all the steers were obtained on days SI, 83, 85, S7, and 89.
These blood samples were collected, processed, stored and analyzed as described in the
adaptation period.
6.2.1.4 Withdrawal Period (days Wl-W5)
Once anionic salt and vitamin D3 supplementation ended, the steers were
maintained for a further 5 days under the same experimental conditions to evaluate post-
treatment effects. The steers were fed with the high Ca diet ad libitum.' Feeding pattern
and feed intake monitoring were as described in previous periods.
Blood samples from all the steers were obtained on days WI and W5. These
blood samples were collected, processed, stored and analyzed as described in the
adaptation period.
6.2.2 Laboratory Analyses
6.2.2.1 Total and Ionized Ca Determinations
Concentrations of total and ionized Ca in serum were determined by indirect
potentiometry utilizing a calcium ion selective electrode as described in Chapter III.
6.2.2.2 Parathyroid Hormone (PTH) Determination
Concentrations ofPTH in serum were determined by immunoradiometric assay as
described in Chapter V. Further details of the assay are presented in Appendix A.
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6.2.2.3 Calcitonin Hormone Determination
Concentrations of calcitonin in serum determined by a double-antibody radio-
immunoassay as described in Chapter IV. Further details of the assay are presented in
Appendix B.
6.2.2.4 Vitamin D3 and 25-Hydroxyvitamin D3 (25(OH)D3) Determinations
Concentrations of vitamin D3and 25(OH)D3 in plasma were determined by
reverse-phase high-performance liquid chromatography (HPLC) as described in Chapter
V. Further details of the assay are presented in Appendix C.
6.2.2.5 1,25-Dihydroxy vitamin D3(1,25(OH)2D3) Determination
Concentrations of 1,25(OHhD3 in serum were determined by radioimmunoassay
as described in Chapter V. Further details of the assay are presented in Appendix D.
6.2.2.6 Blood Gas Analysis
Blood gas analysis was carried out by using the Radiometer 288 System
(Radiometer 288 System, Copenhagen, Denmark). The analysis included pH, partial
pressure of carbon dioxide (pC02), total carbon dioxide (tC02), partial pressure of
oxygen (P02), bicarbonate (HC03-), base excess (BE), hemoglobin (tHb), sodium (Na),
potassium (K), chloride (CI) and anion gap (AG). The description for each analysis is
presented in Appendix E.
6.2.3 Statistical Analysis
The data from feed intake and blood sample analyses were analyzed using the
Analysis of Variance Technique including Repeated Measures Analysis using the
General Lineal Model procedure of SAS (SAS 1989) to compare treatments within days
and over time.
The following model was used for the repeated measures analysis:
Model: Yijk = J.l + ai + tij + 8k + (a8)ij + Cijk
where:
Yijk = is the response at time k on animal j in treatment i.
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J.l = is the overall mean.
ai is a fixed effect of treatment i.
'tij is a random effect of animal j in treatment i.
8k = is a fixed effect of time k.
(a8)ij = is a fixed interaction effect of treatment i with time k.
Eijk = is the random error at time k on animal j in treatment i.
Single degree of freedom contrasts:
A = Pre-treatment control value versus low Ca groups.
B = Control animals versus vitamin D3 supplemented steers.
C = 0.6 versus 1.2 MID D3treatments.
D = 1.2 versus 2.4 MID D3 treatments.
6.3 Results
6.3.1 Feed Intake (DMI)
Feed intake during the adaptation period averaged 9.93 ± 1.16 kg DM. Feed
intake was not affected (P<0.05) during the fourteen days of feeding the low Ca diet.
During the supplemental period the high Ca diet (fed at 85 % ofad libitum) was
supplemented with anionic salts at -1500 and -3000 mEq/hd/d for 3 (SI-S3) and 7 (S4-
S10) days, respectively, and vitamin D3 (0, 0.6, 1.2 or 2.4 MIU/hd/d). Anionic salts did
not decrease (P<0.05) feed intake of control animals (group 1) during the first seven days
of supplementation. However, feed intake was decreased (P<0.05) during the last 3 days
of this period. Feed intake of the group 1 steers was depressed by 26.1 %on day S10
relative to pre-supplementation of anionic salts (Table 6.3).
Feed intake was not different (P>O.05) between anionic and vitamin D3 treated
steers or between levels of supplemental vitamin D3 from days S1 to S3. However, it
started to decrease from day S4, reaching minimum values toward the end of this period:
6.19, 5.57, 3.84 and 4.04 kg which represented a decrease, relative to their intakes on day
S4 (initiation of -3000 mEq/d) of approximately 26, 34, 54 and 49 % for the 0, 0.6, 1.2
and 2.4 Mill treatments, respectively (Table 6.3). The pattern of decline was similar for
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Table 6.3. The effects of anionic salts and vitamin D3 supplementation on feed intake
(DMI) of finishing Hereford steers (448 ± 26 kg BW).
DMI (kg)
Group Contrast Z
Days 1 2 3 4 SEM A B C D
Adaptation Period (normal Ca diet ad libitum):
A19 9.82 10.10 10.17 9.63 0.56
Low Ca Diet Period (low Ca diet ad libitum):
L14 9.82 10.44 9.94 9.62 0.58
Supplemental Period (high Ca diet; 85% of ad libitum) Y:
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
-1500 ntEq/d:
S1 8.36 8.79 8.58 7.99 0.42 0.8922 0.8496 0.7205 0.3348
S2 8.42 8.84 8.33 8.04 0.47 0.9583 0.9741 0.4525 0.6740
S3 8.37 8.55 8.23 8.05 0.49 0.9007 0.8723 0.6492 0.7988
-3000 mEq/d:
S4 8.38 8.45 8.29 7.93 0.50 0.9113 0.7949 0.8218 0.6217
S5 8.06 7.79 7.60 6.89 0.55 0.5909 0.3355 0.8125 0.3729
S6 7.76 7.18 6.93 6.50 0.63 0.3473 0.2408 0.7783 0.6386
S7 7.37 6.74 6.65 5.71 0.68 0.1468 0.2237 0.9255 0.3484
S8 6.34 6.37 5.35 4.54 0.86 0.0059 0.3696 0.4162 0.5179
S9 6.31 6.20 4.06 4.10 0.96 0.0053 0.1896 0.1342 0.9756
S10 6.19 5.57 3.84 4.04 0.88 0.0033 0.1124 0.1844 0.8793
Withdrawal Period (high Ca diet ad libitum):
WI 7.77 7.30 6.47 5.57 0.72 0.1289 0.4272 0.3857
W2 8.67 8.41 4.23 4.57 1.25 0.0601 0.0312 0.8469
W3 8.94 8.57 5.86 5.06 1.08 0.0694 0.0963 0.6082
W4 9.06 8.95 6.91 5.43 1.04 0.1216 0.1839 0.3306
Z Contrasts: A = Average during the low Ca period (85% restriction= 8.46 kg) versus
anionic salts (group 1) / B = Control vs vitamin D3treatments / C = 0.6 vs 1.2 Mill D3
/ D =1.2 vs 2.4 Mill D3
Y High Ca diet with a DCAB = 2.19 mEq/d.
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all groups of steers. From days S7 to S10 there was a difference (P<0.05) between
control steers (group 1) and vitamin D3 supplemented steers, although, there were no
differences (P>0.05) among vitamin D3 groups. Feed intake tended to be decreased in an
inverse relationship to the amount ofvitamin D3 supplemented. Once supplementation
ended feed intake for all steers began to recover.
The DCAB of the ration consumed by the steers was a function of the DCAB
content of the high Ca diet (2.19 mEq/kg DM), the level of anionic salts supplemented (-
1500 or -3000 mEqlhdld), and the actual DMI of the steers. For example, if a steer
consumed 10 kg ofDM per day of the high Ca diet, the DCAB would be 21.9 mEq/d.
Anionic salt supplementation at -1500 mEqlhdld (hand mixing), results in DCAB of-
1478 mEqlhdld with a DMI of 10 kg. Thus, the.DCAB of the steers (all groups) during
the first three days of the supplemental period averaged -1472 ±46.1 mEqlhdld.
However, when the supplementation of anionic salts was increased to -3000 mEqlhdld,
the DCAB ranged from -2936 to -2478 mEqlhdld from days S4 to S10, with no
difference (P>0.05) among groups.
The average consumption of the vitamin D3 supplement was 94.3 % (0.55
MID/d), 87.8 % (1.0 MID/d) and 88.9 % (2.1 MID/d) of the targeted intake for the 0.6,
1.2 and 2.4 MIDlhdld treatments, respectively.
6.3.2 Total and Ionized Ca Concentrations
Total and ionized serum Ca concentrations during the adaptation period averaged
9.81 ± 0.34 and 4.99 ± 0.19 mgjdl, respectively. These averages were not affected
(P>0.05) by feeding the low Ca diet, with the exception of group 1 and 4 that had lower
(P<0.05) ionized and total Ca concentrations on day L14, respectively. In order to know
the effect of anionic salts on serum Ca the average concentrations from the low Ca period
were contrasted with the measurements from the steers supplemented with anionic salts
only. Anionic salts increased (P<0.05) total Ca and ionized Ca concentrations during the
supplemental and withdrawal periods, with the exception of day SI (total Ca) and W5
(ionized Ca) (Tables 6.4 and 6.5 and Figures 6.1 and 6.2).
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Table 6.4. The effects of anionic salts and vitamin D3 supplementation on total serum
Ca concentrations of finishing Hereford steers (448 ± 26 kg BW).
Total Ca (mg/dl)
Group Contrast Z
Days 1 2 3 4 SEM A B C D
Adaptation Period (normal Ca diet ad libitum):
A19 9.78 9.83 9.78 9.86 0.17
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 9.70 9.79 9.58 9.56 0.10
L14 9.64 9.81 9.68 9.46 0.10
Supplemental Period (high Ca diet; 85% of ad libitum) x:
Vitamin D3 Level (MIU/hdld)
0 0.6 1.2 2.4
-1500 mEq/d:
Sl 9.57 9.84 9.70 9.52 0.11 0.5293 0.3407 0.3770 0.2367
S3 9.93 10.12 10.21 10.07 0.14 ·0.0341 0.2061 0.6509 0.4863
- 3000 rrtEq/d:
S5 10.04 10.52 10.79 10.80 0.22 0.0037 0.0177 0.3896 0.9796
S7 10.11 10.70 11.43 11.35 0.27 0.0007 0.0042 0.0743 0.8382
S9 9.98 10.83 11.25 11.73 0.38 0.0138 0.0098 0.4527 0.3876
Withdrawal Period (high Ca diet ad libitum):
WI 9.89 10.97 11.07 12.24 0.41
W5 9.94 10.55 10.81 11.51 0.37
Repeated Measures Analysis:
0.0677 0.0054 0.8613 0.0635
0.0254 0.0322 0.6350 0.2020
Treatment
Time
Time x treatment
P value
0.0167
<0.0001
<0.0001
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 4 had lower (P<0.05) concentration on day L14).
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Figure 6.1. Effect of feeding a low Ca diet for 14 days prior to supplementation of
anionic salts (-1500 mEq/hd/d from 81-83 and -3000 mEq/hd/d from 84-810) and
vitamin D3 (0, 0.6, 1.2 and 2.4 MIU/hd/d) to a high Ca diet for 10 days on total serum Ca
concentrations of finishing Hereford steers (448 ± 26 kg)(A =adaptation; L=low Ca;
S=supplemental; and W=withdrawal periods).
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Table 6.5. The effect of anionic salts and vitamin D3 supplementation on ionized serum
Ca concentrations of finishing Hereford steers (448 ±26 kg BW).
Ionized Ca (mgldl)
Group Contrast Z
Days 1 2 3 4 SEM A B C D
Adaptation Period (normal Ca diet ad libitum):
A19 4.93 4.98 4.99 5.06 0.09
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 4.94 4.93 4.83 4.94 0.05
L14 4.81 4.95 4.88 4.82 0.05
Supplemental Period (high Ca diet; 85% ofad libitum) x:
Vitamin D3 Level (MIU/hdld)
0 0.6 1.2 2.4
-1500 mEq/d:
Sl 4.85 4.91 4.86 4.88 0.04 0.5430 0.4775 0.4563 0.8023
S3 5.02 5.10 5.21 5.17 0.06 0.0494 0.0632 0.2305 0.6381
- 3000 mEq/d:
S5 5.26 5.42 5.53 5.54 0.11 <0.0001 0.0672 0.4653 0.9162
S7 5.40 5.55 5.97 5.95 0.14 <0.0001 0.0179 0.0506 0.9362
S9 5.43 5.78 5.98 6.21 0.20 <0.0001 0.0265 0.4864 0.4366
Withdrawal Period (high Ca diet ad libitum):
WI 5.36 5.90 5.91 6.52 0.21 <0.0001 0.0079 0.9793 0.0625
W5 4.95 5.14 5.39 5.76 0.21 0.3512 0.0673 0.4199 0.2370
Repeated Measures Analysis:
P value
Treatment 0.0197
Time <0.0001
Time x treatment 0.0037
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
y Comparison: Average adaptation period vs low Ca period
(Only group 1 had lower (P<0.05) concentration on day LI4).
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Figure 6.2. Effect of feeding a low Ca diet for 14 days prior to supplementation of
anionic salts (-1500 mEq/hd/d from 81-83 and -3000 mEq/hd/d from 84-810) and
vitamin D3 (0, 0.6, 1.2 and 2.4 MIU/hd/d) to a high Ca diet for 10 days on ionized serum
Ca concentrations of finishing Hereford steers (448 ±26 kg)(A =adaptation; L=low Ca;
S=supplemental; and W=withdrawal periods).
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Total and ionized Ca upon supplementation (-1500 mEq/d and vitamin D3) began
to increase (P<0.05), with no difference (P>0.05) between the control and vitamin D3
treated animals (Figures 6.1 and 6.2). From day 84 to 810 (-3000 mEq/d and vitamin D3)
total and ionized Ca continued rising (P<O.OOOl) and a clear differentiation (P<0.05)
between control and the vitamin D3 treatments was found, but not within levels of
vitamin D3 (P>0.05) (Tables 6.4 and 6.5 and Figures 6.1 and 6.2).
Maximum total Ca concentrations achieved were 10.11 (87), 10.97 (WI), 11.43
(87) and 12.24 (WI) mgjdl for the 0,0.6, 1.2 and 2.4 MID D3 treatments, respectively.
This represents a 3.1, 11.8, 16.5 and 24.8 % increase relative to the pre-treatment control
value, respectively (Table 6.4 and Figure 6.1). Maximum ionized Ca concentrations were
5.43 (87), 5.90 (WI), 5.98 (87) and 6.25 (WI) mgjdl for the 0, 0.6, 1.2 and 2.4 MID D3
treatments, respectively. This represents an 8.8, 18.2 19.8 and 30.7 % increase relative to
the pre-treatment control value, respectively (Table 6.5 and Figure 6.2).
Ionized to total Ca ratio during the adaptation period averaged 50.86 ± 1.06 %.
This average was not altered (P>0.05) by the low Ca diet. Anionic salt supplementation
at the level of -1500 mEq/d had no effect (P>0.05) on this ratio. However, at the level of
-3000 mEq/d, the ionized to total Ca ratio was increased (P<O.OOOl), an effect that
continued until the first day of the withdrawal period. There was no difference (P>0.05)
between the anionic salt group and the vitamin D3 treatments, with the exception
(P<0.05) of days 85 and 87. There was no difference (P>0.05) among the vitamin D3
treatments. After day WI, the Ca ratio dropped in all groups, attaining a minimum value
that was lower (P<0.05) than in the adaptation period (Table 6.6).
6.3.3 Vitamin D3 and 25-Hydroxyvitamin D3 (25(OH)D3)
Vitamin D3 plasma concentrations during the adaptation period averaged 16.81 ±
5.04 ngjmt. The low Ca diet decreased (P<0.05) vitamin D3 plasma concentration in all
groups on day L7, however, concentrations returned to normal by day L14. Anionic salts
at -1500 mEq/d decreased (P<0.05) and at -3000 mEq/d had no effect (P>0.05) on
plasma vitamin D3 concentrations. However, during the withdrawal period,
concentrations ofvitamin D3 were higher (P<O.OOOl) in cattle that were fed the anionic
salts relative to values for cattle fed the low Ca diet (Table 6.7 and Figure 6.3).
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Table 6.6. The effect of anionic salts and vitamin D3 supplementation on ionized to total
Ca ratio of finishing Hereford steers (448 ± 26 kg BW).
Ionized to Total Ca Ratio (%)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 50.42 50.62 51.02 51.39 0.48
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 50.99 50.46 50.42 51.74 0.40
L14 49.88 50.50 50.42 51.03 0.42
A
Contrast Z
B C D
Supplemental Period (high Ca diet; 85% of ad libitum) x:
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 50.70 49.92 50.13 51.28 0.46 0.9616 0.6284 0.7487 0.0966
S3 50.61 50.43 51.03 51.33 0.32 0.8975 0.4081 0.2109 0.5358
- 3000 mEq/d:
S5 52.35 51.49 51.24 51.35 0.40 0.0018 0.0489 0.6699 0.8470
S7 53.40 51.90 52.27 52.40 0.39 <0.0001 0.0167 0.5158 0.8229
S9 54.46 53.43 53.15 53.02 0.62 <0.0001 0.0998 0.7594 0.8826
Withdrawal Period (high Ca diet ad libitum):
WI 54.23 53.86 53.37 53.34
W5 49.79 48.76 49.92 49.93
Repeated Measures Analysis:
0.74 <0.0001 0.4239 0.6453 0.9760
0.55 0.0857 0.6961 0.1552 0.9859
Treatment
Time
Time x treatment
P
value
0.1938
<0.0001
0.5696
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 MID D3 treatment / D =1.2 vs 2.4 MID D3
treatment.
Y Comparison: Average adaptation period vs low Ca period
(No difference (P<0.05) among groups).
.
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Table 6.7. The effect of anionic salts and vitamin D3 supplementation on plasma
vitamin D3 concentrations of finishing Hereford steers (448 ± 26 kg BW).
Vitamin D3 (ngltnl)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 13.17 15.04 20.54 18.48 1.99
Low Ca Diet Period (low Ca diet ad libitum) Y:
A
Contrast Z
B C D
L7 9.60 12.08 10.87
L14 15.24 17.64 16.45
8.96
19.49
1.49
2.15
Supplemental Period (high Ca diet; 85% ofad libitum) x:
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
SI 11.03 12.29 15.38 14.74 1.74 0.0215 0.1424 0.2280 0.7976
S3 9.05 39.77 53.02 79.15 4.14 0.0029 <0.0001 0.0381 0.0004
- 3000 mEq/d:
S5 19.21 46.61 78.24 122.55 6.85 0.4423 <0.0001 0.0049 0.0003
S7 11.99 38.47 70.91 118.83 5.72 0.0502 <0.0001 0.0010 <0.0001
S9 16.43 37.87 64.23 81.16 3.63 0.7658 <0.0001 0.0001 0.0046
Withdrawal Period (high Ca diet ad libitum):
WI 24.56 50.13 44.59 82.81 4.44
W5 28.31 36.49 32.90 48.35 2.41
Repeated Measures Analysis:
0.0006 <0.0001 0.3913 <0.0001
<0.0001 0.0012 0.3068 0.0003
Treatment
Time
Time x treatment
P value
<0.0001
<0.0001
<0.0001
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 treatment / D =1.2 vs 2.4 Mill D3
treatment.
Y Comparison: Average adaptation period vs low Ca period
(All the four groups had lower (P<0.05) concentration on day L7).
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Figure 6.3. Effect of feeding a low Ca diet for 14 days prior to supplementation of
anionic salts (-1500 mEq/hd/d from 81-83 and -3000 mEq/hd/d from 84-810) and
vitamin D3 (0, 0.6, 1.2 and 2.4 MIU/hd/d) to a high Ca diet for 10 days on plasma vitamin
D3 concentrations of finishing Hereford steers (448 ± 26 kg)(A =adaptation; L=low Ca;
S=supplemental; and W=withdrawal periods).
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Plasma concentrations ofvitamin D3 were not different (P>0.05) between steers
supplemented with anionic salts or in combination with vitamin D3, irrespective of the
level of vitamin D3fed, on day S1. However, plasma vitamin D3 concentrations
increased (P<O.OOOI) in steers supplemented with vitamin D3 from day S3 to W5, with
clear differentiation (P<0.05) among vitamin D3treatments (Table 6.7 and Figure 6.3).
Plasma vitamin D3 concentration response curves described a bell shaped curve,
with the degree of response directly related to the level of vitamin D3 supplemented. The
response was observed almost immediately after supplenlentation initiated and returned
almost to normal by the end of the withdrawal period. Maximum plasma vit~in D3
concentrations were 28.31 (W5), 50.13 (WI), 78.24 (S5) and 122.55 (S5) ng/ml, which
represented a 1.7-, 3.0-,4.6- and 7.3-fold increase relative to pretreatment values for the
0, 0.6, 1.2 and 2.4 Mill treatments (Table 7.6 and Figure 6.3).
Plasma 25(OH)D3 concentrations during the adaptation period averaged 20.77 ±
3.39 ng/ml. This average was not affected (P>0.05) by the low Ca diet. Anionic salt
supplementation decreased (P<0.05) the concentration of 25(OH)D3 during the first 6
days of supplementation, and on day WI. Combination of anionic salts and vitamin D3
induced sustained (P<O.OOOI) increases in plasma 25(OH)D3 that started to rise almost
immediately after supplementation began, reaching maximum values toward the end of
the withdrawal period. There were large differences (P<O.OOOI) in 25(OH)D3 levels
between anionic salt and vitamin D3 supplemented steers. Differences (P<0.05) in
plasma 25(OH)D3 among vitamin D3treatments were evident in both supplemental and
withdrawal periods. Maximum 25(OH)D3concentrations were 63.81 (WI), 97.34 (WI),
and 154.54 (W5) ng/ml, which represented a 3.1-,4.7- and 7.4-fold increase relative to
adaptation period values for the 0.6, 1.2 and 2.4 Mill treatments, respectively (Table 6.8
and Figure 6.4).
6.3.4 Calciotrophic Hormones
Serum concentrations of the parathyroid hormone (PTH), I,25-dihydroxyvitamin
D3 and calcitonin were determined immediately after supplementation of anionic salts
and vitamin D3 ended (WI). Supplementation ofvitamin D3 decreased (P<O.OOOI) PTH
values, and there also was a difference (P<0.05) between the 0.6 and 1.2 Mill D3
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Table 6.8. The effect of anionic salts and vitamin D3supplementation on plasma 25-
hydroxyvitamin D3(25(OH)D3) levels of finishing Hereford steers (448 ± 26 kg).
25(OH)D3 (nglml)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 19.96 19.35 23.08 20.69 1.49
Low Ca Diet Period (low Ca diet ad libitum) Y:
A
Contrast Z
B C D
L7 18.26 17.95 16.87
L14 19.79 19.07 20.49
18.14
17.46
1.23
1.17
Supplemental Period (high Ca diet; 85% ofad libitum) x:
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 15.24 19.86 17.29 18.61 1.27 0.0019 0.0370 0.1723 0.4730
S3 15.93 25.35 36.61 49.51 2.57 0.0127 <0.0001 0.0070 0.0027
- 3000 mEq/d:
S5 16.27 34.79 56.67 90.91 3.24 0.0292 <0.0001 0.0002 <0.0001
S7 16.85 46.34 66.58 109.50 3.71 0.1027 <0.0001 0.0005 <0.0001
S9 19.66 51.81 85.80 132.35 5.56 0.2537 <0.0001 0.0005 <0.0001
Withdrawal Period (high Ca diet ad libitum):
WI 16.36 63.81 97.34 146.14 4.42
W5 16.71 60.53 95.30 156.54 7.39
Repeated Measures Analysis:
0.0361 <0.0001 <0.0001 <0.0001
0.0768 <0.0001 0.0043 <0.0001
Treatment
Time
Time x treatment
P value
<0.0001
<0.0001
<0.0001
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 treatment / D =1.2 vs 2.4 Mill D3
treatment.
Y Comparison: Average adaptation period vs low Ca period
(Only group 3 had lower (P<0.05) concentration on day L7).
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Figure 6.4. Effect of feeding a low Ca diet for 14 days prior to supplementation of
anionic salts (-1500 mEq/hd/d from 81-83 and -3000 mEq/hd/d from 84-810) and
vitamin D3(0, 0.6, 1.2 and 2.4 MIU/hd/day) to a high Ca diet for 10 days on plasma 25-
hydroxyvitamin D3 (25(OH)D3) levels of finishing Hereford steers (448 ± 26
kg)(A =adaptation; L=low Ca; S=supplemental; and W=withdrawaI periods).
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Table 6.9. The 'effect of anionic salts and vitamin D3 supplementation on circulating
concentration of the calciotrophic hormones in finishing Hereford steers (448 ± 26 kg
BW) at the first day of the withdrawal (WI) period.
Calciotrophic Hormones (pglml)
Vitamin D3 Level (MIU/hd/d) Contrast Z
Days o 0.6 1.2 2.4 SEM A B C
Parathyroid Hormone (PTH):
WI 21.22 12.92 4.14 4.32 2.20 <0.0001 0.0124
0.9536
1,25-Dihydroxyvitamin D3:
WI 27.36 52.68 67.74 78.52 8.11 0.0007 0.2079 0.3616
Calcitonin:
WI 304.85 300.55 291.63 313.80 16.02 0.8791 '0.6990 0.3422
Z Contrasts:
A = Control (anion salts only) vs Vitamin D3 treatments.
B = 0.6 vs 1.2 MIU D3treatments
C = 1.2 vs 2.4 MIU D3treatments
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treatments, but not between the 1.2 and 2.4 MID D3 treatments (Table 6.9). The
1,25(OH)2D3 concentration was increased (P<O.OOI) as a result ofvitamin D3
supplementation, although there was no difference (P>0.05) between vitamin D3
treatments (Table 6.9). Calcitonin concentrations were not significantly altered (P>0.05)
as a consequence of vitamin D3 supplementation (Table 6.9).
6.3.5 Acid-Base Status
Blood pH values during the adaptation period averaged 7.40 ±0.02. During the
low Ca period, blood pH was decreased (P<0.05) in all groups on day L14. Anionic salts
at -1500 mEq/d did not affect (P>0.05) blood pH values. However, feeding the anionic
salts at -3000 mEq/d reduced (P<O.OOOI) blood pH. This effect was still evident at the
beginning of the withdrawal period. The depressing effect of anionic salts on pH was
such that when ionic salts were withdrawn, pH values were slightly higher (P<0.05) than
normal on day W5. There was no difference (P>0.05) in pH values between cattle fed
anionic salts and those fed anionic salts plus vitamin D3, no difference (P>0.05) was also
found between vitamin D3 treatments. The repeated measures analysis showed a highly
significant effect of time (P<O.OOOI), but not treatment (P=0.7014) or time by treatment
interaction (P=0.6959). Indicating that pH values were effectively altered from normal as
a result of anionic salt supplementation (Table 6.10 and Figure 6.5).
This same pattern of response for blood pH values to anionic salt supplementation
was observed for blood total carbon dioxide (tC02), bicarbonate (HC03-), and base
excess (BE) values. However, partial pressure of carbon dioxide (PC02), partial pressure
ofoxygen (P02) and anionic gap (AG) were not significantly altered (P<0.05) at any
level of anionic salt or vitamin D3 supplementation. The results tables for PC02, tC02,
p02, HC03-, BE and AG are presented in Appendix E.
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Table 6.10. The effect of anionic salts and vitamin D3supplementation on blood pH
values of finishing Hereford steers (448 ± 26 kg BW).
Blood pH
Group Contrast Z
Days I 2 3 4 SEM A B C D
Adaptation Period (normal Ca diet ad libitum):
AI9 7.41 7.40 7.40 7.39 0.01
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 7.39 7.40 7.40 7.40 0.01
L14 7.40 7.38 7.39 7.37 0.01
Supplemental Period (high Ca diet; 85% ofad libitum) x:
Vitamin D3 Level (MIUlhdJd)
0 0.6 1.2 2.4
- 1500 mEq/d:
SI 7.39 7.38 7.39 7.37 0.01 0.8099 0.5976 0.7458 0.3372
S3 7.38 7.39 7.38 7.38 0.01 0.5049 0.7828 0.5020 0.6857
- 3000 mEq/d:
S5 7.34 7.34 7.34 7.37 0.01 0.0122 0.6565 1.0000 0.0829
S7 7.30 7.30 7.27 7.32 0.02 <0.0001 0.8838 0.3322 0.744
S9 7.29 7.30 7.27 7.32 0.02 <0.0001 0.8600 0.2706 0.0713
Withdrawal Period (high Ca diet ad libitum):
WI 7.30 7.29 7.29 7.30
W5 7.43 7.42 7.40 7.41
Repeated Measures Analysis:
0.02 <0.0001 0.9344 0.2706 0.6875
0.02 0.0445 0.4426 0.8403 0.7705
Treatment
Time
Time x treatment
P value
0.7014
<0.0001
0.6959
Z Contrasts: A = Average low Ca period vs anionic salts (group I) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low C~ period
(Only group 4 had lower (P<0.05) concentration on day L14).
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Figure 6.5. Effect of feeding a low Ca diet for 14 days prior to supplementation of
anionic salts (-1500 mEq/hd/d from 81-83 and -3000 mEq/hd/d from 84-810) and
vitamin D3 (0, 0.6, 1.2 and 2.4 MIU/hd/day) to a high Ca diet for 10 days on blood pH
concentrations of finishing Hereford steers (448 ± 26 kg)(A =adaptation; L =low Ca;
S=supplemental; and W=withdrawal periods).
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6.4 Discussion
The main objective of this experiment was detemline if it is possible to enhance the
effect ofvitamin D3 supplementation on increasing total and ionized serum Ca
concentrations through the manipulation of dietary Ca and the feeding of anionic salts. A
low Ca diet was fed initially for fourteen days prior to supplementation ofvitamin D3• In
the previous experiment it was found that the feeding a low Ca diet decreased total and
ionized serum Ca as well as plasma vitamin D3 concentrations during the first days of
feeding. It was concluded in this study that the low Ca diet might have primed the Ca
homeostatic mechanism in the steers. For this reason, the same approach was used in this
experiment. It has also been shown that the acidification of the diet through the addition
of anionic salts causes hypercalciuria (Moore 1970; Horst et al. 1997). This phenomenon
also activates the Ca homeostatic mechanisms, principally by increasing the efficiency of
intestinal Ca absorption. For this reason, a ration high in Ca was fed while
supplementation of anionic salts and vitamin D3 was carried out. On the other hand,
anionic salts appear to be unpalatable and can lead to a depression of intake (Block
1984). For this reason, such products should be added gradually to the ration. Thus,
anionic salts were supplemented first at -1500 and then at -3000 mEq/hd/d, for 3 and 7
days, respectively.
Feed intake in this experiment was depressed as a result of anionic salt
supplementation more than due to vitamin D3. However, the effect was only significant at
the highest level of anionic salts (-3000 mEq/d). The decline in intake followed a trend
that was inversely related to the levels of vitamin D3 supplemented (time by treatment
interaction, P = 0.0002). The lack of significant (P>0.05) effect of vitamin D3 on feed
intake may be due to the fact that lower levels ofvitamin D3 were supplemented
compared with previous experiments of this series and with other studies (Swanek et al.
1997, 1999; Montgomery et al. 2000; Karges et al. 2001).
Anionic salts are considered unpalatable (Oetzel et al. 1991), and their addition,
depending on the amount used, have maintained (Jackson et al. 1992; Vagnoni and
aetzel 1998) or depressed (Tucker et al. 1988, 1992; Gaynor et al. 1989; Erdman 1993)
feed intake in dairy cattle. The depression in intake appears to be related to alteration of
the normal acid-base balance (Block 1984; LeClerc and Block 1989; Horst et al. 1997).
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The nonnal acid-base balance of the steers was not altered (P<0.05) by feeding a
high Ca diet and supplemented with anionic salts at -1500 mEq/d and vitamin D3.
However, when anionic salts were increased to -3000 mEq/d and vitamin D31evels
maintained, the acid-base status deviated from nonnal (lower blood pH, tC02, HC03-,
and BE; P<0.05). It is possible that a metabolic acidosis was produced at this time in
which the nonnal homeostatic mechanisms (renal excretion and respiratory rate) were
able to buffer the excess of anions, such that the nonnal blood pH and the other
parameters were maintained. No changes in blood pH have been observed in dry cows
fed with acidified diets at -1200 mEq/hd/d (Pehrson et al. 1999) or -2000 mEq/d (Oetzel
et ale 1991). The acid-base characteristic of the blood is described by pH, which refers to
hydrogen ion (H+) activity. Metabolism ofproteins, carbohydrates, and fats yields high
amounts ofH+ every day, and these ions (protons) are highly reactive. Thus, maintaining
a constant blood pH is critical for nonnal body function, because changes in the nonnal
[H+] result in alterations in charge and molecular configuration ofproteins, which in tum
affects enzyme function and cellular structure (DiBartola 2000).
Maintenance ofpH in blood is in direct relationship with bicarbonate and PC02,
as is shown by the Henderson-Hasselbach equation: blood pH = 6.1 x log 10 [HC03-/(0.03
x pC02)] (Guyton and Hall 1997). So, alterations in blood bicarbonate or blood pC02
will have an immediate effect on blood pH. In order to maintain a constant ratio between
bicarbonate and pC02, the organism adjusts respiration rate to control pC02 and renal
excretion to control bicarbonate concentrations (Kaneko 1989; DiBartola 2000). In this
study, anionic salts decreased bicarbonate and pC02 concentrations, which resulted in a
decreased pH. Bicarbonate was decreased either by loss or buffering ofnon-carbonic
acid. Significant declines in blood pH and bicarbonate are indicative that the steers
suffered metabolic acidosis (Autran de Morais 1993, 1994; Constable 1999). The
decreased pC02 was a response to compensate for the acidosis. An explanation for how
anionic salts induced acidosis is the fact that CI is often absorbed from the
gastrointestinal tract in exchange for the secretion ofbicarbonate ion (Kaneko et ale
1997). Thus an excess of CI and S ions in the gastrointestinal tract might cause a
decrease in bicarbonate ions, altering the nonnal blood bicarbonate-pC02 ratio, and thus
depressing blood pH.
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It has been found that feeding acidified diets has resulted in higher plasma Ca
concentrations in dairy cattle (Block 1984, 1994), in goats (Fredeen et ale 1988) and
laying hens (Cohen et al. 1972). Total and ionized serum Ca levels were increased by
anionic salt supplementation in this study by approximately 3 and 9 %, respectively. This
response seems to be related to the induction ofmetabolic acidosis, which causes initially
hypercalciuria (Tucker et ale 1992). This excess ofCa excretion is likely the result of
hydrogen excretion interfering with Ca absorption (Gaynor et al. 1989), which might
cause sufficient loss of Ca from the plasma pool to activate Ca homeostatic mechanisms
(Oetzel et ale 1991). Thus, when plasma Ca decreased, stimulation ofplasma PTH (Goff
et ale 1991; Phillippo et ale 1994) and 1,25(OHh03 (Gaynor et ale 1989; Goffet ale 1991;
Abu Oamir et ale 1994) occurs, which in tum activates bone and intestinal Ca resorption
and absorption mechanisms (Block 1984; Oetzel et ale 1988; Gaynor et ale 1989; LeClerc
and Block 1989). In this experiment, serum PTH, 1,25(OHh03 and calcitonin were
measured at the end of the supplemental period, and at this point, PTH was decreased
(P<O.05) while 1,25(OHh03 was increased (P<0.05), responses that were related to the
amount ofvitamin 03 fed. As discussed in the previous chapter (Chapter V), vitamin 0 3
supplementation likely induced higher synthesis of 1,25(OH)203, either directly or via
25(OH)03 which in tum led to elevated levels of Ca in serum. This effect was likely due
to excess of substrate (25(OH)03) overwhelming normal homeostatic mechanisms (Horst
et ale 1997).
With respect to the objectives of this study, the most important effect of anionic
salt supplementation was that it helped to elicit the response in serum Ca to vitamin 03
supplementation. In the previous experiment (Chapter V), maximum serum total Ca
concentrations for the 2.5 and 5 Mill treatments were 11.50 and 12.41 mgldl,
respectively, while in the present study they were 11.43 and 12.24 mgldl for the 1.2 and
2.4 Mill treatments, respectively. That is, serum Ca concentrations were similar between
experiments but now using only half of the amount ofvitamin 03. On the other hand,
ionized Ca concentrations in the previous experiment were 5.57 and 6.03 mgldl for the
2.5 and 5 MID treatment, respectively, and for this experiment they were 5.98 and 6.52
mgldl for the 1.2 and 2.4 Mill treatments, respectively. In this case, the response was
even higher, with ionized Ca levels exceeding the limits of6.03 mgldl from 5 MID
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treatment in the previous experiment. The increase was approximately 0.5 mgldl of
ionized Ca over the 5 MID treatment without anionic salts. This is a very interesting
finding because the total serum Ca concentrations found in previous experiments for the
5 Mill treatment were in very good agreement with the range in which significant
improvements in beef tenderization were obtained (Swanek et al. 1997, 1999;
Montgomery et al. 1998, 2000; and Karges et al. 1999a,b, 2001). Furthennore, the
increase in ionized Ca is critical as ionized or free Ca is the fraction of the total Ca in the
extracellular fluid that can be transferred to other tissues. In particular, muscle, where the
high Ca levels can stimulate higher activity of the calpain proteolytic system and
consequently enhance beef tenderness (Boehm et al. 1998; Geesink and Koohmaraie
1999; Montgomery et al. 2000).
These results suggest that by reducing the level of vitamin 03 to 0.6, 1.2 or 2.4
Mill 03/hd/d in combination with the feeding ofanionic salts at -3000 mEq/hd/d may be
an alternative method of stimulating high serum Ca levels and to improve beef
tenderness. However, before this can be stated with certainty, further re~earch is required
to determine the actual effect on the eating quality ofbeef and the potential for carcass
residues of vitamin 03.
6.5 Conclusions
The low Ca diet appeared to be a feasible way to prime the Ca homeostatic
mechanisms as feeding this diet resulted in lower total and ionized serum Ca
concentrations, as well as plasma vitamin 03 and 25(OH)03 concentrations. The acid-
base status of the steers was not altered, however. Anionic salt supplemen~ation
effectively increased total and ionized Ca concentrations and helped to enhance the effect
ofvitamin 03 supplementation, as serum Ca concentrations were similar or higher than
the concentrations achieved with 5 Mill 03/hd/d fed in previous experiments. This
response of serum Ca was accomplished by the alteration of the nonnal acid-base status
of the steers, which resulted in a mild metabolic acidosis that was not compensated for by
respiratory means.
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This response in serum Ca as a result of feeding anionic salts (-3000 n1Eq/hd/d)
and vitamin D3 (1.2 and 2.4 MIU/hd/d) is a possible alternative to feeding 5 Mill or
greater amounts of vitamin D3 to improve beef tenderness. Further research is required to
define the benefits and/or limitations of such an approach.
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CHAPTER VII
GENERAL DISCUSSION AND CONCLUSIONS
7.1 General Discussion
Tenderness is considered to be one an important determinants ofbeef quality and
it is very likely to be the most important organoleptic characteristic ofmeat (Greaser
1986; Smith et al. 1995). Tender meat is priced higher than less tender meat (Boleman et
ai. 1997). With respect to beef there are two main problems with tenderness, its lack of
consistency and uniformity (Morgan et ai. 1991a; Smith et ai. 1995; Pringle et ai. 1999).
Several premortem (age, sex, nutrition, etc.) and postmortem (handling of the animal,
processing, etc.) factors affect meat tenderness. Among them, the rate and extent of
postmortem tenderization appears to be important for the final degree of tenderness
(Dayton et al. 1981; Huff-Lonergan et ai. 1996; Goll et ai. 1998). The proteolytic
enzyme system known as calpains (Jl-calpain, m-calpain, and calpastatin) is considered to
be one of the principal group ofproteases involved in postmortem myofibril degradation
(Koohmaraie et ai. 1988a,b, 1989). The calpains are activated by calcium (Ca), and
when intracellular Ca in muscle is increased, enzymes activity is increased (Koohmaraie
et ai. 1990; Ilian et ai. 2001). Increased activity of the calpains has been hypothesized to
result in more tender beef (Swanek et ai. 1999; Montgomery et ai. 2000; Karges et ai.
2001). To increase the Ca concentration in muscle two procedures can be followed,
injection ofcalcium chloride (CaCh) directly into meat (Miller et ai. 1995), or by
supplementing vitamin D3 to feedlot animals for a short period of time prior to slaughter.
Vitamin D3 supplementation can potentially overcome the disadvantages of the CaCh
such as that of extra costs for handling of carcass and meat cuts, the potential for off-
flavors associated with CaCh, and the fact that Ca is potentially more homogeneously
distributed throughout the whole animal with vitamin D3 feeding. High levels of vitamin
D3 (5 or more MIU/hd/d) have been used to increase plasma Ca concentrations in feedlot
cattle and subsequently increase the concentration ofCa in muscle, and this excess of Ca
in muscle has stimulated higher proteolytic activity, resulting in important reductions in
shear force values and consequently in improvements in beeftendemess (Swanek et ai.
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1997, 1999; Montgomery et at. 1998; 2000; Karges et al. 2001). However,
supplementation ofhigh levels of vitamin D3 imposes two main problems, the first is
related to animal welfare and the second with food safety. Feeding high levels of vitamin
D3 tends to depress feed intake and affect feedlot performance (Karges et al. 1999b). The
second and most important concern is in relation to the accumulation ofvitamin D3
and/or its metabolites in meat and other edible tissues (Owens et al. 1998; Montgomery
et al. 2000). Excess of vitamin D3 in meat can induce vitamin D3 toxicity, which can
cause formation of renal stones and calcification ofedible tissues (Glerup and Eriksen
2001). Hence, it is important if this management practice is to gain widespread
acceptance that strategies be devised to reduce the levels of supplemental vitamin D3
required to increase plasma Ca levels such that the risk of residual vitamin D3 and its
metabolites in the carcass is reduced.
Thus, the objective of this research project was to characterize the effect of
supplemental vitamin D3 on Ca homeostasis of finishing steers under Western Canadian
feedlot conditions, and with this knowledge, integrate alternatives aimed to reduce the
levels of vitamin D3that can be used to increase serum Ca concentrations sufficiently to
enhance beef tenderness. In the first experiment (Chapter III) the objective was to
characterize the effect of titrated doses ofvitamin D3 on feed intake and serum Ca
concentrations of finishing steers fed a common Western Canadian finishing diet. In the
second experiment (Chapter IV) the objective was to evaluate the effect of vitamin D3on
feed intake, and circulating Ca, calcium-regulating hormones, vitamin D3 and 25(OH)D3
concentrations, in order to understand how vitamin D3 affects Ca homeostasis. In the
third experiment (Chapter V) the objective was to know if dietary Ca manipulation (low
Ca diet) could be a suitable method to sensitize Ca homeostatic mechanisms and so
enhance the serum Ca response to vitamin D3 supplementation, preferably at lower levels
than reported in the literature. In the fourth experiment (Chapter VI), the objective was
to know ifdietary Ca manipulation (low and high Ca diets) coupled to anionic salt
supplementation could be a suitable method to improve the serum Ca response to lower
levels of supplemental vitamin D3.
Results from experiments 1 to 4 showed that total and ionized serum Ca levels of
control steers averaged 10.14 ± 0.35 and 5.03 ± 0.10 mg/dl, respectively (Table 7.1 and
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7.2). Supplemental vitamin D3 at levels of 1.25, 2.5 or 5 MIU/hd/d for 7 days
(experiments 1 to 3) induced significant increases in these values, and the response was
directly related with the amount of vitamin D3 supplemented. This situation was
confirmed by the high coefficients of correlation obtained between levels of vitamin D3
supplementation and the resulting increase in total (R = 0.9909) and ionized (R = 0.9751)
serum Ca concentrations from experiments 1 to 4 (Tables 7.1 and 7.2).
Maximum total and ionized serum Ca concentrations were reached 3 to 5 days
after supplementation of vitamin D3 ended, a situation that had not been reported before
in the literature. This aspect is ofparticular importance because vitamin D3 tends to
depress feed intake, affecting subsequently animal feedlot performance (daily gain
weight, gut fill, etc.) and/or carcass characteristics (Karges et al. 1999c; Berry et al.
2000). However, it was observed (experiments 1 to 4) that feed intake started to recover
as soon as vitamin D3 supplementation was withdrawn. Thus, if the supplemented
animals are slaughtered not immediately after supplementation (as it has been done in all
the published studies) but approximately 5 days later, the supplemented animals will have
first, the opportunity to reestablish their feed intake and general condition, and secondly,
and most importantly, around this time plasma and muscle Ca concentrations will be at
their highest.
There seems to be agreement in the published literature that the administration of
5 Mill ofvitamin D3 per head per day constitutes the minimum amount required to raise
plasma Ca levels to the point where improvements in beef tenderization are obtained
(Swanek et al. 1997, 1999; Montgomery et al. 1998,2000, in press; Karges et al. 2001).
This research showed that 5 Mill D3 daily for 5 to 10 days increased total plasma Ca,
with respect to control animals by approximately 2.0 mgldl. In experiment 1 to 3,
supplementation of 5 MIU D3 daily, increased total serum Ca concentration by
approximately 2.0 mgldl (from 10.25 to 12.32) (Table 7.1). Thus, the increase in serum
Ca levels was in good agreement with the above studies. On the other hand, ionized
serum Ca concentrations were increased by approximately 1.0 mgldl (from 5.05 to 6.01)
(Table 7.2). Ionized Ca is physiologically the most important form ofCa in the body.
Few other studies have reported the effect ofvitamin D3 supplementation on ionized Ca.
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Table 7.1. Effect of vitamin D3 supplementation on total serum Ca concentrations of
finishing steers (experiments 1 to 4).
Total Serum Ca
Vitamin D3 Vitamin D3 Maximum Increment Increment Correlation
(MID/hd/d) (MID total value from control from control Coefficient Z
period) (mg/dl) (mg/dl) (%)
Experiment 1:
0 0 10.61
1.25 8.75 11.03 0.42 4.0
2.50 17.50 11.67 1.06 10.0
5.00 35.00 12.43 1.82 17.0 0.9947
Experiment 2:
0 0 10.18
2.50 17.50 11.02 0.84 8.0
5.00 35.00 12.12 1.94 19.0 0.9970
Experiment 3:
0 0 9.90
1.25 8.75 10.65 0.75 7.6
2.50 17.50 11.50 1.60 16.0
5.00 35.00 12.41 2.51 25.4 0.9899
Average 1-3:
0 0 10.23
1.25 8.75 10.84 0.61 6.0
2.50 17.50 11.40 1.35 13.0
5.00 35.00 12.32 2.09 20.4 0.9975
Experiment 4:
0 0 9.81
oy 0 10.11 0.30 3.0
0.6 6.0 10.97 0.86 8.5
1.2 12.0 11.43 1.32 13.0
2.4 24.0 12.24 2.13 21.0 0.9822
Z Correlation between levels of supplemental vitamin D3 and response in total serum Ca
concentrations.
Y Anionic salt supplementation only
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Table 7.2. Effect of vitamin D3 supplenlentation on ionized serum Ca concentrations of
finishing steers (experiments 1 to 4).
Ionized Serum Ca
Vitamin D3 Vitamin D3 Maximum Increment Increment Correlation
(MIU/hd/d) (MID, total value from control from control Coefficient Z
period) (mgldl) (mgldl) (%)
Experiment 1:
0 0 5.12
1.25 8.75 5.39 0.27 5.3
2.50 17.50 5.73 0.61 12.0
5.00 35.00 6.03 0.91 18.0 0.9828
Experiment 2:
0 0 5.06
2.50 17.50 5.36 0.30 6.0
5.00 35.00 5.98 0.92 18.0 0.9649
Experiment 3:
0 0 4.78
1.25 8.75 5.00 0.22 4.6
2.50 17.50 5.57 0.79 16.5
5.00 35.00 6.03 1.25 26.0 0.9749
Average 1-3:
0 0 4.99
1.25 8.75 5.20 0.15 4.2
2.50 17.50 5.55 0.60 11.2
5.00 35.00 6.01 0.96 20.4 0.9964
Experiment 4:
0 0 4.99
oy 0 5.43 0.44 9.0
0.6 6.0 5.90 0.47 9.0
1.2 12.0 5.98 0.55 10.0
2.4 24.0 6.52 1.09 20.0 0.9778
Z Correlation between levels of supplemental vitamin D3 and response in ionized serum
Ca concentrations.
Y Anionic salt supplementation only
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Manipulation of dietary Ca (low Ca diet) alone (experiment 3) did not improve
the response of serum Ca to vitamin D3 supplementation. This is despite the fact that Ca
homeostatic mechanisms appeared to be stimulated by low Ca feeding, as serum Ca and
plasma vitamin D3 concentrations were lower than control values during the first 2 to 4
days of feeding the low Ca diet. This response is somewhat different than that observed
for dairy cows that were fed low Ca diets prior to parturition to prevent milk fever. The
likely explanation is that dairy cows experience a significant Ca stress with the onset of
lactation. Low Ca feeding sensitizes the Ca homeostatic mechanisms to this need. In
finishing steers no such stress is imposed, thus no response in plasma Ca was observed
when dietary Ca levels were reduced
Acidification ofprepartum diets has also been used to elevate plasma Ca
concentrations in dairy cows and so reduce the incidence ofmilk fever. It was
hypothesized that the addition ofanionic salts to the diet of the finishing steers could
function as a suitable Ca stressor to enhance the response to vitamin D3 feeding. This is
due to the fact that anionic salts cause hypercalciuria (Fredeen et ale 1988; Gaynor et ale
1989) and it is recommended to use diets high in Ca when adding anionic salts (Block
1984; LeClerc and Block 1989). In experiment 4, finishing steers were fed with a low Ca
diet for 14 days, and then switched to a high Ca diet plus anionic salts and
supplementation ofvitamin D3 for 10 days. Anionic salts were added at -1500 mEq/d
during the first 3 days of supplementation, and at -3000 mEq/d for the remaining 7 days
of this period. Vitamin D3 was supplemented at levels of0, 0.6, 1.2 and 2.4 MID/hd/d. It
should be noted that in this experiment, the 1.2 and 2.4 MID D3 treatments represented
only 48 and 70 %, respectively, of the levels fed in experiments 1 to 3 (Table 7.1 and
7.2). Total and ionized serum Ca concentrations were significantly increased as a result
of dietary Ca manipulation, anionic salt and vitamin D3 supplementation. In experiments
1 to 3, supplementation of 1.25,2.5 and 5 MID D3 elevated total serum Ca concentration
to 10.84, 11.58, and 12.32 mg/dl, respectively (Table 7.1). Average ionized Ca levels
were 5.20,5.55, and 6.01 mg/dl, respectively (Table 7.2). Supplementation of0.6, 1.2
and 2.4 MID D3 in experiment 4 elevated total Ca concentrations to 10.97, 11.43, and
12.24 mg/dl, respectively (Table 7.1), and ionized Ca levels to 5.90, 5.98, and 6.52 mg/dl,
respectively (Table 7.2). These results indicate that the amount of supplemental vitamin
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D3 required to induce equivalent total Ca concentration to the 5 Mill D3treatment was
effectively reduced by approximately 65 and 30 % (1.2 and 2.4 MID D3treatments,
respectively) (Table 7.1). This response was even higher with ionized Ca. The 1.2 MID
D3treatment induced approximately 13 and 7 % more ionized Ca than the 1.25 and 2.5
Mill D3 treatments. The 2.4 Mill D3 treatment, induced approximately 15 and 8 % more
ionized Ca than the 2.5 and 5 Mill D3 treatments, respectively (Table 7.2). That is, the
nutritional management (low Ca diet and anionic salts) effectively improved the serum
Ca response to vitamin D3supplementation. This aspect represents one of the most
meaningful findings from this research. The amount of vitamin D3required to increase
ionized Ca to levels sufficiently high to cause an impact on beef tenderness can be
reduced by dietary manipulation with anionic salts. In experiments 1 to 3, the 5, MID D3
treatment increased ionized Ca to an average of6.01 mg/dl, while in experiment 4 the 0.6
and 1.2 Mill D3treatments resulted in 5.90 and 5.98 mg/dl, respectively. This means that
the amount ofvitamin D3 required to induce equivalent ionized Ca concentrations to 5
Mill D3 treatment was effectively reduced by approximately 80 and 65 % (0.6 and 1.2
Mill D3 treatments, respectively) (Table 7.2).
It is very likely that this reduction in the amount of vitamin D3 fed will reduce
carcass residues of vitamin D3 and its metabolites appreciably. Further work should be
carried out to detennine if feeding this reduced level ofvitamin D3 in combination with
anionic salts will not only raise serum Ca to levels where tenderness ofbeef is improved
but also to detennine the extent of any tissue residue problem.
The second objective of this research project was to know how vitamin D3
supplementation affected Ca homeostasis in order to understand how high doses of
vitamin D3 increased the concentration of Ca in serum. It was found that
supplementation ofhigh levels ofvitamin D3 caused elevated levels ofvitamin D3 and
25(OH)D3 in plasma, a response that was directly related to the amount of vitamin D3
supplemented. However, the response patterns were different for vitamin D3 and
25(OH)D3. Plasma vitamin D3 concentrations increased as supplementation proceeded
and began to fall as supplementation ended. In contrast, plasma 25(OH)D3
concentrations increased linearly throughout the supplemental and withdrawal periods,
attaining maximal concentrations at the end of the latter period. This suggests that once
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vitamin D3is absorbed from the small intestine, it is transferred to the liver and
hydroxylated by the 25-hydroxylase enzyme. The rapid rise in plasma 25(OH)D3levels
suggests that this step in ruminants, as in other species, is not tightly regulated.
Parathyroid hormone (PTH) concentration in plasma was decreased by vitamin D3
feeding. This finding was in agreement with the literature, because serum Ca levels were
elevated causing a mild hypercalcemia, and plasma vitamin D3 and 25(OH)D3
concentrations were at levels much higher than normal. These factors affect the synthesis
and release ofPTH from the parathyroid glands (Rhoades and Tanner 1995; Guyton and
Hall 2000). Furthermore, PTH regulates the activity of the 1a-hydroxylase enzyme,
which is primarily found in the kidneys. This enzyme is responsible for the second
hydroxylation of the vitamin D3 to its hormonal form, 1,25(OH)2D3 (DeLuca 1979; Smith
et al. 1983; West 1991). It is generally assumed that this is a tightly controlled step and
that the plasma concentration of 1,25(OH)2D3 should be low as a consequence ofhigh
levels ofCa, vitamin D3, and 25(OH)D3, and low levels ofPTH in plasma. However,
when the concentration of 1,25(OH)2D3 in serum was analyzed in experiment 3 and 4, it
was found that the concentrations of this metabolite were higher in the supplemented
animals than in controls, with the increase being in direct relationship to the amount of
vitamin D3 supplemented.
The increase in 1,25(OHhD3 could be due to two reasons associated with an
excess of25(OH)D3 in plasma. An excess of25(OH)D3 could stimulate the activity of
the la-hydroxylase enzyme and induce higher synthesis of 1,25(OH)2D3 as noted in
experiments 3 and 4. Secondly, while cellular receptors are highly specific for
1,25(OH)2D3, it has been shown that an excess of 25(OH)D3 in plasma can bind to the
receptors and induce the effect of 1,25(OHhD3 in bone, kidneys and intestine (Smith et
al. 1983; West 19991; Bhagavan 1992). This statement is based on the fact that
concentrations ofplasma 25(OH)D3continued increasing during the withdrawal period
(experiments 2 to 4), and serum Ca concentrations followed a similar response pattern
(experiment 1 to 4). In conclusion, supplementation of vitamin D3 appears to increase
serum Ca concentration through increases in the action of 25(OH)D3 and 1,25(OH)2D3 in
kidneys, bone and intestine.
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Serum calcitonin concentrations were detennined in experiments 2 to 4, however
no significant response from this honnone was found as a result ofvitamin D3
supplementation, even though elevated serum Ca levels were evident in all the
experiments. This lack of response has been observed in some species, for this reason
calcitonin is considered to be weaker than PTH and 1,25(OH)2DJ in controlling plasma
Ca concentrations (Smith et al. 1983; Bhagavan 1992; Guyton and Hall 1997). However,
in marine species, where sea water contains elevated levels of Ca, calcitonin plays an
active role in regulating plasma Ca concentrations (Rosol et al. 1995).
The results found in this thesis show that feeding as low as 0.6 Mill D3/hd/d
coupled to dietary Ca manipulation and anionic salt supplementation can be an effective
method to raise serum Ca levels when cattle are fed feedlot diets common to Western
Canada. However, before this technique can be used commercially, more research work
has to be done in order to assure,t4at vitamin D3 supplementation maximizes biological
(animal welfare and food safety) and economic (animal perfonnance and beefquality)
responses. This work should focus on evaluation of treatment on tenderness (shear force
and palatability), and the effects on residues in muscle, liver, kidneys and adipose tissue
relationship. Finally, there is a need to define the relationship between dietary Ca and
anionic salts manipulation more closely in order to avoid the negative effects on feed
intake and subsequently on animal perfonnance.
7.2 General Conclusions
The results of this study showed that:
o Total and ionized serum Ca concentrations were increased by vitamin D3
supplementation to levels similar to or higher than those reported in the literature
using the same amounts ofvitamin D3 per day. Values were increased to
threshold levels where improvements in beef tenderness have been reported by
other workers. Total and ionized Ca concentrations rose in a parallel reaching
their maximum concentrations toward the end of the withdrawal period. The 5
Mill D3 treatment caused an average increase (experiments 1 to 3) of2.0 and 1.0
mgldl of total and ionized serum Ca concentrations, respectively.
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o Plasma vitamin D3 concentrations were increased in a quadratic fashion, attaining
their maximum values towards the end of the supplemental period. In contrast,
25(OH)D3concentrations were linearly increased, reaching their n1aximum values
toward the end of the withdrawal period. The concentrations of these two
metabolites started to rise immediately upon supplementation of vitamin D3. This
indicates that once vitamin D3entered the circulation it was rapidly hydroxylated
in the liver to the 25(OH)D3. The 5 Mill D3treatment (experiments 2 and 3)
increased plasma vitamin D3 and 25(OH)zD3 concentrations by approximately 15-
to 30-fold and 7- to 15-fold, respectively, compared to unsupplemented steers.
This indicates that supplementation of 5 MID D3 daily increases the
concentrations ofvitamin D3 in plasma, and is very likely to result in significant
residues ofvitamin D3 and its metabolites in muscle and other edible tissues.
o In relation to the calciotrophic honnones it was found that the concentration of
PTH in serum was decreased, a response that corresponded to its physiological
role on Ca metabolism. Somewhat unexpectly, the concentration of 1,25(OH)zD3
in serum was increased, indicating failure ofnonnal homeostatic control measures
in the face ofhigh levels ofvitamin D3 feeding.
o Feeding a low Ca diet prior to vitamin D3supplementation did not improve the
response to vitamin D3 supplementation in inducing higher serum Ca
concentrations than nonnal Ca diets. However, low Ca diets sensitized Ca
homeostatic mechanisms because total and ionized serum Ca, plasma vitamin D3
and 25(OH)D3 concentrations were lower than nonnal during the first four days of
feeding.
o The addition of 1.25, 2.5 or 5 Mill D3to common barley grain-base feedlot
finishing diets caused a significant decline in feed intake. The depression in feed
intake and its recovery followed an inverse relationship with the amount of
vitamin D3 supplemented. This observation led to the conclusion that the
negative effect ofvitamin D3 on feed intake was not related to palatability factors,
but most likely due to physiological and/or metabolic alterations.
o The fact that total and ionized Ca concentrations were highest during the
withdrawal periods opens the possibility ofreducing the negative effect on feed
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intake if the supplemented animals are slaughtered following a 3 to 5 day
withdrawal period. The animals will have the opportunity to recover feed intake
and other feedlot performance characteristics, and thus reduce the likelihood of
affecting carcass quality characteristics.
o Manipulation of dietary Ca plus supplementation of anionic salts (-3000 mEq/d)
and low levels ofvitamin D3 (0.6, 1.2 and 2.4 MIU/hd/d) increased serum Ca
concentration to levels consistent with improvements in beef tenderness found in
other studies. This was accomplished with as low as 20 % of the vitamin D3 that
was fed in other studies. Further work is required to study the effect on beef
tenderness, on residual effects on meat and other edible tissues, and on the levels
of anionic salts that could be fed without affecting feed intake.
o The use of lower levels ofvitamin D3 to elevate serum Ca concentrations to levels
high enough to improve beef tenderness will lead to an important reduction in
residues ofvitamin D3 (and/or its metabolites) that are found in meat and other
edible tissues, and consequently reduce the risk for vitamin D3 toxicity in
consumers.
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APPENDIX A
Determination of the Parathyroid Hormone (PTH)
Experiment 2 - Chapter IV
The native or intact human parathyroid hormone (iPTH) is an 84 amino acid
polypeptide, which is biosynthesized in the parathyroid gland. The Intact PTH
Immunoassay carries out the measurement of the biologically intact 84 amino acid chain
of PTH, which is a two-site immunoradiometric assay (IRMA)(lntact PTH- Parathyroid
Hormone 100T Kit-Catalog No. 40-2170. Nichols Institute Diagnostics. San Juan
Capistrano, CA. USA).
Two different goat polyclonal antibodies to human PTH, purified to be specific to
two different regions of the PTH molecule were used. One antibody bound the mid-
region and C-terminal PTH 38-84, this antibody was immobilized onto plastic beads.
The other antibody bound the N-terminal PTH 1-34, this was radiolabeled for detection.
The sample (bovine serum) was incubated simultaneously with the antibody-
coated bead and 1251-labeled antibody. Thus, the intact PTH present in the sample was
bound by both the immobilized and the labeled antibodies to form a complex:
Bead Anti-PTH (39-84) -------- Intact PTH (1-84) ------ 1251Anti-PTH (1-34)
Although mid-region and C-terminal fragments are bound by the antibody coated
bead, only the intact PTH 1-84 forms the complex necessary for detection. At the end of
the assay incubation, the bead was washed to remove unbound components and the
radioactivity bound to the solid phase was measured in a gamma counter. A dose
response curve of radioactivity versus concentration was generated using results obtained
from standards, which were assayed concurrently with the unknowns. Concentrations of
intact PTH present in the controls and in the samples were determined directly from this
curve (Radioisotopic Assay. Intact PTH - Parathyroid Hormone. Nichols Institute
Diagnostics).
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Materials:
Reagent A = PTH Antibody Coated Beads.
Reagent B = 125I_PTH Antibody Solution.
Reagent C = Intact PTH Zero Standard.
Reagents D2-H = Intact Standards.
Reagents I = Wash Solution Concentrate.
Reagents J-K = Intact PTH Controls 1 & 2.
Assay Procedure:
200 JlL of standard (reagents C-H), control (Reagents J-K) and plasma
samples were placed in individual test tubes.
100 JlL of the 125I_PTH Antibody Solution (Reagent B) were added to all
tubes.
Tubes were thoroughly mixed (vortexed).
Using Bead Dispenser one bead (Reagent A) was added to each test tube.
Then test tubes were covered with parafllm and incubated at room
temperature for approximately 24 h.
Beads were washed twice by dispensing 2.0 ml ofworking Wash Solution
into each tube, and the reaction mixture was decanted from each tube.
Each tube was counted in a gamma counter for one minute to measure
concentration.
Performance Characteristics:
Precision: the precision (intra-assay variance) of the assay was calculated
from replicate determinations on each of two quality control sera in a
single assay (CV = 5.35 %).
Accuracy: correlation coefficient (r) = 0.98 when compared to
radioimmunoassay (Nichols Institute Diagnostics rnS-PTH).
Sensitivity: 1 pg/ml. Defined as the smallest single value which can be
distinguished from zero at the 95% confidence limit.
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Experiments 3 (Chapters V) and 4 (Chapter VI)
Parathyroid hormone was determined in serum samples by the Coat-A-Count
Intact PTH IRMA (Diagnostic Products Corporation. Los Angeles, CA. USA), which is
an immunoradiometric assay designed for the quantitative measurement of intact
parathyroid hormone (parathyrin, PTH). PTH is a single-chain polypeptide containing 84
amino acids, exerts significant influence in the maintenance ofoptimal Ca ion
concentrations.
Principle of the Procedure:
Coat-A-Count Intact PTH IRMA is a solid-phase immunoradiometric assay
employing 1251-labeled affinity-purified polyclonal anti-PTH (1-34) antibody in liquid
phase, in conjunction with affinity-purified polyclonal anti-PTH (44-84) antibodies
immobilized to the wall of a polystyrene tube. Intact PTH is captured between the anti-
PTH immobilized on the tube and the radio-labeled anti-PTH. Unbound 1251-labeled
anti-PTH antibody is removed by decanting the reaction mixture and washing the tube;
this reduces nonspecific binding to a very low level, and ensures excellent low-end
precision. The PTH concentration is directly proportional to the radioactivity present in
the tube after the wash step. The radioactivity is counted using a gamma counter, after
which the concentration of PTH in the sample is obtained by comparing the counts-per-
minute with those obtained for the standards.
Materials:
PTH AB-Coated Tubes (IPH1).
1251PTH Ab (IPH2).
Intact PTH Calibrators (PHI3-9).
Buffered Wash Solution Concentrate (1 TSBW).
Intact PTH Controls (PHCOI-2).
Immunoradiometric Assay Procedure:
Calibrators, controls, serum samples and assay tubes were all kept on ice
while setting up the assay, due to the highly labile nature of intact PTH.
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Fourteen PTH Ab-Coated Tubes A (nonspecific binding) and B through G
("maximum binding") were labeled in duplicate. Additional PTH Ab-
Coated Tubes, also were labeled in duplicates, for control and samples.
200 ilL of each calibrator, control and sample were pipeted into the
prepared tubes.
100 ilL of 1251PTH Ab were added to every tube.
All tubes were gently vortexed.
Incubation was carried out for 24 hours at 4°C.
All tubes were thoroughly decanted. 2 ml of Buffered Wash Solution
were added to each tube. After a wait of 1-2 min, the tubes were again
thoroughly decanted. The addition of the buffered solution and
decantation was repeated one more time.
The tubes were set in a gamma counter and count for one minute.
Counts-per-minute (CPM) for all tubes was corrected by subtracting the
average CPM ofthe non specific binding tubes (calibrator A).
Performance Data:
Sensitivity: 1.0 pg/ml. The assay-s detection limit, defined as the
concentration two standard deviations above the response at zero dose.
Precision: intraassay (within-run) coefficient ofvariation = 6.46 %.
Specificity: the Coat-A-Count Intact PTH IRMA antibodies are highly
specific for intact PTH, with particularly low cross reactivity to the most
PTH fragments, as well as to other naturally occurring compounds in the
serum samples.
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APPENDIXB
Determination of the Calcitonin Hormone
Experiments 2 (Chapters IV), 3 (Chapter V) and 4 (Chapter VI)
Calcitonin concentrations in serum were detennined by a double-antibody 1251_
Radioimmunoassay (Diagnostic Products Corporation. Los Angeles, CA. USA). The
assay is designated for quantitative measurement of calcitonin (thyrocalcitonin) in serum
(Catalog No. KLCD). Human calcitonin is a single-chain peptide hormone produced
primarily in the thyroid gland, where the parafollicular "C" cells secrete it. The
physiological significance ofcalcitonin is uncertain, but it does have a modest Ca- and
phosphorus-lowering effect. Rising and falling Ca levels normally modulate its
secretion, with an increase in circulating Ca prompting an increase in the calcitonin level.
A fasting basal range of 3-19 pg/ml for healthy adults, based on radioimmunoassays of
extracted plasma. Elevated levels (> 100 pg/ml) are encountered in a variety of
pathological conditions.
Principle of the Procedure:
DCP's Double Antibody Calcitonin procedure is a sequential competitive
radioimmunoassay. The sample is first preincubated with anti-calcitonin antiserum.
125I-Iabeled calcitonin then competes with calcitonin in the sample for antibody sites.
After incubation for a fixed time, separation ofbound from free is achieved by the PEG-
accelerated double-antibody method. Finally, the antibody-bound fraction is precipitated
and counted. Sample concentrations are read from a calibration curve.
Materials:
Calcitonin Antiserum (CLD1).
1251Calcitonin (CLD2).
Calcitonin Calibrators (CLD3-8).
Precipitating Solution (CLGG).
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Calcitonin Controls (CLCl-2).
Assay Procedure:
Sixteen tubes in duplicate were labeled: T (total counts), NSB (nonspecific
binding), A (maximum binding) and B through F. And additional tubes
for control and samples, also in duplicates, were labeled.
200 J.!L of the zero calibrator A were pipeted into the NSB and A tubes,
and 200 J.!L of each of the remaining calibrators B through F into
correspondingly labeled tubes. And 200 J.1L of each serum sample and
control were pipeted into the prepared tubes.
100 J.1L of Calcitonin Antiserum were added to all tubes except the NSB
and T tubes. All tubes were vortexed.
All tubes (except T tubes) were incubated for 3 hours at room temperature.
100 J.1L of 1251Calcitonin were added to all tubes and then vortexed.
All tubes (except T tubes) were incubated for 18 hours at -4°C.
Then, 1.0 ml of cold Precipitating Solution was added to all tubes and then
vortexed. '
All tubes were incubated for 30 minutes at room temperature.
All tubes were centrifuge for 15 minutes at 3000 x g.
Using a foam decanting rack, the supernatants were decanted, and the
precipitate was retained for counting.
All tubes were placed in a gamma counter, and each tube was counted for
1 min.
Calculation of results: calcitonin concentrations were calculated from a
logit-Iog representation, in which count-per-minute (CPM) 'from serum
samples were corrected by CPM of the nonspecific binding tubes.
Performance Data:
Sensitivity: 16 pglml. As a minimal detectable dose of the assay.
Precision: intra-assay (within-run) a CV of 5.32 %. Inter-assay (run-to-
run) a CV of 0.44 % (n=2).
190
Specificity: the antiserum is highly specific for human calcitonin, with an extremely low
cross reactivity to other peptides present in the sample.
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APPENDIXC
Determination of Vitamin D3 and 25-hydroxyvitamin D3
Experiment 2 (Chapter IV)
Vitamin D3 and its metabolite 25-hydroxivitamin D3 (25(OH)D3) were analyzed
using a high-performance liquid chromatography (HPLC) technique. This separation
technique is based on two main phases, the stationary (represented by the column) and
the liquid (represented by the mobile phase). In this analysis, a silica-based carbon 18
packed HPLC column was used which represented the non-polar phase and the mobile
phase, which was an organic solvent represented. the polar phase. The column used was a
reverse-phase Luna column CI8 3f.lI50 x 4.60 mm (Phenomenex, Torrance, CA. USA),
and acetonitrile for the mobile phase, under isocratic conditions.
Assay Procedure:
1) Plasma Preparation from untreated animals:
a. Acetonitrile extraction:
1. Two ml of acetonitrile were placed in a glass test tube.
11. One I ml ofplasma was added in a drop-wise fashion.
iii. The solution was thoroughly vortexed for 30 sec and then
centrifuged at 3000 rpm for 10 min.
IV. The supernatant was collected and transferred to a separate tube.
b. Chloroform extraction:
1. To the supernatant, 1 ml ofchloroform was added.
11. The solution was thoroughly vortexed for 30 sec and then
centrifuged at 3000 rpm for 10 min.
111. The organic (bottom) layer was collected and transferred to a
separate glass test tube.
IV. The solution was then exposed to a steady stream ofnitrogen until
completely dry.
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v. To this test tube, containing the dried residue, 0.5 ml of acetonitrile
was added and then vortexed for 30 sec.
VI. The solution was filtered through a 0.45 Jlm filter attached to a
glass syringe.
vii. The filtered solution was transferred to an atTlber vial, which was
ready for injection onto the HPLC.
2) Plasma preparation from treated animals:
a. Acetonitrile extraction:
1. 800 JlL of acetonitrile were placed in a glass test tube.
11. 200 JlL ofplasma were added in a drop-wise fashion.
111. The solution was thoroughly vortexed for 30 sec and then it was
centrifuged at 3000 rpm for 10 min, resulting in two layers, a solid
one at the bottom and a liquid (supernatant).
IV. The supernatant was filtered through 0.45 Jlm filter attached to a
glass syringe.
v. The filtered solution was transferred to an amber vial, which was
ready for injection to the HPLC.
The samples dissolved in acetonitrile were injected by an autosampling device
(Sampler Processor, Water 715, Ultra Wisp. Waters™. Waters Limited. Mississauga, ON
Canada) onto the head of the column. Each sample was carried through the column by a
continuous flow (1.2 mVmin) ofmobile phase (acetonitrile) from the pump. The elution
times for 25(OH)D3 was 3.0 min while that for vitamin D3 was 8.6 min. A typical
chromatograph for this separation is illustrated in Fig. C.I.
Identification and quantification ofvitamin D3 and 25(OH)D3 was carried out by
using a photodiode array detector (Photodiode Array Detector, Waters 996. WatersTM.
Waters Limited. Mississauga, ON Canada) at 265 nm.
Analysis of 130 blood samples were carried out in duplicate, with coefficients of
variation for 6.12 for vitamin D3 and 3.97 for 25(OH)D3.
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Calibration CurVes:
Calibration curves were created by using standards ofboth analytes, vitamin D3
and 25(OH)D3, diluted in acetonitrile at the concentrations of2, 4, 8, 16, 32, 64 and 128
ng/ml. The coefficients of correlation and regression for both analytes were R = 0.9999
and R2 = 0.9999, respectively, in the majority of the cases but never lower than 0.999
(Figures C.2 and C.3). Integration and calculation of calibration curves were
automatically perfonned by the computer software (Millennium). The output from the
computer was a chromatograph showing the absorbance peaks with infonnation about
their retention or elution time, peak area, peak high and concentration (in ng/ml of sample
injected) for the vitamin D3 and 25(OH)D3 analytes for each sample (Figure C.l).
Calculation of the Final Concentrations:
To convert the output from the HPLC analysis (ng/ml of sample injected) to
ng/ml ofplasma, the results were adjusted according to the sample's extraction
procedure. In the case of the acetonitrile-chlorofonn procedure, the results were
corrected by two factors: a) by the volume of reconstitution in acetonitrile (0.5 ml); and
b) by the volume of the bottom layer collected (in accordance with the maximum volume
collected without disturbing the upper layer), which was calculated to be around 90%.
Condensation and dilution factors considered were 2 (because 0.5 ml were used to
reconstitute the sample) and 1.1 (because only 90% of the layer was collected).
Therefore, the results from the HPLC output were multiplied by 1.1 and divided by 2 to
obtain the concentration in ng/ml ofplasma.
Similarly, two correction factors were use in the one-step acetonitrile extraction,
the first had to do with the plasma-acetonitrile ratio (1 :4); and the second, with the
volume of the sediment that was fonned after centrifugation and which was calculated to
be 10%. Thus, the results were multiplied by 5 and then by 0.9 to obtain the final
concentration in ng/ml ofplasma.
Equipment:
HPLC Waters (Waters™. Waters Limited. Mississauga, ON Canada):
i. Water 715. Ultra Wisp. Sample Processor.
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Figure C.3. Typical standard curve for estimation of25(OH)D3 using a HPLC assay.
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11. Water 600. Controller.
iii. Waters 996. Photodiode Array Detector.
IV. Software: Millennium (Waters™. Waters Limited. Mississauga,
ON. Canada).
Column:
i. Type: silica-based reverse-phase.
ii. Phenomenex: Luna (Torrance, CA. USA)
111. C18 3J.! 150 x 4.60 mm.
Assay conditions:
1. Mobile phase: Acetonitrile
11. Flow rate: 1.2 mVmin.
111. Injection: 150 J.!L
iv. Running time: 10 min.
Centrifuge: Beckman G6.
Vortex: Genie 2™. Fisherbrand®
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Experiments 3 (Chapters V) and 4 (Chapter VI)
Vitamin D3and its metabolite 25(OH)D3 were analyzed using a high-performance
liquid chromatography (HPLC) assay.
Assay Procedure:
1) Analyte Extraction:
a. 1 ml of acetonitrile was placed in a glass test tube (10 x 70 rom).
b. 0.5 ml ofplasma was added in a drop-wise fashion.
c. The solution was thoroughly vortexed for about 60 sec.
d. This mix was centrifuged at 3000 rpm for 15 min.
e. The supernatant was filtered through 0.45 J.lm filter attached to a glass
syringe and transferred to 1.7 ml amber vials.
f. Samples were ready for injection onto the HPLC.
2) Injection Characteristics:
a. Amount injected: 100 J.lL.
b. Running time: 15 min.
c. Mobile phase: Acetonitrile (isocratic).
d. Flow rate: 2 ml/min..
e. Column: Prodigy ODS3 100A 5J.l250 x 4.60 rom (Phenomenex).
f. Wavelength: 266 run.
3) Equipment:
a. HPLC Agilent. 1100 Series (Agilent Technologies, Waldbronn,
Germany):
i. Vacuum Degasser.
ii. Autosampler.
iii. Quaternary Pump.
IV. Thermostatted Column Compartment.
v. Diode Array Detector and Multiple Wavelength Detectors.
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VI. Software: ChemStation (Hewllet-Packard. Agilent Technologies,
Waldbronn, Germany)
b. Centrifuge: Centrifuge: Beckman J6-MC.
c. Vortex: Genie 2™. Fisherbrand®.
4) Calibration Curves:
a. Calibration curves were created by using standards ofboth analytes,
vitamin D3and 25(OH)D3, diluted in acetonitrile at the concentrations of
3.125, 6.25, 12.5, 25.0, 50.0 and 100 ng/ITll.
b. Correlations coefficients for both analytes were: R = 0.999 or higher
(Figures C.4 and C.5).
c. The calibration curves were automatically calculated and integrated by the
computer software ChemStation (Hewlett-Packard. Agilent Technologies,
Waldbronn, Germany).
5) Results:
a. Identification of the peaks of interest was in relation to the standards of
both compounds, vitamin D3 and 25(OH)D3. Figure C.6 illustrates a
typical chromatograph from the HPLC analysis (identification and
quantification) ofvitamin D3 and 25(OH)D3 from plasma.
b. Quantification was based on peak area according to the calibration curves.
c. Two correction factors were applied to the sample's peak area to convert
the absorbance units to concentration in ng/ITll. The first was the dilution
factor of 3, which corresponded to the extraction procedure (2 parts of
acetonitrile and 1 part ofplasma). The second had to do with the
quantification of the total volume of the sample after centrifugation, in
which the solid phase constituted approximately 10 % of the total volume.
For this reason, a factor of 1.1 was applied to convert concentration in
ng/ml of solution injected to ng/ml ofplasma.
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Figure C.4. Typical standard curve for estimation ofvitamin D3 using a HPLC assay.
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Figure C.6 Determination and separation ofvitamin D3 and 25(OH)D3 from plasma. A
typical chromatograph from the reverse-phase HPLC analysis.
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Method Validation:
Plasma samples (1 ml) were extracted with 2, 3 or 4 ml of acetonitrile, which
were equivalent to extraction ratios of 1:2, 1:3 and 1:4, respectively. The peak areas from
these levels of extraction were highly correlated: R = 0.9318 for vitamin D3 and
R = 0.9673 for 25(OH)D3. This indicates that any of the ratios of extraction involved
could be used to process plasma samples in order to extract vitamin D3or 25(OH)D3 with
good acc~acy. We chose the 1:2 ratio because a lower dilution represented more
concentration of the analyte(s) and thus better probability of identification during the
HPLC analysis. This was a concern principally from untreated steers. However, plasma
samples were stored in a 1.7 ml centrifuge clear vials, which were filled to approximately
1.5 ml. Thus, in order to carry out the analysis in duplicate, it was necessary to reduce
the aliquot to 0.5 ml ofplasma and 1 ml of acetonitrile. The correlation coefficients for
0.5 ml ofplasma and acetonitrile in a 1:2 ratio were: R = 0.8953 for vitamin D3and R =
0.9781 for 25(OH)D3. In experiment 3 (Chapter V) 234 plasma samples were analyzed
in duplicate, with a coefficient ofvariation of 17.0 for vitamin D3 and 4.9 for 25(OH)D3.
In experiment 4 (Chapter VI) there were 200 plasma samples analyzed in duplicate with a
coefficient of variation of 1604 for vitamin D3 and 1104 for 25(OH)D3. Even though,
these coefficients of variation (CV) for these two analytes seem to be high, the actual
amounts corresponded very well. For example, vitamin D3 concentrations of24.83 and
31.02 ng/ml for duplicates gave a CV of 15.7; and 25(OH)D3concentrations of 17Al and
20.39 ng/ml for duplicates gave a CV of 11.2. Values that were considered acceptable
under the objective of this research project, which was to identify the general trends in
vitamin D3 and 25(OH)D3 concentrations in plasma as a result ofvitamin D3
supplementation.
Another test consisted in the evaluation of the recovery rate: to 4 ml of
acetonitrile, 2 ml ofplasma were added in a drop wise fashion, the solution was then
thoroughly mixed (vortexed for approximately 30 sec), then centrifuge at 3000 rpm for
10 min, the supernatant collected and filtered through 0.45 Jlm filter attached to a glass
syringe. Two ml of this solution was set apart and called native, another 2 ml were set in
a different test tube and was spiked with 20 ng ofboth vitamin D3 and 25(OH)D3 and
called spiked solution. One ml ofnative and spiked solution were directly injected into
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the HPLC and the other ml ofboth solutions was used for chloroform extraction (method
previ.ously described that was used for vitamin D extraction from untreated animals).
The difference between the chloroform extraction and original solution was designated as
the recover rate, which was for both metabolites (vitamin D3 and 25(OH)D3) around 90 to
100 %. Concluding that this procedure was suitable for vitamin D3 and 25(OH)D3
extraction from bovine plasma at physiological levels.
The HPLC apparatus was tested using ten injections of the same standard under
the same conditions of the analyses described above. A standard containing both vitamin
D3 and 25(0H)D3, at the concentration of 3.125 ng/ml was injected ten consecutive
times. The resultant coefficient ofvariation for vitamin D3 was 12.9 and for 25(OH)D3
was 6.45. Thereafter, a standard containing a 100 ng/ml ofboth analytes was injected ten
times. The coefficient of variation for vitamin D3 was 4.9 and for 25(OH)D3 was 2.17.
Plasma from an untreated steer was processed under the same conditions of the standards
and the analysis of the experimental samples and injected ten consecutive times. The
coefficient ofvariation for vitamin D3was 12.2 and for 25(OH)D3was 5.23.
Furthermore, plasma from five different steers (external to the experimental ones) was
assayed in quadruplicate. The mean values for vitamin D3 and 25(OH)D3 concentrations
were 12.4 ± 2.6 and 13.6 ± 1.5, with coefficient ofvariations of 11.6 and 4.3,
respectively. This condition confirmed the good reproducibility of the analytical
procedure.
Additionally, it was identified that after 60 to 80 injections, the column started to
lose sensitivity, as the chromatographs showed no clear definition of the peaks
(shoulders, wrong integration, etc.), and/or additional peaks, and/or the baseline started to
lose its parallelism. These alterations could be due to accumulation ofproteins in the
column. For this reason, the system had to be washed in a cycle ofmethanol-double
distilled water-acetonitrile for approximately 2 h every 60 to 80 injections or in some
cases earlier, according to the characteristics of the chromatographs.
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APPENDIXD
Determination of 1,25-Dihydroxyvitamin D3 [1,25(OH)2D31
Experiments 3 (Chapter V) and 4 (Chapter VI)
Serum concentrations of 1,25(OH)2D3 were determined by the 1,25-
Dihydroxyvitamin D 1251RIA Kit Catalog No. 65100E (DiaSorin Inc. Stillwater, MN.
USA). The DiaSorin 1,25(OHhD assay consists ofa two-step procedure. The assay
involves a preliminary extraction and subsequent purification of the vitamin D
metabolites from serum using ClsOH "Extra Clean" cartridges. Following extraction, the
treated sample is then assayed using a competitive RIA procedure. The RIA method is
based on a polyclonal antibody that is specific for both 1,25(OH)2D2 and 1,25(OH)2D3.
The sample, antibody and tracer are incubated for 2 hours at 20-25°C. Phase separation
is accomplished after a 20 min incubation at 20-25°C with a second antibody
precipitating complex. After centrifugation and decantation, the bound fraction
remaining in the pellet is counted in a gamma counter. Values are calculated directly
from a standard curve of known concentrations. The final concentration of the
1,25(OHhD in serum is expressed as pglml.
Material and Reagents:
ClsOH "Extra Clean" cartridges.
1,25(OH)2D NSB Buffer.
1,25(OHhD 0 Standard.
1,25(OHhD3 Standards (A-E).
1,25(OH)2D Antiserum.
1251 1,25(OHhD3.
1,25(OH)2D3 Pretreatment Solution.
1,25(OH)2D Controls: Levell (normal), Level 2 (elevated).
Goat Anti-Rabbit (GAR) Precipitating Complex.
95% Ethanol: 95% ethanol and 5% water.
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Assay Procedure: .
Reagents were allowed to equilibrate to room temperature.
Disposable borosilicate tubes, in duplicates, were labeled for each standard (zero,
A-E), control and samples. 7S J.lL of the reconstituted standard, control and
sample extracts were added into the duplicate assay tubes.
7S J.lL from the TC (Total Count) tube were added into duplicate assay tubes.
This step was repeated for the NSB duplicate assay tubes.
300 J.lL ofNSB buffer were added into the NSB tubes.
300 J.lL of the primary antibody were added into all tubes except the TC and NSB
tubes.
All tubes were thoroughly vortexed and then incubated for 2 hours (± IS-min) at
20-2SoC.
All the tubes were centrifuged for 20 min at 20-2SoC at 1800 x g, except the TC
tubes.
The GAR Precipitating Complex was reconstituted and mixed S-1 0 min before
use to ensure homogeneous suspension.
SOO J.lL of the well-mixed GAR Precipitating Complex were added into all tubes
except the TC tubes, which were incubated for 20 min (± S min) at 20-2SoC.
All the tubes were centrifuged for 20 min at 20-2SoC at 1800 x g, except the TC
tubes.
The supernatants were decanted, except the TC tubes, using a foam rack tube
holder by inverting the rack into a waste container. The inverted rack was place
onto absorbent paper for 2-3 min, and the tubes were gently blotted to ensure that
all liquid was removed.
Radioactivity was measured by counting all tubes for 1 min on a gamma counter.
Maximum binding: average counts per minute (CPM) of 0 standard tubes/average
CPM of total count tubes.
Nonspecific binding: average CPM of the NSB tubes/average CPM of total count
tubes.
20S
Perfonnance Data:
Sensitivity: ~ 4.0 pglml. Defined as the lowest quantity differentiated from zero
at 2 standard deviations below the means cpm of the zero standard.
Accuracy: correlation coefficients of 0.86 and 0.96, when compared to the
original and modified DiaSorin Radio-Receptor (RRA) kits, respectively.
Specificity: assay highly specific to 1,25(OHhD2 and 1,25(OH)2D3 with cross-
reactivity around 100%.
Intraassay coefficient of variation of 2.0 %.
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APPENDIXE
Determination of Acid-Base Balance Status
The acid-base balance status of the finishing steers was determined by analysis of
whole blood samples using the Blood Gases Analysis (Radiometer 288 System,
Copenhagen, Denmark):
5.1 pH Electrode System:
The acid-base characteristics of the blood is described by pH, which refers to
hydrogen ion activity, that is, the product ofhydrogen ion activity coefficient and the
hydrogen ion concentration, which in turns determines the acidity ofblood. For
definition, the pH value increases with decreasing [H+] and vice versa. The pH
measurement system consists of a measuring electrode, capable of detecting hydrogen
ions, as well as a reference electrode. The pH electrode is a glass electrode, which
develops a potential difference when the pH of the sample differs from the pH of the
electrode fill solution.
5.2 Partial pressure of Carbon Dioxide (PC02) Electrode System:
Carbon dioxide (C02) is a natural product of cellular metabolism. Disturbance in
the partial pressure of C02 in the blood indicate disorders in acid-base balance. The
pC02 measurement system consists of a glass pH electrode separated from a sample by a
membrane permeable to gaseous C02. The internal Ag/AgCI reference electrode
provides a stable reference potential. A bicarbonate fill solution is utilized in the pC02
electrode. As CO2 from the sample diffuses through the membrane and reaches
equilibrium, the pH ofthe bicarbonate fill solution changes, and is detected by the glass
pH electrode. The change in pH is related to the log of the partial pressure ofC02.
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5.3 Total Carbon Dioxide (tC02):
Total carbon dioxide (tC02), in combination with pH and PC02, is useful in
distinguishing between metabolic and respiratory acid-base disorders. The following
equation is used:
tC02 = (0.031 pC02) + [HC03-]
5.4 Partial pressure of oxygen (P02) Electrode System:
The extent of oxygen (02) exchange in the lungs and the ability of the blood to
adequately perfuse the body tissues with 02 may be assessed in part by determining the
partial pressure of02 (P02) in whole blood. The p02 measurement system is based upon
a 02 electrode. This electrodes is amperometric, measuring the current produced by an
electrolytic process which taker place due to the presence of 02. The p02 electrode
consists of a Pt (platinum) cathode, an Ag (silver) anode, an electrolyte fill solution and
an 02 permeable membrane. A constant voltage, called the polarizing voltage, is
maintained between the anode and the cathode. When dissolved 02 from the sample
diffuses across the membrane into the fill solution, it is reduced at the cathode due to the
applied voltage. The circuit is completed at the anode, when the Ag is oxidized. The
magnitude of the resulting current is proportional to the p02 in the sample.
5.5 Bicarbonate (HC03):
Most of the C02 in the blood is present in the form ofbicarbonate ions (HC03-).
The rate ofHC03- ions to pC02 in the blood depends upon the acid-base balance, and in
conjunction with other data, is useful in assessing the extent to which metabolic renal
control contribute to the acid-base disturbance that exists. The relationship ofpC02 to
HC03- is described by the equation:
CO2 + H20 ~ H2C03 ~ H+ + HC03-
5.6 Base Excess (BE):
The term BE refers to the expression which approximates the amount of acid or
base which would be needed to titrate 1 L ofblood back to a pH of7.4. The BE in blood
with a 7.4, pC02 of40 mm Hg, tHb of 15 gldL and a temperature of37°C is zero. BE is
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useful in the management ofpatients with acid-base dis,orders as it permits the estimation
of the number of equivalents ofNaHC03 or NH4CI required to correct pH to normal.
5.7 Anion Gap (AG):
The AG is an approximation of the difference between unmeasured cations and
anIons:
209
Table E.l. The effect of anionic salts and vitamin D3 supplementation on partial
pressure of carbon dioxide (pC02) in blood of finishing Hereford steers (448 ± 26 kg).
pC02 (mm/Hg)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 44.24 45.34 41.38 45.10 1.02
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 44.14 43.72 42.96 42.84 0.95
L14 43.56 42.70 43.22 44.12 1.10
A
Contrast Z
B C D
Supplemental Period (high Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 43.82 43.42 43.68 45.50 0.99 0.7223 0.7431 0.8546 0.2107
S3 42.40 40.50 42.02 42.68 0.73 0.3869 0.4386 0.1586 0.5299
- 3000 mEq/d:
S5 42.20 42.50 41.38 42.96 1.32 0.3006 0.9588 0.5574 0.4104
S7 40.50 40.88 41.78 42.22 1.37 0.1552 0.4868 0.6487 0.8233
S9 40.44 38.10 41.64 40.74 1.32 0.0133 0.8566 0.0763 0.6364
Withdrawal Period (high Ca diet ad libitum):
WI 41.80 39.50 41.18 41.90 1.50 0.1700 0.5959 0.4413 0.7394
W5 45.16 44.46 44.90 44.88 1.24 0.1354 0.7768 0.8053 0.9911
Repeated Measures Analysis:
P value
Treatment 0.5905
Time <0.0001
Time x treatment 0.9145
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low Ca period
(No difference (P>0.05) between groups at any day).
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Table E.2. The effect of anionic salts and vitamin D3 supplementation on total carbon
dioxide (tC02) concentration in blood of finishing Hereford steers (448 ±26 kg).
tC02(mmol/L)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 29.48 29.26 26.96 29.76 0.57
Low Ca Diet Period (low Ca diet ad libitum) Y:
A
Contrast Z
B C D
L7 28.10 28.28 28.10
L14 28.08 26.58 27.40
27.92
27.10
0.50
0.78
Supplemental Period (high Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
SI 27.72 27.16 27.26 27.54 0.62 0.9860 0.5846 0.9108 0.7540
S3 26.56 25.56 25.92 26.72 0.78 0.4270 0.5907 0.7479 0.4779
- 3000 mEq/d:
S5 24.18 24.22 23.64 25.96 0.78 0.0167 0.6435 0.6078 0.0525
S7 21.24 21.34 20.64 23.04 0.82 <0.0001 0.6536 0.5549 0.0552
S9 21.00 19.90 20.46 22.22 1.26 <0.0001 0.9246 0.7576 0.3385
Withdrawal Period (high Ca diet ad libitum):
WI 21.98 20.52 20.92 22.18 1.60 0.0002 0.6818 0.8622 0.5862
W5 31.60 30.60 29.38 30.08 1.80 0.0083 0.4584 0.6384 0.7869
Repeated Measures Analysis:
P value
Treatment 0.6815
Time <0.0001
Time x treatment 0.9460
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 MID D3 / D =1.2 vs 2.4 MID D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 2 had lower (P<0.05) concentration on day LI4).
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Table E.3. The effect of anionic salts and vitamin D3 supplementation on partial
pressure of oxygen (p02) in blood of finishing Hereford steers (448 ±26 kg).
p02 (mmlHg)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 38.48 36.30 35.88 35.60 2.90
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 34.36 34.80 34.88 35.06 1.24
L14 32.92 34.08 36.22 33.92 1.18
A
Contrast Z
B C D
Supplemental Period (high Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 43.06 36.86 43.88 41.16 3.31 <0.0001 0.5345 0.1532 0.5694
S3 32.96 35.72 35.14 33.34 0.98 0.3226 0.1368 0.6813 0.2126
- 3000 mEq/d:
S5 37.32 35.36 37.70 36.40 1.75 0.0821 0.6862 0.3595 0.6074
S7 37.24 36.66 36.84 37.74 1.57 0.0910 0.9309 0.9365 0.6912
S9 35.26 36.78 33.88 37.34 1.56 0.6442 0.6860 0.2062 0.1355
Withdrawal Period (high Ca diet ad libitum):
WI 36.50 38.22 36.34 36.38 1.93
W5 35.60 35.84 36.02 38.30 1.36
Repeated Measures Analysis:
0.2159 0.8204 0.4778 0.9885
0.4990 0.4864 0.9267 0.2535
Treatment
Time
Time x treatment
P value
0.9655
<0.0001
0.4659
Z Contrasts: A =Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 4 had lower (P<0.05) concentration on day L14)
212
Table E.4. The effect of anionic salts and vitamin D3 supplementation on blood
bicarbonate (HC03) concentrations of finishing Hereford steers (448 ±26 kg).
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 28.14 27.82 25.70 27.34 0.56
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 26.74 26.96 26.76 26.60 0.49
L14 26.72 25.32 26.04 25.74 0.75
A
Contrast Z
B C D
Supplemental Period (high Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 26.38 25.86 26.30 26.14 0.65 0.9885 0.7126 0.6369 0.8633
S3 25.22 24.30 24.42 25.40 0.77 0.4133 0.5700 0.9132 0.3793
- 3000 mEq/d:
S5 22.86 22.90 22.36 24.62 0.76 0.0147 0.6277 0.6218 0.0514
S7 20.00 20.00 19.32 21.70 0.79 <0.0001 0.7134 0.5501 0.0484
89 09.72 18.70 19.14 20.94 1.22 <0.0001 0.9294 0.8019 0.3121
Withdrawal Period (high Ca diet ad libitum):
WI 20.70 19.30 19.62 20.90 1.56 0.0002 0.6789 0.8866 0.5702
W5 30.20 29.22 27.98 28.72 1.77 0.0078 0.4557 0.6266 0.7710
Repeated Measures Analysis:
P value
Treatment 0.6804
Time <0.0001
Time x treatment 0.9375
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 MID D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 2 had lower (P<0.05) concentration on day L14).
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Table E.5. The effect of anionic salts and vitamin D3 supplenlentation on blood base
excess (BE) concentrations of finishing Hereford steers (448 ±26 kg).
Base Excess (mmollL)
Group
Days 1 2 3 4 SEM A
Contrast Z
B C D
Adaptation Period (nonnal Ca diet ad libitum):
A19 3.76 3.14 1.48 2.58 0.62
Low Ca Diet Period (low Ca diet ad libitum) Y:
L7 2.08 2.46 2.36
L14 2.20 0.60 1.44
2.22
0.80
0.62
0.81
0.9545 0.6401 0.6272 0.5793
0.4518 0.6810 0.8853 0.4186
0.80
0.87
1.00
0.78
Supplemental Period (high Ca diet; D3 treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hd/d)
o 0.6 1.2 2.4
-1500 mEq/d:
SI 1.68 1.08 1.64
S3 0.58 -0.06 -0.24
- 3000 mEq/d:
S5 -2.38 -2.38 -2.80 -0.24 0.79 0.0110 0.5372 0.7110 0.0353
S7 -5.76 -5.74 -6.96 -3.82 0.94 <0.0001 0.8186 0.3730 0.0314
S9 -6.16 -6.88 -7.22 -4.56 1.37 <0.0001 0.9703 0.8631 0.1893
Withdrawal Period (high Ca diet ad libitum):
WI -5.52 -6.52 -6.42 -5.04 1.78 <0.0001 0.7480 0.9689 0.5919
W5 5.82 4.84 3.34 4.16 1.91 0.0130 0.4496 0.5857 0.7650
Repeated Measures Analysis:
Treatment
Time
Time x treatment
P value
0.6862
<0.0001
0.8692
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 2 and 4 had lower (P<0.05) concentration on day L14).
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Table E.6. The effect of anionic salts and vitamin D3 supplementation on anion gap
(AG) concentration in blood of finishing Hereford steers (448 ± 26 kg).
Anion Gap (mmol/L)
Group
Days 1 2 3 4 SEM
Adaptation Period (normal Ca diet ad libitum):
A19 12.46 12.50 13.40 11.84 1.04
Low Ca Diet Period (low Ca diet ad libitum) Y:
A
Contrast Z
B C D
L7
L14
9.60
10.96
9.52 10.06
11.06 9.94
9.18
9.64
9.18
9.64
Supplemental Period (high Ca diet; D3treatments fed at 85% ofad libitum):
Vitamin D3 Level (MIU/hdld)
0 0.6 1.2 2.4
- 1500 mEq/d:
Sl 11.90 12.02 12.18 11.46 1.28 0.1203 0.9929 0.9305 0.6955
S3 14.50 15.58 16.42 1308 1.28 0.0005 0.7264 0.6491 0.0838
- 3000 mEq/d:
S5 16.88 17.48 16.98 15.72 1.00 <0.0001 0.8955 0.7271 0.3840
S7 12.86 14.74 15.38 13.14 0.95 0.0215 0.2361 0.6343 0.0406
S9 11.02 12.50 12.52 9.72 0.86 0.3990 0.5807 0.9871 0.0351
Withdrawal Period (high Ca diet ad libitum):
WI 12.24 14.02 14.84 12.30 1.01 0.0685 0.2209 0.5725 0.0932
W5 10.28 11.68 11.94 10.84 1.10 0.8139 0.3550 0.8690 0.4885
Repeated Measures Analysis:
P value
Treatment 0.3705
Time <0.0001
Time x treatment 0.4644
Z Contrasts: A = Average low Ca period vs anionic salts (group1) / B = Control vs
vitamin D3 treatments / C = 0.6 vs 1.2 Mill D3 / D =1.2 vs 2.4 Mill D3
Y Comparison: Average adaptation period vs low Ca period
(Only group 1 and 2 had no lower (P>0.05) concentrations on day L14).
215
